data_2mr6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mr6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 70.32 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 64.43 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 73.1 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 74.44 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 74.24 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 71.23 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.462 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 74.34 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 74.42 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.447 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 74.53 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 75.11 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 73.2 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 71.43 111.226 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 74.32 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 75.44 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 74.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.559 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 74.45 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.454 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 73.31 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 72.53 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 73.33 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 75.04 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 72.31 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.43 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.676 HG13 HD12 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 75.24 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 74.33 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.51 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 74.45 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 64.34 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 71.4 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 65.2 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.43 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.633 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 75.1 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 73.42 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 73.42 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.454 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 73.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 73.01 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.676 HD12 HG13 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 75.1 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 71.0 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 60.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 74.12 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 75.51 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 71.24 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 72.04 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 75.21 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 75.32 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 72.24 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 74.22 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 73.3 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.592 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 74.44 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 73.53 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 72.4 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.674 ' HA ' HG13 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 72.3 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 74.42 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 73.35 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 72.53 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 75.53 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 74.24 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 75.4 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.41 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 74.54 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 75.02 111.931 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 75.44 110.18 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 118' ' ' LYS . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 74.4 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 73.14 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 75.0 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 71.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 72.3 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 72.42 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.769 HG21 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 74.02 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.636 HD22 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 HG11 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 74.34 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 61.34 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 74.53 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.685 HG21 HG12 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 73.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 73.03 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 75.12 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 72.44 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 74.42 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 74.12 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 72.24 113.717 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 71.32 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 75.11 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 71.31 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 71.51 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.22 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 74.13 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 72.23 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 75.3 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 72.34 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.615 ' HG3' HD22 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 75.12 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 75.11 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 74.32 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 75.25 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HB ' HD22 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 73.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 52.13 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.613 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 70.2 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 74.55 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 63.35 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.51 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 74.23 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 75.53 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.23 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 72.32 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 75.45 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 63.01 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD22 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 75.03 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 75.32 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG13 ' HB1' ' A' ' 70' ' ' ALA . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 74.21 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 72.21 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 72.23 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.4 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 70.31 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 73.32 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 72.12 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 74.05 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.736 ' HA ' HG13 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 75.43 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 65.41 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.53 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 62.34 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 74.44 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.505 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.477 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 75.13 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 74.02 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 74.05 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.507 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 71.33 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 72.12 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 73.5 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 74.03 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 54.11 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.42 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HE3' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 73.43 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 65.42 111.502 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 75.3 111.167 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.831 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 64.34 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 74.1 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 74.15 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 75.44 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 74.11 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.55 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 75.24 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.585 HD13 HG12 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 74.04 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.35 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 72.52 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 75.23 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 74.55 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 75.51 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 72.43 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 74.43 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 73.44 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 71.31 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 74.25 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 75.2 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 74.14 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 73.32 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 75.14 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 75.21 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 73.32 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 73.53 107.084 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 73.13 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 75.13 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 71.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 73.14 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 74.44 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.44 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 75.21 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 73.53 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 71.42 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 74.35 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.544 ' HB2' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 75.13 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.5 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 74.41 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.34 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 74.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.23 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 74.44 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.677 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 71.1 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 71.03 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 75.53 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 73.02 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 71.01 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.43 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 73.32 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 73.22 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 53.32 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 74.45 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 72.42 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 74.51 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.4 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 74.12 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 74.13 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 73.03 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 62.15 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 71.4 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 73.41 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.453 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 75.35 112.228 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 74.24 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 75.21 109.584 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 73.41 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 75.52 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 74.14 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.469 HD12 HG11 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 60.33 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.21 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 71.23 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 74.12 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 73.25 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 75.1 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 74.43 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 73.14 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 75.02 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 62.44 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 72.42 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.527 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 74.42 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 64.34 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 70.5 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 53.23 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 72.53 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 75.23 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 74.11 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 72.22 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 73.22 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 74.15 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 72.45 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 72.15 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 73.13 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 75.43 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 74.41 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.724 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 74.32 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 62.42 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.724 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 73.44 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 74.3 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 75.51 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 73.44 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 75.43 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.35 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 73.13 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 74.3 109.062 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG13 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 74.21 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 74.01 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 75.15 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.5 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 72.51 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.725 ' HA ' HG12 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 75.24 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 73.44 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 74.52 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 74.21 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 72.43 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.42 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 64.4 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.14 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 74.51 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 74.34 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 75.43 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 74.12 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 75.15 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 72.35 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 74.4 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 63.24 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 62.1 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.171 -0.372 . . . . 61.05 112.171 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 74.34 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.42 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 74.22 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.558 HD22 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 75.44 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 74.32 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 74.41 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 62.42 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.447 HG23 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 74.0 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 75.11 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 73.54 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 75.23 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.525 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 74.23 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 74.22 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.21 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 74.14 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 65.04 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 74.13 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 74.05 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.44 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 74.43 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG11 HD11 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 73.33 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 72.32 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 74.41 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 74.31 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.32 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 74.5 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 75.33 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 65.03 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.558 ' HB ' HD22 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 74.34 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.51 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 62.42 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 74.22 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 72.23 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.23 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 64.44 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.43 112.448 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 62.35 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 75.03 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 72.21 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.47 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 70' ' ' ALA . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 62.44 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 71.15 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 72.42 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 72.13 111.591 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 71.2 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 75.12 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.486 ' HZ3' ' HB3' ' A' ' 90' ' ' GLU . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 71.14 110.507 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.705 ' HA ' HG13 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 74.3 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 71.31 110.449 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 72.03 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 70.14 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 63.21 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 75.13 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 65.33 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 74.41 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.41 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 74.51 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 72.15 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 74.4 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 75.02 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 71.42 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 74.22 108.794 168.635 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 71.42 108.543 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.33 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 75.43 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 73.03 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.53 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.541 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 74.33 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 74.51 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 75.21 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 74.31 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 75.31 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 64.42 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 75.2 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 70.14 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 71.45 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 60.15 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.747 HG23 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 74.14 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 74.43 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HE3' HD13 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 75.05 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 72.41 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 75.21 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 74.14 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.578 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.499 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 74.31 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 73.04 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 72.31 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.653 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.772 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.772 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 75.22 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.726 ' HG2' HG21 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 72.52 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.44 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.571 ' HB2' HG23 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 72.34 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 65.33 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 75.51 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 71.31 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 74.42 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 73.24 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 74.44 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 74.34 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 72.13 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 73.21 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.546 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 65.32 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.653 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 74.3 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 64.03 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.458 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 74.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 74.22 110.082 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 73.23 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 52.53 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 61.42 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 73.22 110.59 172.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 74.25 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 72.34 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.685 ' HA ' HG13 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 75.41 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 74.35 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 74.04 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 74.33 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.32 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 70.13 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.485 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 72.41 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 73.31 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 74.22 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.23 111.246 -170.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 73.31 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 61.24 111.229 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.44 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 71.31 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 75.21 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 75.41 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 74.43 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 75.32 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.478 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 64.35 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 52.43 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 75.4 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 75.41 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 65.4 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 73.11 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 75.4 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.424 HD12 HG12 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 71.13 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 73.01 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 71.14 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 72.11 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 73.14 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 74.42 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 73.52 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 74.23 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 74.43 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 65.24 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.14 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 71.31 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HG2' HD12 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 72.43 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 74.4 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 64.11 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 71.43 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.636 ' HB3' ' HZ1' ' A' ' 46' ' ' LYS . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.42 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 74.24 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HZ1' ' HB3' ' A' ' 42' ' ' GLU . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 75.34 111.352 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 73.22 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 75.24 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.688 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 71.11 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 70.13 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 73.53 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 74.33 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 75.31 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.539 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.5 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 63.2 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 64.12 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 73.3 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 74.32 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB3' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 75.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 72.04 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.581 HD12 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 73.44 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 72.31 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 75.52 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 74.34 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.434 ' HB2' HG11 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 72.32 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 70.22 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 75.4 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 74.12 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 74.14 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 62.14 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 75.43 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 74.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 72.52 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.777 ' HA ' HG12 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 74.43 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 73.34 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 71.42 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 73.33 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 71.34 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 71.02 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 74.25 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 74.54 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 73.04 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 64.51 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 75.03 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 75.13 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.474 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 75.54 111.025 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 75.42 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 74.54 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 65.21 107.446 173.241 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 74.13 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 72.43 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 74.14 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 66' ' ' ALA . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 65.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 55.33 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 71.31 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 73.4 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 71.45 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 54.25 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 73.54 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HA ' HE21 ' A' ' 23' ' ' GLN . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.672 HE21 ' HA ' ' A' ' 20' ' ' LYS . 47.6 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 75.15 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.25 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 74.2 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 71.13 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.434 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.33 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 72.12 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 74.44 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 65.1 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 74.32 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 75.23 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.55 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 74.44 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.65 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 75.24 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 73.24 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.42 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 75.2 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' HD21 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 74.21 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 74.13 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.21 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 73.52 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 64.32 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.642 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.41 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.652 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.41 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 74.31 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 73.23 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 45.3 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 74.14 111.234 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 63.23 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.623 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 74.12 109.138 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 HD11 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 HG22 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 71.1 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 63.44 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 74.44 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 72.03 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 73.23 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.644 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 73.11 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 72.23 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.414 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 75.31 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 64.53 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 74.34 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 64.5 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.773 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 74.12 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 71.43 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 73.31 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 75.02 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 74.12 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 71.3 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 74.13 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 74.03 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 73.03 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.3 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 74.21 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.415 HG22 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.42 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 51.31 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 64.12 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 65.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 72.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 73.42 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 74.42 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 75.15 111.193 172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 73.31 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.33 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 75.24 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 75.13 113.619 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 75.15 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 72.42 113.001 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 72.21 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 74.34 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 74.44 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.23 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 74.44 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 74.13 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.598 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 74.53 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.489 ' HB ' HD21 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 65.24 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 75.5 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 73.24 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 73.41 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 73.43 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 75.23 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 74.43 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 73.35 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 61.14 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 72.32 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 72.4 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.683 ' HB3' HG21 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 75.02 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 74.12 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' A' ' 106' ' ' VAL . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 75.21 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 70.32 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 63.52 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 74.01 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HD11 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.41 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 71.1 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.689 ' HA ' HG12 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 74.11 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 73.43 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HZ1' ' HB3' ' A' ' 100' ' ' LYS . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 71.31 111.996 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 73.13 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 75.43 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 74.13 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 74.5 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 113' ' ' ASP . 2.0 p-10 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 73.01 112.268 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HB2' ' ND2' ' A' ' 111' ' ' ASN . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 72.44 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.433 ' HB2' ' HZ1' ' A' ' 120' ' ' LYS . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 72.14 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 65.21 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 54.11 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 72.43 111.323 -174.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 112.039 -0.424 . . . . 73.05 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.616 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 74.33 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.581 HG23 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 73.04 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD11 HG11 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.21 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 61.32 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 75.53 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.648 HG23 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 72.31 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HB3' HD21 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 73.52 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 73.02 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.52 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 73.02 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 74.02 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 74.24 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.41 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 75.42 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 73.42 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HZ1' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 74.24 111.37 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 75.23 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.57 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 75.53 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 36' ' ' ASP . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 72.31 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 73.21 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 74.42 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 71.45 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 75.52 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' HD21 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 74.33 108.36 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 72.41 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 60.34 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 63.53 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 74.1 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 75.1 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 72.53 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 75.04 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 63.31 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.458 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 74.04 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 73.13 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 71.35 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.476 HG13 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 73.1 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.533 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 72.23 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 73.44 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 74.13 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.648 HG11 HG23 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 72.2 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 75.22 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 73.02 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 72.33 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.44 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 74.13 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 32.21 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.759 ' HA ' HG13 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 75.31 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.42 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 74.42 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 73.41 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.533 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 75.35 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.45 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 75.03 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 71.14 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 71.24 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 74.24 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 73.5 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 72.04 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.685 ' HB3' ' HZ3' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 74.21 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 75.35 111.334 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 74.11 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.435 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 65.53 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.519 0 N-CA-C 109.551 -1.42 . . . . 75.24 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 72.15 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 75.43 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 74.23 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 74.13 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 74.34 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.493 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 74.4 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HG3' HG22 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 75.01 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 75.0 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 74.3 111.529 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 65.42 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 74.25 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 54.41 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.45 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 75.24 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 74.43 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.54 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 73.42 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 75.43 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 62.34 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 73.24 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 73.44 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 71.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.21 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.46 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 74.23 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 53.3 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 72.34 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 73.23 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.518 HD13 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 63.21 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 65.13 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 74.13 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 73.55 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 74.31 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.633 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 71.22 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.506 ' HB2' HG21 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 71.14 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 72.31 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' A' ' 106' ' ' VAL . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 74.34 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 71.1 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 75.43 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 74.13 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 70.22 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.599 ' HA ' HG13 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 72.02 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 74.31 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 74.15 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 73.14 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 74.04 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 71.22 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 74.23 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 72.11 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 75.24 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 74.15 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 72.54 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.514 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 62.52 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 75.33 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 65.13 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.49 ' HB2' ' HZ1' ' A' ' 116' ' ' LYS . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.5 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 63.51 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 64.43 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 75.15 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 73.33 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 74.45 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 64.41 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 74.44 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 74.1 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 74.15 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 73.1 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 75.13 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 75.34 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 72.33 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 75.1 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 75.41 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 73.34 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 72.2 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 73.1 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.439 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.41 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.44 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 73.54 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 74.1 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 75.15 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 75.45 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.571 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 73.42 111.271 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.682 ' HG2' HG23 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 75.34 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.426 HG22 HG13 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.635 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 72.12 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.439 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 64.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 71.12 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 75.25 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 74.43 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 64.55 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 71.11 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 74.41 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 74.2 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 75.55 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 73.42 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.41 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 74.55 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.457 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 74.51 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 HD12 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 74.13 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' HG ' ' HB3' ' A' ' 88' ' ' ASP . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 74.15 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HG ' ' A' ' 86' ' ' SER . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 72.41 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.32 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.56 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 74.03 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 74.34 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.45 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 73.33 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 75.3 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.42 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 74.32 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 74.02 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.55 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 60.32 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 73.34 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 64.32 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 73.12 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 74.2 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.559 ' HA ' HG23 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 71.02 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 74.05 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 74.22 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 74.21 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 74.43 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.405 HG21 HG13 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 73.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HG2' ' HZ3' ' A' ' 20' ' ' LYS . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 71.52 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 75.04 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HZ3' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 73.14 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG23 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 71.35 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 74.4 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 74.22 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.15 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 71.44 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 74.12 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.699 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 74.4 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 72.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 74.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 75.43 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 74.21 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 65.3 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 75.15 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.563 ' HG2' HG23 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 62.21 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 75.54 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 72.23 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 74.1 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 75.14 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 54.01 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.587 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 73.21 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 73.51 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.508 HD11 HG13 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 72.23 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 73.13 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.566 HE21 ' HE1' ' A' ' 104' ' ' TYR . 7.3 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 64.12 110.662 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 74.24 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 75.32 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.461 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.54 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 65.3 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 73.52 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 74.32 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 70.24 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG12 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 74.23 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG2' HG13 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.31 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 74.5 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 75.12 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HE1' HE21 ' A' ' 74' ' ' GLN . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 73.12 108.803 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.461 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 72.22 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.33 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 70.34 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 72.05 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 63.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 72.14 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.5 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 73.13 111.178 173.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 64.35 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.523 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 73.11 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 74.25 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.454 HG21 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 64.31 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 75.12 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.625 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 71.45 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.25 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 63.12 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 71.14 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 75.21 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 74.45 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 75.12 110.784 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 75.02 109.703 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 73.53 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 73.53 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 73.31 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 73.24 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.43 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 75.54 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 74.42 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 71.52 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 72.32 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.15 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 74.32 113.088 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 73.43 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 75.14 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.533 ' HB2' HG22 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 74.52 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 75.25 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 72.43 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 74.52 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 72.23 109.85 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 74.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 53.24 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.33 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 74.3 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 74.32 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 73.22 107.917 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 74.41 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 HD11 HG12 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 75.15 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 72.24 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 72.11 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 74.24 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 71.25 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.4 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 74.23 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 73.41 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.35 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 74.2 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 72.51 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.619 ' HA ' HG12 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 75.34 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 71.32 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 74.04 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 74.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 71.54 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 75.05 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 74.53 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 71.04 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.747 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 74.11 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 75.5 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.44 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 71.25 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 75.23 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 71.51 109.953 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 72.31 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 73.3 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.416 HG22 HG11 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 73.04 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 43.43 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 75.55 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.59 HG23 HG13 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 74.03 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 73.44 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 70.14 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 71.41 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 73.31 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 73.23 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 72.51 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 65.23 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 64.21 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 74.14 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.575 HG21 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 73.43 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 72.41 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 74.34 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 73.55 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 64.04 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 72.31 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 70.34 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.55 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 71.14 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 72.34 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' HG23 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG21 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 75.54 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 75.24 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 72.43 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 75.53 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 73.44 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.567 HG23 HD13 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' HG11 ' A' ' 80' ' ' VAL . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 72.34 111.718 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 72.22 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 72.31 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 75.22 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 73.35 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 72.34 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 70.35 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 HG11 ' HB2' ' A' ' 70' ' ' ALA . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 HG11 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 72.41 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 72.55 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 75.34 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 71.15 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 75.31 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 71.42 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 73.32 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 71.34 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.725 ' HA ' HG13 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 74.31 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 55.41 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 74.32 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 74.2 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 73.23 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 75.41 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 73.32 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.5 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 73.33 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 74.43 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 73.23 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 75.52 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 74.32 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.457 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 72.14 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 73.54 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 73.54 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 75.1 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD21 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 74.53 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 70.11 108.366 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 74.44 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 64.45 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 73.51 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 75.5 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 73.25 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 75.54 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 73.44 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 74.53 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.41 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 71.11 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 71.42 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 73.3 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 71.34 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 72.21 112.889 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.51 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 72.32 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 73.41 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 73.43 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.34 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 75.04 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 73.43 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 74.13 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 75.24 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD21 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 74.53 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 71.53 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 61.43 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 73.51 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.646 HD11 HG13 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 72.44 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.44 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.463 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 75.33 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.549 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 72.23 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 64.53 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 65.51 109.76 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 73.55 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 75.11 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 75.32 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 74.13 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.25 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 74.23 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.653 ' HA ' HG13 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 75.14 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 75.15 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 75.34 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 74.1 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 65.31 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 75.11 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.513 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 72.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 74.15 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' A' ' 17' ' ' GLU . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 71.32 110.738 -177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 64.53 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 74.22 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 74.23 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 73.22 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 71.4 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 128' ' ' SER . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.515 ' HB2' HG23 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 110.601 -1.0 . . . . 74.34 110.601 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 73.55 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.34 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 75.42 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 73.44 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 75.14 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 73.12 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 73.1 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 72.4 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 74.51 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 74.22 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 75.14 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.657 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.448 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 71.52 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 63.51 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 75.53 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 65.44 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 65.11 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 60.25 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' HG22 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 73.01 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.591 HG22 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 72.4 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 73.44 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 75.4 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' HH ' ' A' ' 72' ' ' TYR . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.44 110.813 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 73.22 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 72.44 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.35 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 75.44 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 72.2 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 74.14 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 73.53 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG11 ' HB1' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 72.03 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 63.31 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 72.23 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 74.1 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.513 ' HH ' ' HB2' ' A' ' 45' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 75.11 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 75.12 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 74.22 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 72.21 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.25 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 73.23 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 74.05 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 73.34 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 71.33 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 75.25 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 72.43 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 75.34 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 75.54 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 70.15 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.15 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 75.44 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 74.52 110.756 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 75.14 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 73.25 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 75.44 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.601 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 75.32 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 73.32 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 73.31 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 75.35 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 75.15 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 72.42 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 72.1 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 74.33 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 74.32 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.444 ' HA ' HG22 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 73.04 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 N-CA-C 111.857 -0.497 . . . . 61.54 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 74.45 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 64.32 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 75.25 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 70.32 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 74.32 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 74.15 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.421 HG23 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 71.53 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 73.31 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 73.13 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 75.52 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 72.34 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 74.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 74.11 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 74.43 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 74.31 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 71.13 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 74.3 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 75.33 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 72.03 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 65.41 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 74.11 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 73.23 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 74.11 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 75.32 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 74.5 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 72.5 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 75.13 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 72.21 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 74.04 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 75.43 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HG2' HG11 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 63.33 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 75.33 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 72.11 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 73.41 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 73.21 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 61.41 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 72.1 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 74.24 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.464 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 74.22 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 74.21 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 74.31 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 73.2 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 74.34 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 73.22 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 64.45 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.42 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.24 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 HD12 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 73.34 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 70.22 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 72.12 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 64.2 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 71.45 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 70.44 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.712 ' HA ' HG13 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 62.14 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 74.15 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 74.21 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 74.04 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.45 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 72.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.53 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.45 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 74.31 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 74.33 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 74.21 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 73.14 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 74.1 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 74.13 112.528 170.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 111.635 -0.586 . . . . 73.43 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 75.52 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 73.22 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 73.31 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.544 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 72.41 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.538 HG22 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 75.1 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 74.12 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' O ' HG22 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.3 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 71.41 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 74.15 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 75.43 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 75.51 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 64.4 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 74.34 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 71.53 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 75.4 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.504 HG21 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 74.12 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 72.34 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 52.35 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 73.3 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 74.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 54.12 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.51 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 72.41 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 74.44 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 73.43 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 62.35 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 74.11 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 74.3 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 75.15 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 73.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 65.43 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 71.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 75.03 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 64.41 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 43.21 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.58 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 70.42 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 74.44 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 74.03 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 74.31 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 71.25 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG13 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 73.31 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 72.34 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 72.24 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 73.31 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 64.31 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 74.15 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 70.23 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 72.0 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 72.32 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 72.45 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 75.12 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 74.51 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 72.44 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 71.33 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 75.15 110.963 -177.282 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 61.41 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 63.03 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.595 HG23 HD22 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 72.4 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 74.03 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 75.03 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 75.0 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 72.4 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 72.15 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 74.02 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 74.02 110.954 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 21.4 mm-40 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 74.14 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 71.51 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 75.24 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 73.4 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 72.43 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 74.1 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 75.12 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 73.51 112.316 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 74.34 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 74.34 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 62.33 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.53 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.562 HG11 HD12 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 74.03 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 73.31 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 63.25 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 71.43 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 75.11 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 70.33 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 75.24 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 63.42 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 54.43 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.24 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.562 HD12 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 63.33 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 70.51 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 74.12 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 73.34 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 74.13 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 75.52 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 74.13 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 74.33 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 75.25 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 74.12 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 62.21 112.021 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 63.22 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 75.25 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.71 ' HA ' HG13 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 74.22 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 72.24 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.71 HG13 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 75.32 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 72.23 110.793 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 72.01 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 74.1 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 71.03 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 75.11 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 73.11 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 71.12 109.496 176.745 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.257 -0.275 . . . . 73.22 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.36 148.47 5.84 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 70.32 110.835 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 64.43 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 73.1 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 74.44 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 74.24 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 71.23 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.462 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 74.34 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 74.42 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.447 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 74.53 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 75.11 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 73.2 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 71.43 111.226 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 74.32 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 75.44 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 74.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.559 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 74.45 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.454 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 73.31 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 72.53 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 73.33 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 75.04 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 72.31 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.43 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.676 HG13 HD12 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 75.24 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 74.33 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.51 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 74.45 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 64.34 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 71.4 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 65.2 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.43 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.633 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 75.1 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 73.42 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 73.42 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.454 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 73.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 73.01 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.676 HD12 HG13 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 75.1 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 71.0 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 60.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 74.12 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 75.51 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 71.24 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 72.04 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 75.21 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 75.32 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 72.24 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 74.22 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 73.3 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.592 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 74.44 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 73.53 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 72.4 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.674 ' HA ' HG13 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 72.3 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 74.42 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 73.35 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 72.53 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 75.53 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 74.24 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 75.4 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.41 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 74.54 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 75.02 111.931 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 75.44 110.18 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 118' ' ' LYS . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 74.4 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 73.14 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 75.0 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 71.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 72.3 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 72.42 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -71.67 118.63 14.74 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.98 138.94 48.48 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.054 0.942 . . . . 73.05 109.894 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -160.4 -69.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.573 -0.899 . . . . 71.15 108.573 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -81.93 98.58 8.63 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.289 -1.004 . . . . 71.43 108.289 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.98 121.84 11.56 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 124.249 0.968 . . . . 64.53 108.812 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -71.13 82.09 0.7 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.986 0.804 . . . . 71.13 109.163 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -106.6 160.81 15.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.615 1.166 . . . . 73.23 111.305 -173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -85.59 95.46 9.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.472 -0.786 . . . . 73.44 110.166 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.794 -0.817 . . . . 72.11 108.794 171.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.677 0.251 . . . . 74.0 111.677 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.97 -169.59 42.66 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.769 HG21 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 74.02 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.636 HD22 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 HG12 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 HG11 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 74.34 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 61.34 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 74.53 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.685 HG21 HG12 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 73.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 73.03 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 75.12 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 72.44 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 74.42 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 74.12 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 131' ' ' HIS . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 72.24 113.717 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 71.32 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 75.11 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.613 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 71.31 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 71.51 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.22 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 74.13 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 72.23 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 75.3 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 72.34 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.615 ' HG3' HD22 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 75.12 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 75.11 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 74.32 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 75.25 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HB ' HD22 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 73.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 52.13 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.613 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 70.2 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 74.55 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 63.35 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.51 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 74.23 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 75.53 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.23 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 72.32 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 75.45 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 63.01 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD22 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 75.03 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 75.32 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG13 ' HB1' ' A' ' 70' ' ' ALA . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 74.21 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 72.21 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 72.23 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.4 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 70.31 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 73.32 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 72.12 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 74.05 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.736 ' HA ' HG13 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 75.43 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 65.41 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.53 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 62.34 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 74.44 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.505 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.477 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 75.13 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 74.02 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 74.05 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.507 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 71.33 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 72.12 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 73.5 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 74.03 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 54.11 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.42 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HE3' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 73.43 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 65.42 111.502 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -64.46 102.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 75.3 111.167 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.5 mt -100.17 157.95 16.21 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.717 -0.846 . . . . 72.51 108.717 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 25' ' ' HIS . 42.4 mt-10 -64.39 119.5 10.48 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.674 -0.861 . . . . 74.13 108.674 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.439 ' HE1' ' HD2' ' A' ' 27' ' ' PRO . 46.6 m80 -58.05 -22.26 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.349 1.46 . . . . 72.01 112.865 -171.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -86.93 20.72 2.52 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.75 0.82 . . . . 73.42 110.718 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 58.88 36.35 24.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.384 1.474 . . . . 74.44 112.036 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 62.77 30.81 16.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.247 1.019 . . . . 73.53 112.501 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -83.75 11.85 6.82 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.543 0.337 . . . . 72.2 111.391 170.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 125.126 1.37 . . . . 72.4 110.53 175.801 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.813 -0.44 . . . . 74.3 109.813 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.74 129.12 6.38 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 64.34 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.571 HD22 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 74.1 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 74.15 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 75.44 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 74.11 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.55 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 75.24 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.585 HD13 HG12 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 74.04 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.35 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 72.52 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 75.23 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 74.55 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 75.51 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 72.43 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' O ' HG22 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 74.43 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 73.44 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 71.31 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 74.25 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 75.2 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 74.14 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 73.32 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.45 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 75.14 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 75.21 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 73.32 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 73.53 107.084 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.582 ' HB2' HG23 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 73.13 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 75.13 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 71.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 73.14 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 74.44 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.44 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 75.21 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 73.53 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 71.42 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 74.35 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.544 ' HB2' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 75.13 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.5 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 74.41 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.34 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 74.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.23 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 74.44 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.677 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 71.1 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 71.03 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 75.53 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 73.02 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 71.01 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.43 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 73.32 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 73.22 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 53.32 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 74.45 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.487 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 72.42 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 74.51 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.4 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 74.12 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 74.13 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 73.03 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 62.15 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 71.4 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 73.41 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.453 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 75.35 112.228 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 74.24 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m -67.44 99.49 0.75 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 75.21 109.584 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.061 0.945 . . . . 72.44 110.587 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -99.22 -72.08 0.67 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -89.61 115.44 27.0 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 109.568 -0.53 . . . . 74.34 109.568 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -112.55 89.9 3.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.857 0.863 . . . . 74.35 109.347 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -150.7 94.5 2.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.335 1.054 . . . . 75.41 109.651 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -72.67 114.24 10.59 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.315 -0.994 . . . . 72.35 108.315 169.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -80.35 74.0 7.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.953 0.501 . . . . 74.2 111.301 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.6 t60 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.918 1.287 . . . . 74.42 107.661 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.712 -0.477 . . . . 62.45 109.712 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.34 153.88 8.03 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 -172.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 73.41 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 75.52 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 74.14 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD12 HG11 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 60.33 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.21 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 71.23 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 74.12 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 73.25 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 75.1 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 74.43 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 73.14 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 75.02 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 62.44 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 72.42 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.527 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 74.42 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 64.34 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 70.5 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 53.23 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 72.53 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 75.23 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 74.11 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 72.22 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 73.22 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 74.15 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 72.45 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 72.15 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 73.13 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 75.43 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 74.41 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.724 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 74.32 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.527 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 62.42 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.509 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.724 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 73.44 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 74.3 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 75.51 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 73.44 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 75.43 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 HD12 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.35 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 73.13 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 74.3 109.062 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG13 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 74.21 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 74.01 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 75.15 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.5 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 72.51 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.725 ' HA ' HG12 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 75.24 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 73.44 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 74.52 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 74.21 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 72.43 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.42 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 64.4 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.14 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 74.51 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 74.34 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 75.43 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 74.12 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 75.15 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 72.35 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.598 ' HG2' HD21 ' A' ' 129' ' ' LEU . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 74.4 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.465 ' HA ' HG23 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 63.24 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 62.1 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p -77.18 80.97 3.69 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.598 HD21 ' HG2' ' A' ' 124' ' ' GLU . 32.0 mt -131.89 -67.5 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.455 1.102 . . . . 75.22 108.866 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.15 135.37 14.91 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.69 -1.141 . . . . 64.35 109.029 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -156.63 32.01 0.32 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.298 1.047 . . . . 62.34 108.31 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -81.05 74.29 8.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.648 -1.16 . . . . 72.04 109.078 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -76.74 78.73 3.36 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.103 -0.953 . . . . 75.42 110.023 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -62.51 -35.77 80.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.279 -0.873 . . . . 73.21 110.699 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -148.74 -52.13 0.17 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.806 -1.088 . . . . 75.33 108.297 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 CA--C 1.564 1.519 0 O-C-N 124.637 1.21 . . . . 72.04 109.258 -178.504 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.72 -0.474 . . . . 71.33 109.72 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.09 122.17 28.75 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.354 0.409 . . . . 61.05 112.171 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 74.34 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.42 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 74.22 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.558 HD22 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 75.44 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 74.32 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 74.41 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 62.42 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.447 HG23 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 74.0 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 75.11 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 73.54 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 75.23 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.525 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 74.23 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 74.22 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.21 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 74.14 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 65.04 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 74.13 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 74.05 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.44 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 74.43 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG11 HD11 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 73.33 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 72.32 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 74.41 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 74.31 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.32 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 74.5 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 75.33 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 65.03 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.558 ' HB ' HD22 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 74.34 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.51 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 62.42 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 74.22 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 72.23 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.23 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 64.44 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.43 112.448 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 62.35 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 75.03 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 72.21 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.47 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 70' ' ' ALA . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 62.44 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 71.15 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 72.42 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 72.13 111.591 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 71.2 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 75.12 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.486 ' HZ3' ' HB3' ' A' ' 90' ' ' GLU . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 71.14 110.507 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.705 ' HA ' HG13 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 74.3 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 71.31 110.449 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 72.03 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 70.14 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 63.21 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 75.13 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.533 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 65.33 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 74.41 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.41 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.525 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 74.51 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 72.15 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 74.4 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 75.02 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 71.42 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m -76.8 75.72 3.43 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 74.22 108.794 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.5 mt -99.59 141.08 32.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.667 -1.151 . . . . 75.13 109.891 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.587 ' HG2' ' H ' ' A' ' 132' ' ' HIS . 12.9 tt0 -109.8 148.96 30.53 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.377 -0.601 . . . . 73.5 109.377 170.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -130.4 7.03 4.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.125 0.97 . . . . 74.22 111.313 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.587 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 54.0 t60 -79.2 -60.83 2.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.629 0.371 . . . . 65.14 110.39 -173.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -86.81 66.29 9.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.036 -0.727 . . . . 74.41 109.036 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -74.61 -22.42 58.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.094 -0.957 . . . . 75.12 110.715 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -121.9 -57.69 1.78 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.053 0.941 . . . . 75.34 108.784 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.257 1.459 0 C-N-CA 123.473 0.709 . . . . 73.11 110.303 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.76 40.62 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 71.42 108.543 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.33 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 75.43 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 73.03 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.53 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.541 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 74.33 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 74.51 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' HG22 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 75.21 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 74.31 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 75.31 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 64.42 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 75.2 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 70.14 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 71.45 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 60.15 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.747 HG23 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 74.14 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 74.43 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HE3' HD13 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 75.05 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 72.41 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 75.21 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 74.14 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.578 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 74.31 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 73.04 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 72.31 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.653 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.772 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.772 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 75.22 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' HG2' HG21 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 72.52 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.44 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.571 ' HB2' HG23 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 72.34 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 65.33 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 75.51 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 71.31 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 74.42 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 73.24 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 74.44 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 74.34 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 72.13 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 73.21 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.546 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 65.32 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.653 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 74.3 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 64.03 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.458 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 74.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 74.22 110.082 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 73.23 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 52.53 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 61.42 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 73.22 110.59 172.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 74.25 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 72.34 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.685 ' HA ' HG13 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 75.41 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 74.35 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 74.04 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 74.33 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.32 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.685 HG13 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 70.13 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.485 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 72.41 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 73.31 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 74.22 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.23 111.246 -170.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 73.31 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 61.24 111.229 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.44 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 71.31 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 75.21 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 75.41 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 74.43 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 75.32 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.478 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 64.35 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 52.43 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -66.48 103.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.1 mt -111.5 140.5 46.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.557 0.743 . . . . 71.51 109.871 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.96 123.16 26.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.979 -0.748 . . . . 64.25 108.979 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -97.4 142.63 29.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.921 0.488 . . . . 72.5 111.008 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -146.82 137.37 23.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.465 1.106 . . . . 74.24 108.41 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -140.16 107.34 5.48 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.841 . . . . 62.44 108.731 171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -69.89 134.94 48.98 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.329 -0.989 . . . . 75.33 108.329 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -72.37 -47.08 52.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.609 0.242 . . . . 75.52 110.918 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.531 -0.914 . . . . 73.41 108.531 -178.768 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.678 -0.49 . . . . 64.4 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.77 120.28 0.91 Allowed Glycine 0 C--N 1.352 1.432 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 -172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.688 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 75.4 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 75.41 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 65.4 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 73.11 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 75.4 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD12 HG12 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 71.13 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 73.01 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 71.14 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 72.11 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 73.14 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 74.42 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 73.52 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 74.23 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 74.43 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 65.24 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.14 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 71.31 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.581 ' HG2' HD12 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 72.43 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 74.4 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 64.11 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 71.43 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.636 ' HB3' ' HZ1' ' A' ' 46' ' ' LYS . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.42 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 74.24 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HZ1' ' HB3' ' A' ' 42' ' ' GLU . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 75.34 111.352 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 73.22 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 75.24 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.688 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 71.11 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 70.13 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 73.53 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 74.33 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 75.31 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.539 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.5 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 63.2 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 64.12 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 73.3 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 74.32 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB3' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 75.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 72.04 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.581 HD12 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 73.44 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 72.31 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 75.52 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 74.34 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.434 ' HB2' HG11 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 72.32 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 70.22 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 75.4 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 74.12 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 74.14 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 62.14 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 75.43 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 74.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 72.52 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.777 ' HA ' HG12 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 74.43 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 73.34 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 71.42 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 73.33 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 71.34 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 71.02 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 74.25 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 74.54 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 73.04 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 64.51 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 75.03 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 75.13 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.474 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 75.54 111.025 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 131' ' ' HIS . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 75.42 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 74.54 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -122.67 -68.11 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 65.21 107.446 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.36 138.19 50.41 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.889 -1.051 . . . . 72.4 109.062 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -85.95 112.6 21.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.023 -1.473 . . . . 73.33 107.023 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 22.6 p80 -61.39 -40.58 94.88 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.484 0.49 . . . . 75.04 110.588 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 47.88 82.86 0.04 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.628 1.571 . . . . 74.05 112.638 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.9 m170 62.17 36.55 14.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.345 1.058 . . . . 72.51 111.052 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -66.95 -61.2 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.334 0.654 . . . . 73.31 110.306 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 64.81 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.223 1.409 . . . . 75.21 113.99 170.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.4 m80 . . . . . 0 C--O 1.245 0.852 0 C-N-CA 123.868 0.867 . . . . 72.2 108.868 169.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.437 -0.579 . . . . 72.33 109.437 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.06 167.23 11.04 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 74.13 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 72.43 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 74.14 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 66' ' ' ALA . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 65.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 55.33 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 71.31 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 73.4 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 71.45 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 54.25 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 73.54 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HA ' HE21 ' A' ' 23' ' ' GLN . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.672 HE21 ' HA ' ' A' ' 20' ' ' LYS . 47.6 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 75.15 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.25 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 74.2 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 71.13 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.434 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.33 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 72.12 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 74.44 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 65.1 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 74.32 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 75.23 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.55 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 74.44 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.65 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 75.24 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 73.24 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.42 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 75.2 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' HD21 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 74.21 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 74.13 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.21 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 73.52 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 64.32 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.642 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.41 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.652 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.41 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 74.31 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 73.23 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 45.3 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 74.14 111.234 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 63.23 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.623 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 74.12 109.138 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 HD11 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG12 HG22 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 71.1 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 63.44 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 74.44 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 72.03 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 73.23 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.644 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 73.11 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 72.23 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.414 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 75.31 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 64.53 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 74.34 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 64.5 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.773 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 74.12 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 71.43 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 73.31 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 75.02 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 74.12 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m -74.41 91.84 2.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 66.1 mt -90.18 151.0 21.77 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.052 0.941 . . . . 73.14 110.111 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -56.78 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.0 163.22 26.9 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.666 -1.152 . . . . 64.12 111.45 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -62.58 113.56 3.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.934 -1.03 . . . . 74.11 109.615 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -64.15 -40.65 96.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.196 0.598 . . . . 73.3 109.903 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -144.97 109.38 4.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.152 0.981 . . . . 74.22 108.653 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -113.01 83.09 1.77 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.534 0.734 . . . . 74.42 110.04 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 124.239 1.016 . . . . 70.41 108.534 170.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 111.423 0.157 . . . . 75.31 111.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.15 -159.82 28.76 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 71.3 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 74.13 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 74.03 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 73.03 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.3 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 74.21 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.415 HG22 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.42 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 51.31 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 64.12 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 65.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 72.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 73.42 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 74.42 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 75.15 111.193 172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 73.31 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.33 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 75.24 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 75.13 113.619 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 75.15 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 72.42 113.001 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 72.21 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 74.34 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 74.44 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.23 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 74.44 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 74.13 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.598 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 74.53 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.489 ' HB ' HD21 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 65.24 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 75.5 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 73.24 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 73.41 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 73.43 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 75.23 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 74.43 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 73.35 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 61.14 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 72.32 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 72.4 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.683 ' HB3' HG21 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 75.02 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 74.12 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' HB ' HG21 ' A' ' 106' ' ' VAL . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 75.21 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 70.32 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 63.52 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 74.01 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HD11 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.41 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 71.1 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.689 ' HA ' HG12 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 74.11 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 73.43 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HZ1' ' HB3' ' A' ' 100' ' ' LYS . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 71.31 111.996 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 73.13 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 75.43 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 74.13 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 74.5 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 113' ' ' ASP . 2.0 p-10 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 73.01 112.268 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HB2' ' ND2' ' A' ' 111' ' ' ASN . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 72.44 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' HB2' ' HZ1' ' A' ' 120' ' ' LYS . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 72.14 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 65.21 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 54.11 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -69.97 89.3 0.6 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 72.43 111.323 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.636 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 94.3 mt -74.78 164.33 26.69 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.098 0.559 . . . . 75.22 111.165 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.14 133.77 53.57 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 108.082 -1.081 . . . . 73.31 108.082 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -66.32 92.1 0.18 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.277 1.031 . . . . 73.2 111.08 -171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 82.2 t60 55.46 -91.1 0.03 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.38 1.472 . . . . 74.21 110.453 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -165.28 118.81 1.22 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.738 1.615 . . . . 75.42 107.535 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -79.47 105.64 10.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.928 0.491 . . . . 72.23 110.321 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -78.7 169.08 18.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.974 0.91 . . . . 71.42 110.802 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 124.114 0.966 . . . . 75.51 109.124 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.334 -0.617 . . . . 73.44 109.334 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.27 129.3 20.15 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.608 0.567 . . . . 73.05 112.039 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.616 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 74.33 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.581 HG23 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 73.04 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD11 HG11 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.21 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 61.32 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 75.53 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.648 HG23 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 72.31 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HB3' HD21 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 73.52 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 73.02 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.52 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 73.02 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 74.02 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 74.24 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.41 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 75.42 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 73.42 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HZ1' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 74.24 111.37 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 75.23 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 75.53 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 36' ' ' ASP . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 72.31 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 73.21 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 HG22 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 74.42 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 71.45 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.585 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 75.52 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' HD21 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 74.33 108.36 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 72.41 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 60.34 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 63.53 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 74.1 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 75.1 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 72.53 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 75.04 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 63.31 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB1' HG13 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 74.04 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 73.13 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 71.35 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.476 HG13 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 73.1 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.533 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 72.23 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 73.44 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 74.13 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.648 HG11 HG23 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 72.2 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 75.22 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 73.02 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 72.33 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.44 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 74.13 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 32.21 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.759 ' HA ' HG13 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 75.31 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.42 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 74.42 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 73.41 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.533 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 75.35 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.45 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 75.03 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 71.14 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 71.24 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 74.24 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 73.5 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 72.04 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.685 ' HB3' ' HZ3' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 74.21 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 75.35 111.334 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 74.11 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.435 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 65.53 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m -117.16 -73.09 0.66 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.43 -179.16 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 74.33 109.985 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.78 132.65 37.96 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.843 -0.799 . . . . 74.42 108.843 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 19.7 t-80 -76.17 92.91 3.29 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.082 -0.711 . . . . 75.01 109.082 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -79.61 175.37 10.67 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.472 -1.24 . . . . 75.11 110.268 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -96.04 138.71 33.27 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.385 0.674 . . . . 74.23 109.974 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -89.09 94.09 9.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.086 -0.961 . . . . 75.23 108.499 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -140.25 121.67 15.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.232 -0.895 . . . . 74.44 109.928 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 23.8 p80 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.995 0.918 . . . . 72.35 109.221 173.11 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.753 -0.462 . . . . 73.13 109.753 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.16 152.56 52.77 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 109.551 -1.42 . . . . 75.24 109.551 164.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 72.15 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 75.43 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 74.23 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 74.13 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 74.34 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.493 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 74.4 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HG3' HG22 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 75.01 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 75.0 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 74.3 111.529 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 65.42 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 74.25 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 54.41 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.45 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 75.24 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 74.43 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.54 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 73.42 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 75.43 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 62.34 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 73.24 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 73.44 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 71.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.21 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.46 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 74.23 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 53.3 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 72.34 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 73.23 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.518 HD13 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 63.21 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 65.13 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 74.13 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 73.55 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 74.31 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.633 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 71.22 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.506 ' HB2' HG21 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 71.14 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 72.31 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' A' ' 106' ' ' VAL . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 74.34 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 71.1 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 75.43 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 74.13 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 70.22 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.599 ' HA ' HG13 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 72.02 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 74.31 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 74.15 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 73.14 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 74.04 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 71.22 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 74.23 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 72.11 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 75.24 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 74.15 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 72.54 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.514 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 62.52 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 75.33 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 65.13 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.49 ' HB2' ' HZ1' ' A' ' 116' ' ' LYS . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.5 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 63.51 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m -81.08 -57.4 3.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 7.7 mp 65.98 167.81 0.21 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.957 1.303 . . . . 75.24 112.692 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.64 168.55 9.26 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.931 0.892 . . . . 72.31 108.959 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.41 86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.632 0.729 . . . . 73.35 109.633 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -116.0 -54.21 2.51 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.976 -1.12 . . . . 65.11 107.976 171.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 m80 61.75 25.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.618 -1.173 . . . . 75.11 111.711 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -130.89 166.72 20.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.752 1.221 . . . . 71.14 108.251 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -77.63 82.67 4.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.379 -0.601 . . . . 63.34 109.379 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.213 -0.662 . . . . 74.11 109.213 177.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.42 0.629 . . . . 73.24 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.15 38.74 Favored Glycine 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 64.43 109.506 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 75.15 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 73.33 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 74.45 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 64.41 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 74.44 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 74.1 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 74.15 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 73.1 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 75.13 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 75.34 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 72.33 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 75.1 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 75.41 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 73.34 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 72.2 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 73.1 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.439 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.41 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.44 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 73.54 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 74.1 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 75.15 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 75.45 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.571 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 73.42 111.271 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.682 ' HG2' HG23 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 75.34 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.426 HG22 HG13 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.635 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 72.12 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 64.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 71.12 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 75.25 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 74.43 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 64.55 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 71.11 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 74.41 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 74.2 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 75.55 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 73.42 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.41 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 74.55 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 74.51 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 HD12 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 74.13 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' HG ' ' HB3' ' A' ' 88' ' ' ASP . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 74.15 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HG ' ' A' ' 86' ' ' SER . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 72.41 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.32 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.56 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 74.03 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 74.34 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.45 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 73.33 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 75.3 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.42 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 74.32 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 74.02 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.55 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 60.32 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 73.34 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 64.32 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 73.12 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 74.2 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.559 ' HA ' HG23 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m -72.0 85.54 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.75 -65.01 0.99 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.453 0.701 . . . . 71.53 109.446 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 63.68 12.13 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.401 1.481 . . . . 72.22 112.299 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -145.0 167.02 23.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.779 1.632 . . . . 74.35 107.982 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -76.33 113.65 14.15 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.485 -0.931 . . . . 71.33 108.485 167.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -71.02 -59.51 2.74 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.637 0.775 . . . . 70.32 109.453 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -150.83 -70.35 0.18 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 107.134 -1.432 . . . . 74.32 107.134 170.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -125.31 98.86 5.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.701 -1.963 . . . . 72.23 105.701 171.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.992 1.317 . . . . 71.34 109.23 -162.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.065 0.46 . . . . 73.35 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.66 29.44 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 71.02 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 74.05 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 74.22 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 74.21 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 74.43 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.405 HG21 HG13 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 73.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HG2' ' HZ3' ' A' ' 20' ' ' LYS . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 71.52 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 75.04 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HZ3' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 73.14 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG23 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 71.35 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 74.4 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 74.22 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.15 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 71.44 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 74.12 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.699 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 74.4 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 72.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.729 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 74.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 75.43 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 74.21 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 65.3 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 75.15 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.563 ' HG2' HG23 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 62.21 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 75.54 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 72.23 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 74.1 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 75.14 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 54.01 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.587 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 73.21 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 73.51 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.508 HD11 HG13 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 72.23 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 73.13 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.566 HE21 ' HE1' ' A' ' 104' ' ' TYR . 7.3 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 64.12 110.662 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 74.24 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 75.32 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.461 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.54 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 65.3 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 73.52 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 74.32 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 70.24 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG12 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 74.23 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG2' HG13 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.31 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 74.5 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 75.12 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HE1' HE21 ' A' ' 74' ' ' GLN . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 73.12 108.803 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.461 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 72.22 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.33 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 70.34 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 72.05 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 63.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 72.14 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 129' ' ' LEU . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.5 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 73.13 111.178 173.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 64.35 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p -74.41 -37.69 63.28 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 124' ' ' GLU . 18.9 mt -112.28 -178.08 3.32 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.171 0.589 . . . . 73.34 110.31 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.19 167.49 21.76 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.91 0.884 . . . . 72.34 110.639 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.22 104.39 16.4 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.787 -0.82 . . . . 75.1 108.787 174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -66.5 133.15 49.79 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.891 0.876 . . . . 74.22 110.803 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -95.35 141.67 28.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.763 0.825 . . . . 72.32 109.423 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 m80 64.64 -175.9 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.152 0.981 . . . . 61.14 111.889 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 69.26 -178.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.735 1.214 . . . . 74.44 111.064 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 CA--C 1.556 1.202 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 174.494 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' H2 ' HD22 ' A' ' 78' ' ' LEU . 21.3 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.128 0.49 . . . . 70.03 109.765 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.77 31.74 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 73.11 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 74.25 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.454 HG21 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 64.31 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 75.12 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.625 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 71.45 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.25 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 63.12 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 71.14 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 75.21 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.747 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 74.45 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 75.12 110.784 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 75.02 109.703 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 73.53 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 73.53 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 73.31 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 73.24 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.43 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 75.54 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 74.42 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 71.52 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 72.32 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.15 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 74.32 113.088 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 73.43 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 75.14 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.533 ' HB2' HG22 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 74.52 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 75.25 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 72.43 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 74.52 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 72.23 109.85 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 74.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 53.24 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.33 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 74.3 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 74.32 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD22 ' H2 ' ' A' ' 1' ' ' MET . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 73.22 107.917 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 74.41 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 HD11 HG12 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 75.15 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 72.24 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 72.11 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 74.24 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 71.25 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.4 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 74.23 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 73.41 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.35 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 74.2 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 72.51 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.619 ' HA ' HG12 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 75.34 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 71.32 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 74.04 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 74.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 71.54 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 75.05 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 74.53 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 71.04 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.747 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 74.11 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 75.5 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.44 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 71.25 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 75.23 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m -143.09 87.18 1.95 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.5 mt -135.87 105.51 6.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.601 0.76 . . . . 74.42 110.483 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 130.98 55.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.163 -1.792 . . . . 72.44 106.163 167.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -74.23 81.32 1.82 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.916 -0.772 . . . . 72.4 108.916 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -72.87 102.88 3.54 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.162 -0.927 . . . . 74.53 109.01 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -67.26 88.87 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.564 0.745 . . . . 74.13 109.184 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -83.81 106.34 15.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.927 0.491 . . . . 74.41 110.492 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -145.19 65.25 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.531 1.132 . . . . 72.04 108.105 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.855 1.262 . . . . 75.33 111.282 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.328 -0.619 . . . . 74.42 109.328 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.96 168.57 11.29 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 71.51 109.953 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 72.31 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.513 HD13 HG12 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 73.3 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 HG22 HG11 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 73.04 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 43.43 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 75.55 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.59 HG23 HG13 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 74.03 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 73.44 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 70.14 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 71.41 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 73.31 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 73.23 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 72.51 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 65.23 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 64.21 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 74.14 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.575 HG21 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 73.43 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 72.41 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 74.34 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 73.55 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 64.04 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 72.31 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 70.34 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.55 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 71.14 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 72.34 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' HG23 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 HD11 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG21 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 75.54 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 75.24 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 72.43 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 75.53 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 73.44 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.567 HG23 HD13 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' HG11 ' A' ' 80' ' ' VAL . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 72.34 111.718 -178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 72.22 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 72.31 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 75.22 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 73.35 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 72.34 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 70.35 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.544 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 HG11 ' HB2' ' A' ' 70' ' ' ALA . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 HG11 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.513 HG12 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 72.41 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 72.55 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 75.34 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 71.15 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 75.31 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 71.42 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 73.32 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 71.34 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.725 ' HA ' HG13 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 74.31 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 55.41 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 74.32 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 74.2 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 73.23 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 75.41 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 73.32 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.5 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 73.33 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 74.43 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 73.23 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 75.52 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 74.32 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.457 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 72.14 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 73.54 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 73.54 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HG ' ' HA ' ' A' ' 123' ' ' LEU . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m -75.78 104.58 6.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -141.66 115.26 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.787 0.835 . . . . 75.42 109.157 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.43 -67.56 0.85 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.259 -0.645 . . . . 74.35 109.259 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.27 169.62 16.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.833 0.853 . . . . 72.23 110.131 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -140.26 166.02 25.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.767 1.227 . . . . 74.2 108.729 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 52.65 94.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.213 1.005 . . . . 74.44 112.24 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -73.06 -53.23 11.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.64 0.376 . . . . 74.42 111.51 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.17 -41.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.677 0.275 . . . . 72.11 110.904 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 CA--C 1.551 0.991 0 C-N-CA 123.403 0.681 . . . . 71.42 110.124 -176.237 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mmm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.52 -0.548 . . . . 72.22 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.95 162.08 16.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 75.1 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD21 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 74.53 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 70.11 108.366 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 74.44 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 64.45 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 73.51 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 75.5 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 73.25 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 75.54 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 73.44 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 74.53 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.41 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 71.11 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 71.42 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 73.3 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 71.34 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 72.21 112.889 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.602 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.51 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 72.32 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 73.41 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 73.43 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.34 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 75.04 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 73.43 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 74.13 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 75.24 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD21 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 74.53 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 71.53 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 61.43 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 73.51 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.646 HD11 HG13 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 72.44 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.44 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.463 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 75.33 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.549 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 72.23 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 64.53 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 65.51 109.76 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 73.55 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 75.11 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 75.32 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 74.13 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.25 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 74.23 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.653 ' HA ' HG13 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 75.14 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 75.15 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 75.34 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 74.1 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 65.31 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 75.11 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.513 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 72.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 74.15 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' A' ' 17' ' ' GLU . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 71.32 110.738 -177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 64.53 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 74.22 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 74.23 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 73.22 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 71.4 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 126' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 128' ' ' SER . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.515 ' HB2' HG23 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m -96.87 102.6 14.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.05 71.95 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.21 1.404 . . . . 73.11 110.105 -165.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.72 158.8 35.49 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.889 -1.05 . . . . 72.55 111.069 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.7 123.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.129 1.372 . . . . 71.23 110.365 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -52.65 106.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.129 0.972 . . . . 73.54 112.377 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -65.09 127.94 33.72 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.028 1.331 . . . . 75.05 109.587 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -54.7 -47.71 73.37 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.158 0.911 . . . . 73.22 112.356 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.3 t60 66.88 115.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.414 1.086 . . . . 71.23 111.729 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 109.214 -0.662 . . . . 74.43 109.214 173.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 ttm . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 120.873 0.368 . . . . 72.22 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.65 -179.31 30.85 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.601 -1.0 . . . . 74.34 110.601 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 73.55 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.34 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 75.42 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 73.44 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.498 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 75.14 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 73.12 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 73.1 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 72.4 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 74.51 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 74.22 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 75.14 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.657 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.448 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 71.52 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 63.51 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.628 HG21 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 75.53 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 65.44 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 65.11 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 60.25 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' HG22 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 73.01 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.591 HG22 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 72.4 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 73.44 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 75.4 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' HH ' ' A' ' 72' ' ' TYR . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.44 110.813 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 73.22 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 72.44 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.35 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 75.44 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 72.2 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 74.14 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 73.53 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG11 ' HB1' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 72.03 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 63.31 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 72.23 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 74.1 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.513 ' HH ' ' HB2' ' A' ' 45' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 75.11 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 75.12 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 74.22 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 72.21 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.25 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' HB2' HG21 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 73.23 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 74.05 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 73.34 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 71.33 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 75.25 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 72.43 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 75.34 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 75.54 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 70.15 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.15 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 75.44 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 74.52 110.756 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 75.14 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 73.25 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 75.44 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.601 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 75.32 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 73.32 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 73.31 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 75.35 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.553 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 75.15 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 72.42 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 72.1 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 74.33 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 74.32 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.444 ' HA ' HG22 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 73.04 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p -72.28 -38.33 68.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 95.7 mt 66.07 167.5 0.21 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.847 1.259 . . . . 70.44 112.179 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.55 117.14 22.93 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.516 -0.55 . . . . 65.14 109.516 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -79.57 -33.62 41.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.549 0.69 . . . . 74.5 109.663 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -103.7 171.01 7.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.906 1.282 . . . . 64.32 109.361 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -129.86 147.96 51.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.128 -0.693 . . . . 73.35 109.128 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -111.11 116.92 31.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.29 0.636 . . . . 75.04 109.379 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -172.22 124.37 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.432 0.693 . . . . 71.42 109.962 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 124.803 1.241 . . . . 74.32 110.759 177.766 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.925 -0.398 . . . . 74.4 109.925 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.47 133.34 25.66 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.942 -0.572 . . . . 61.54 111.857 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 74.45 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 64.32 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 75.25 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 70.32 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 74.32 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 74.15 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.421 HG23 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 71.53 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 73.31 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 73.13 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 75.52 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 72.34 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 74.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 74.11 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 74.43 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 74.31 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 71.13 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 74.3 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 75.33 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 72.03 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 65.41 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 74.11 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 73.23 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 74.11 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 75.32 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 74.5 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 72.5 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 75.13 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 72.21 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 74.04 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 75.43 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HG2' HG11 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 63.33 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 75.33 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 72.11 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 73.41 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 73.21 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 61.41 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 72.1 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 74.24 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.464 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 74.22 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 74.21 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 74.31 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 73.2 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 74.34 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 73.22 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 64.45 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.42 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.24 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 HD12 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 73.34 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 70.22 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 72.12 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 64.2 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 71.45 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 70.44 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.712 ' HA ' HG13 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 62.14 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 74.15 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 74.21 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 74.04 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.45 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 72.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.53 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.45 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 74.31 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 74.33 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 74.21 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 73.14 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 74.1 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t 55.86 28.45 12.48 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 74.13 112.528 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.13 167.32 13.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.956 0.903 . . . . 75.31 111.297 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -123.62 98.62 5.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.244 1.018 . . . . 74.21 108.266 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -68.18 91.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.575 -0.898 . . . . 74.55 108.575 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -68.07 156.37 37.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.315 0.646 . . . . 63.54 110.911 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.34 -20.99 63.86 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.382 0.673 . . . . 73.4 111.233 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.52 120.64 36.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.065 0.546 . . . . 72.42 111.209 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -127.9 3.92 5.98 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.283 1.033 . . . . 75.31 109.506 168.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 124.951 1.3 . . . . 71.13 108.161 176.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.237 -0.282 . . . . 73.03 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.22 172.12 17.83 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.903 -0.59 . . . . 73.43 111.635 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 75.52 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 73.22 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 73.31 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.544 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 72.41 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.538 HG22 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 75.1 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 74.12 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' O ' HG22 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.3 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 71.41 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 74.15 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 75.43 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 75.51 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' HB3' HG22 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 64.4 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 74.34 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 71.53 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 75.4 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.504 HG21 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 74.12 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 72.34 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 52.35 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 73.3 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 74.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 54.12 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.51 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 72.41 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 74.44 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 73.43 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 62.35 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 74.11 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 74.3 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB3' HG13 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 75.15 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 73.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 65.43 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 71.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 75.03 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 64.41 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 43.21 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.58 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 70.42 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 74.44 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 74.03 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 74.31 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 71.25 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG13 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 73.31 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 72.34 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 72.24 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 73.31 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 64.31 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 74.15 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 70.23 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 72.0 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 72.32 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.476 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 72.45 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 75.12 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 74.51 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 72.44 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 71.33 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' A' ' 129' ' ' LEU . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m -74.69 76.93 2.04 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 75.15 110.963 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 124' ' ' GLU . 96.7 mt -83.42 153.67 24.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.16 0.984 . . . . 71.14 110.808 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -95.64 52.36 1.35 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.118 0.967 . . . . 75.14 108.739 167.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 29.2 t-80 64.18 -161.67 0.28 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.579 1.152 . . . . 72.12 110.171 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.436 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 74.8 m80 -80.29 13.98 2.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 74.44 112.592 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -75.54 78.93 2.55 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 122.025 0.917 . . . . 72.44 109.657 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -149.61 -58.67 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 105.156 -2.164 . . . . 75.33 105.156 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -161.12 106.29 1.36 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.208 -1.36 . . . . 72.01 107.891 167.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.252 1.208 0 N-CA-C 108.581 -0.896 . . . . 73.1 108.581 172.769 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtm . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.737 -0.468 . . . . 74.42 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.62 135.7 8.06 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 61.41 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 63.03 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.595 HG23 HD22 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 72.4 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 74.03 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 75.03 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 75.0 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 72.4 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 72.15 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 74.02 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 74.02 110.954 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 21.4 mm-40 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 74.14 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 71.51 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 75.24 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 73.4 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 72.43 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 74.1 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 75.12 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 73.51 112.316 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 74.34 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 74.34 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 62.33 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.53 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.562 HG11 HD12 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 74.03 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 73.31 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 63.25 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 71.43 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 75.11 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 70.33 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 75.24 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 63.42 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 54.43 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.24 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.562 HD12 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 63.33 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 70.51 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 74.12 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 73.34 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 74.13 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 75.52 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 74.13 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 74.33 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 75.25 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 74.12 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 62.21 112.021 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 63.22 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 75.25 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.71 ' HA ' HG13 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 74.22 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 72.24 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.71 HG13 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 75.32 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 72.23 110.793 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 72.01 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 74.1 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.595 HD22 HG23 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 71.03 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 75.11 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 73.11 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.62 ' HA ' HG22 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m -64.58 -47.35 79.0 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 71.12 109.496 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 26' ' ' ASP . 3.6 mm? -117.35 163.34 16.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.985 -1.007 . . . . 73.13 109.914 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.73 148.17 13.97 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.069 -1.423 . . . . 72.2 107.714 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 55.19 74.34 0.37 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.182 0.926 . . . . 73.13 110.251 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -55.38 -49.11 73.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.029 -0.73 . . . . 71.24 109.029 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 60.0 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.88 1.272 . . . . 74.44 111.741 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -116.03 145.51 42.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.488 0.715 . . . . 73.35 109.913 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -114.91 142.01 47.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.105 0.962 . . . . 73.22 108.813 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 108.898 -0.778 . . . . 72.42 108.898 172.453 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 62.33 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 54.5 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 72.35 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 73.04 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 24.35 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 61.5 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 51.5 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 63.33 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 55.24 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 65.33 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 55.22 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 44.32 111.226 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 72.33 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 64.13 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.405 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 2.3 m-20 -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 51.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 65.03 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.445 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 62.41 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 71.22 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 71.34 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 63.31 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 63.32 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.25 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 72.2 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 64.31 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.42 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 72.32 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 45.11 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 28' ' ' ASN . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 64.34 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.568 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 64.01 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.1 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.626 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 53.42 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 71.41 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 71.13 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 51.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 53.45 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 65.52 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 54.13 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 45.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 62.51 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 71.23 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 34.41 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 54.22 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 52.45 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 63.44 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 14' ' ' ILE . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 73.33 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 63.13 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 62.54 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 60.54 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 63.14 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.702 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 64.43 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 73.15 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 71.13 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 54.22 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 74.34 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 71.54 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 52.23 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.11 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 73.15 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 70.54 111.931 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 64.13 110.18 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 70.13 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 72.04 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 74.12 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 53.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 64.43 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 71.54 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 73.2 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 63.24 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 54.35 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 65.11 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.692 HG21 HG11 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 72.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 63.24 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 71.23 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 64.11 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 65.1 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 73.04 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 63.54 113.717 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 65.04 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 73.3 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 34.52 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 62.44 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.2 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 64.54 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 61.32 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 74.44 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 71.51 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HG3' HD21 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 71.5 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 71.52 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 62.34 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 63.44 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 71.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 41.44 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.629 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.72 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 63.4 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 72.44 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 53.3 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.0 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 64.34 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 74.04 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.22 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 54.34 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 64.42 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 61.24 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.62 HD21 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 71.1 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' HG22 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 74.03 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.507 HD11 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 73.24 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 73.41 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG11 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 31.44 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 71.13 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.13 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 61.12 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 61.14 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 71.15 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 73.11 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.753 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 73.12 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 61.42 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.675 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.43 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 55.24 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 61.15 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.47 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 53.33 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 63.24 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 65.23 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 64.55 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 72.42 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 64.31 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 51.01 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.12 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 72.14 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 64.23 111.502 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 54.24 111.167 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.831 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 63.53 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD23 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 70.41 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.597 HG11 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 53.25 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 73.02 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.65 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 72.21 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.23 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 73.1 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 70.53 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.13 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 71.43 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 71.11 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 64.21 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 72.01 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 70.02 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 71.53 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 71.42 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 65.11 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 71.22 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 62.22 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 71.23 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 44.05 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 73.12 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 70.34 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 62.42 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 62' ' ' ASP . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 63.4 107.084 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 64.23 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 64.32 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 64.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 61.11 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 63.13 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.42 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 71.13 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 72.35 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 50.01 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 70.05 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 63.32 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.03 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 73.24 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.11 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 63.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.22 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 72.32 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.695 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 64.02 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 60.35 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 74.54 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 72.12 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 62.4 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.24 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 64.23 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 61.03 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 51.51 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 73.31 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.547 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 63.25 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.574 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 72.44 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.35 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 73.32 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 72.42 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 54.44 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 54.41 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 54.43 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 62.43 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 72.15 112.228 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 65.51 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 61.2 109.584 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 64.15 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 63.44 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 62.4 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.479 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 54.32 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.2 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 53.41 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 43.31 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 70.41 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 65.45 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 72.32 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 71.25 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 71.42 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 44.31 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 70.1 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 71.31 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 62.45 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 63.21 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 51.12 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 64.13 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 64.21 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 72.12 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 42.32 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 72.44 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 73.22 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 64.31 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 41.34 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 72.52 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 61.44 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 73.34 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 72.43 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 22.13 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.74 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 60.34 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 73.32 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 70.04 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 52.21 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 62.32 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.12 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 71.21 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 64.34 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 72.35 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 73.54 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 65.34 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.75 ' HA ' HG11 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 70.11 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 65.42 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 71.11 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.456 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 70.11 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.32 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 63.34 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.12 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 70.32 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 54.41 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 63.21 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 73.44 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 70.0 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 71.3 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 55.35 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 61.15 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 51.03 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.171 -0.372 . . . . 61.05 112.171 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 53.02 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.32 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 72.11 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.52 HD23 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 73.43 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 64.44 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 62.31 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 54.24 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG21 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 64.23 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 71.0 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 61.33 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 74.22 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 72.13 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 63.1 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.14 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 71.31 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 61.11 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.456 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 72.34 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 70.11 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.31 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 72.12 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 60.11 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 62.51 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.76 HD11 HG23 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 64.12 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 53.12 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.23 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 71.44 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 73.35 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 54.23 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' HD23 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 52.43 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 54.44 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 64.31 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 52.4 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.14 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 63.34 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.1 112.448 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 54.3 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 74.13 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 71.1 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.469 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 61.2 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' HB2' ' A' ' 107' ' ' TYR . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 61.42 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 71.25 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 70.41 111.591 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 70.42 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 72.31 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 64.32 110.507 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' HG11 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 72.45 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' TYR . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 64.15 110.449 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 70.41 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 40.34 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 54.15 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 72.24 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.546 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 64.01 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 72.34 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.13 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 70.23 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 64.35 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 73.51 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.423 HD11 HG11 ' A' ' 55' ' ' VAL . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 74.5 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 61.33 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 61.33 108.794 168.635 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 52.2 108.543 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.12 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 64.41 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 62.15 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.459 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.11 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 72.2 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 61.3 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 65.44 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 71.44 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 73.54 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 63.32 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 72.44 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 65.44 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 41.33 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 45.13 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.42 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 65.23 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 54.14 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 64.32 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 65.22 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 64.51 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 73.54 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 63.5 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 53.42 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.797 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.797 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 72.3 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 53.14 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.766 ' HB ' HG22 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.12 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' HG21 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 71.35 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 51.03 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 64.33 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 70.34 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 71.54 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 71.21 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 73.31 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 72.11 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.605 HD11 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 41.04 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 63.11 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 60.42 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 70.23 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 62.23 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.449 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 64.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 92' ' ' LEU . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 63.23 110.082 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 71.41 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 51.05 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 54.55 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 86' ' ' SER . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 71.12 110.59 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 73.41 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 54.25 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.449 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 63.05 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 65.41 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 62.43 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 70.42 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.24 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 62.52 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 64.14 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 70.25 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 35.15 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.13 111.246 -170.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 65.32 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 60.34 111.229 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.04 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 63.4 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 70.15 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 72.35 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 52.44 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 45.11 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.483 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 62.14 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 44.44 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 72.42 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 71.25 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 55.22 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.552 HD23 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 63.02 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 63.51 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG13 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 45.44 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 55.0 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 51.52 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 63.05 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 70.54 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 53.34 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 54.53 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 72.03 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 60.32 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 54.32 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.04 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 45.2 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 60.14 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 60.54 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 53.32 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 60.2 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.13 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 70.01 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 74.02 111.352 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.524 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 64.44 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 72.23 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 70.13 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 65.21 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 72.2 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 44.31 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.639 HG11 ' HB2' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.45 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 52.51 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 53.41 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 72.4 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 72.23 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 54.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 51.21 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 70.02 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 52.33 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 71.53 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 73.11 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' HG13 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 54.25 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 63.1 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 61.31 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 52.33 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.547 ' HA ' HD12 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 72.45 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 53.43 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 71.14 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 71.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 65.12 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.803 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 73.23 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 71.23 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 50.3 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 71.32 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.47 ' HB ' HD13 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 70.32 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 70.34 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 65.32 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 73.4 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 71.53 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 50.21 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 74.3 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 73.05 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 65.14 111.025 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 74.1 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 21.42 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 63.41 107.446 173.241 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 73.33 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 63.33 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 73.21 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 82' ' ' VAL . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 60.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 51.43 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 64.24 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 72.42 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 65.12 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 52.4 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 71.34 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 72.41 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.04 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 73.43 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 50.03 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.22 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 63.31 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 60.2 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 61.11 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 71.14 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 72.52 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.553 HG11 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.53 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 62.32 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 74.02 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 71.04 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.0 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 73.42 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 64.11 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 53.35 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.12 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 70.11 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 62.23 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.657 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.33 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 42.44 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 HG11 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 64.54 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 44.05 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 73.4 111.234 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 53.12 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.644 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 73.51 109.138 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 64.13 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 61.53 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 63.34 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 42.01 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 72.01 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.654 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 70.41 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 64.33 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 73.01 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 52.24 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 73.05 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 52.32 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 70.32 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 62.32 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 34.01 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 71.23 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 72.22 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 64.32 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 73.44 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 72.32 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 72.42 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.12 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 73.23 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.24 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 50.15 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 61.43 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 62.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 51.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 64.41 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 72.34 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 119' ' ' LEU . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 50.23 111.193 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 64.0 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.25 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 52.1 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 74.54 113.619 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 73.24 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' NZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 70.43 113.001 -170.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 62.5 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 73.53 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 72.32 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.13 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.419 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 62.35 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 73.3 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 71.22 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HB ' HD23 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 60.41 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 53.11 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 72.1 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 63.44 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 60.21 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 31.14 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 64.2 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.404 HD11 ' NZ ' ' A' ' 37' ' ' LYS . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 44.21 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 44.34 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HA ' HH11 ' A' ' 48' ' ' ARG . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 64.33 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 65.45 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 64.45 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 65.53 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 HD13 ' A' ' 8' ' ' LEU . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 71.03 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 45.11 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 60.3 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 71.35 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.13 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 64.23 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HA ' HG11 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 73.42 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 52.13 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 62.52 111.996 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 64.15 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 54.31 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 72.42 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 64.45 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 71.35 112.268 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 70.33 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 21' ' ' GLU . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 65.41 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 63.44 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 52.0 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 45.13 111.323 -174.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 112.039 -0.424 . . . . 72.41 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 73.55 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 63.21 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 HG13 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.13 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 44.2 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 63.32 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 71.01 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HB3' HD22 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 65.3 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 62.15 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.11 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 71.41 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 64.45 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 64.14 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.24 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 73.34 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 65.14 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 73.23 111.37 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 72.02 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 64.23 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 56' ' ' VAL . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 64.32 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 70.53 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 72.34 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 55.15 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 71.14 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 73.44 108.36 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 51.45 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 51.24 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 53.04 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 73.5 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 73.32 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 65.44 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 72.05 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 62.32 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 71.24 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 34.24 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 63.32 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 54.14 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 70.42 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 62.23 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 70.33 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 63.52 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' HD12 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 72.4 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 71.51 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.41 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 71.41 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 21.34 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.78 ' HA ' HG11 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 74.44 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.31 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 72.23 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 70.45 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 71.02 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 71.21 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 54.32 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 62.31 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 73.44 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 71.31 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 65.34 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 50.33 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 63.42 111.334 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 72.31 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 54.01 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.519 0 N-CA-C 109.551 -1.42 . . . . 71.22 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 43.2 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 74.51 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 72.24 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 71.34 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 72.41 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HG3' HG21 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 71.41 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 63.33 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 72.41 111.529 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 64.3 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 63.04 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 51.22 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.41 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 62.32 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 73.11 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 40' ' ' VAL . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.0 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 53.44 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 72.35 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 51.32 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 63.22 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 78' ' ' LEU . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 71.52 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 60.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.03 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 65.33 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 43.2 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 61.3 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 42.05 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 60.23 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 61.31 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 65.44 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 55.32 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 72.53 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 63.55 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB2' HG22 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 64.51 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 53.24 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 8' ' ' LEU . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.442 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 52.0 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 62.53 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 63.05 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 55.5 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 61.24 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.628 ' HA ' HG11 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 71.24 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 73.11 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 64.1 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 71.44 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 65.14 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 64.21 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 73.32 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 51.02 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 74.05 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.487 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 64.5 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 63.21 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 45.45 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 62.34 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 60.43 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.23 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 62.14 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 62.23 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 51.41 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 64.14 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.468 HD13 HG13 ' A' ' 82' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 73.41 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 63.44 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 62.2 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 71.23 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 73.4 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 64.32 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 70.14 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 63.12 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 71.2 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 73.23 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 70.33 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 70.31 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 63.52 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 71.15 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.443 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.22 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.1 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 72.33 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 72.51 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 63.52 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 73.02 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 71.31 111.271 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 73.41 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 43.33 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 42.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 70.42 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 62.23 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 71.21 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 44.25 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 70.22 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 53.13 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 73.34 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 74.31 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 40.32 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 48' ' ' ARG . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.23 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.607 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 64.32 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 65.33 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 54.1 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 73.54 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 64.12 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.31 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 61.14 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 63.5 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.14 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 62.05 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 70.04 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.12 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 70.42 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.455 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 73.3 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.43 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 53.3 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 64.45 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 61.41 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 53.23 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 72.22 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 55.22 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 70.0 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 54.13 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 72.2 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 73.53 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 34.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 62.11 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 60.01 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HZ2' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 71.11 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 61.22 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 71.34 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 73.12 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.02 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 63.2 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 60.44 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 72.01 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 70.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.74 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 70.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 73.55 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 73.3 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 43.41 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 74.14 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HG2' HG22 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 54.53 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 63.33 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 62.21 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 50.24 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 73.52 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 33.22 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 72.13 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 72.55 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD13 HG11 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 64.01 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 61.22 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 63.53 110.662 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 62.23 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 65.11 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.473 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.23 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 61.24 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 65.41 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 70.1 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 65.51 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 64.42 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.14 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 50.22 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 73.43 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 72.11 108.803 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.473 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 63.11 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.14 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 53.03 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 71.22 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 34.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 54.32 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 72.43 111.178 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 52.45 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.523 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 63.44 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 71.44 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 63.33 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 HG23 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 43.02 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 74.33 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 64.4 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.22 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 61.21 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 64.54 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 73.54 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 54.31 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 52.34 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 53' ' ' PRO . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 41.53 109.703 176.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 61.02 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 71.31 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 71.2 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 62.5 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.42 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 55.32 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 63.32 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 65.02 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 61.23 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.01 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' HG22 ' A' ' 29' ' ' VAL . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 63.12 113.088 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 61.25 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 69' ' ' ILE . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 72.32 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB2' HG21 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 62.11 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 70.34 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.587 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 41.33 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 73.21 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 HG11 ' A' ' 56' ' ' VAL . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 65.43 109.85 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 33.35 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.2 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 72.14 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 51.03 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 63.55 107.917 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 72.42 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 71.25 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.484 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 62.44 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 70.41 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 52.14 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.21 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 63.13 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 72.25 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 62.23 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 72.45 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 24.45 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' HA ' HG11 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 74.21 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 64.22 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 73.12 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 64.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 65.41 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 61.51 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 70.04 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 63.34 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 73.13 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 64.43 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.34 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 70.3 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 73.02 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 53.44 109.953 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 61.04 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 64.32 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 65.4 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 34.24 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 70.1 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.586 HG21 HG11 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 54.53 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 70.41 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 64.41 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 65.21 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 70.41 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 63.5 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 54.22 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 54.53 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 61.23 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 71.01 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 71.23 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 70.13 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 72.53 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 61.44 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 63.5 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 54.34 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 62.12 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.31 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 63.04 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 63.31 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 62.03 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 72.33 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 65.15 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 61.02 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 72.45 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 64.31 111.718 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 61.23 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 31.22 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 41.12 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 55.53 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 61.3 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 55.24 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 64.22 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 62.52 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 72.42 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 64.41 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 53.25 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 64.22 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 65.34 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 63.53 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.749 ' HA ' HG11 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 63.2 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 40.32 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 70.02 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 65.21 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 63.1 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 72.1 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 72.04 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 62.34 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 73.44 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.6 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 52.02 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 71.22 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 70.33 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 63.22 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 52.44 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 71.13 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 73.52 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 53.23 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 84' ' ' ILE . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 63.44 108.366 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 35.22 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 52.13 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 52.13 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 63.14 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 53.03 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 63.5 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 72.34 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 53.15 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.14 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 62.02 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 65.34 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 65.5 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 41.31 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 54.44 112.889 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.12 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 71.24 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 65.35 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 51.34 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.11 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 63.44 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 72.23 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 70.41 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 63.22 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 73.45 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HB2' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 61.32 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 53.3 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 60.43 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 52.2 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.4 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 53.11 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 52.22 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 34.02 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 8' ' ' LEU . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 63.43 109.76 -176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 61.04 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 64.53 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 73.44 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 72.23 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.13 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 53.43 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.671 ' HA ' HG11 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 74.12 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 70.31 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 64.13 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 54.12 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 45.54 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 72.4 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 70.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 71.53 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 70.23 110.738 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 62.22 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 64.3 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 72.21 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 62.51 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 64.42 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.542 ' HB2' HG21 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 110.601 -1.0 . . . . 73.32 110.601 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 64.4 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.25 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 54.43 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 55.02 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 64.32 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 72.35 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 65.14 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 51.24 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 72.2 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 74.53 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.455 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 54.34 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 60.21 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.635 HG22 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 72.02 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 45.12 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 64.51 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 52.54 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' HG23 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 72.14 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 55.33 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 72.54 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 71.24 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.14 110.813 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 65.21 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 60.51 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.12 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 64.42 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 50.15 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 62.42 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 72.4 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB2' HG13 ' A' ' 58' ' ' VAL . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 60.33 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 54.55 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 53.33 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 55.31 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 73.55 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 73.3 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 73.14 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 55.3 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.04 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 72.42 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 72.41 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 70.42 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 62.45 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 70.34 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 65.34 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 71.1 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 65.04 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 55.12 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.764 ' HA ' HG11 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.02 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 72.41 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 71.54 110.756 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 70.35 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 64.21 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 73.24 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.605 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 73.14 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 65.25 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 63.44 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 53.03 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 71.52 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 61.22 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 63.05 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 71.44 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 51.52 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 72.14 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 N-CA-C 111.857 -0.497 . . . . 25.24 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 71.53 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 63.33 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 73.11 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 64.13 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 73.44 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 55.35 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 55.12 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 64.25 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 71.32 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 64.14 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 52.23 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 72.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 73.13 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 54.15 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 62.33 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 63.34 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 65.23 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 74.04 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 64.22 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 64.3 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 54.24 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 65.4 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 54.52 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 63.01 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 61.33 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 51.14 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.41 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 73.32 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 64.53 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 73.41 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 71.21 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 53.43 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 70.15 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 52.21 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 64.12 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 62.31 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 42.21 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 71.23 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 61.12 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 70.53 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 63.22 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 63.42 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 64.3 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 71.43 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 65.21 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 50.33 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.35 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 74.04 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 54.0 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 62.35 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 65.01 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 62.01 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 61.34 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 64.53 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.728 ' HA ' HG11 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 54.53 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 65.52 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 51.54 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 52.23 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.31 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 63.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.31 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 72.53 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.577 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 72.21 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 72.42 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 50.34 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 72.24 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 71.21 112.528 170.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 111.635 -0.586 . . . . 61.32 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 51.11 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 HG22 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 72.02 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 62.02 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 70.45 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 74.25 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 55.21 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.23 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 60.3 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 70.13 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 72.12 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 55.42 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 61.24 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 62.23 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 62.33 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 63.31 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 60.11 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 54.55 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 42.43 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 60.02 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 72.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 52.23 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.41 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.76 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 63.34 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 64.35 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 72.12 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 60.24 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 62.21 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 63.11 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 53.52 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 63.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 61.14 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 55.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 45.43 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 63.43 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 33.54 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.508 HG11 ' HB1' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 62.41 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 64.34 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 70.23 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 71.13 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 62.34 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.713 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 70.42 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 71.22 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 54.34 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 72.5 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 62.11 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.713 HG11 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 73.44 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 63.22 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 71.32 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 62.41 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 64.42 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 70.22 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 73.43 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 43.43 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 62.05 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 62.44 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 63.44 110.963 -177.282 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.684 HG22 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 50.43 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 61.23 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 61.14 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.463 HG23 HG12 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 55.51 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 74.34 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 74.5 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 63.31 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 61.54 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 63.51 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 72.35 110.954 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 12.9 mm100 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 72.3 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 61.22 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 62.13 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 64.03 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.435 HG21 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 52.04 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HA ' HG23 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 62.22 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 73.41 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 60.42 112.316 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.551 ' HG3' HD21 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 72.11 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 64.3 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 55.2 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.42 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 29' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 HG11 ' A' ' 29' ' ' VAL . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 73.25 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HG3' HG21 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 71.42 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 61.13 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 54.4 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 63.12 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 63.43 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 71.15 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 61.44 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 33.25 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.12 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HD13 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 61.41 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 32.44 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 64.33 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.684 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 71.1 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 63.42 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' HG22 ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 64.35 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 7' ' ' VAL . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 64.11 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 63.22 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 73.34 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 62.14 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG3' HH21 ' A' ' 110' ' ' ARG . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 55.24 112.021 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 61.52 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 72.13 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.722 ' HA ' HG11 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 71.01 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 50.04 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.553 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 73.32 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 74.24 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 89' ' ' GLU . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 64.51 110.793 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 54.31 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 72.42 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 42.41 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 64.12 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 53.34 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.645 ' HA ' HG21 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 51.12 109.496 176.745 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.257 -0.275 . . . . 54.41 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.36 148.47 5.84 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 62.33 110.835 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 54.5 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 72.35 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 73.04 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 24.35 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 61.5 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 51.5 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 63.33 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 55.24 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 65.33 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 55.22 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 44.32 111.226 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 72.33 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 64.13 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.405 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 2.3 m-20 -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 51.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 65.03 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.445 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 62.41 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 71.22 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 71.34 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 63.31 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 63.32 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.25 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 72.2 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 64.31 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.42 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 72.32 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 45.11 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 28' ' ' ASN . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 64.34 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.568 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 64.01 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.1 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.626 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 53.42 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 71.41 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 71.13 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 51.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 53.45 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 65.52 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 54.13 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 45.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 62.51 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 71.23 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 34.41 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 54.22 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 52.45 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 63.44 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 14' ' ' ILE . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 73.33 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 63.13 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 62.54 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 60.54 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 63.14 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.702 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 64.43 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 73.15 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 71.13 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 54.22 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 74.34 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 71.54 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 52.23 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.11 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 73.15 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 70.54 111.931 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 64.13 110.18 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 70.13 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 72.04 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 74.12 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 53.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 64.43 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 71.54 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -71.67 118.63 14.74 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.98 138.94 48.48 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.054 0.942 . . . . 54.32 109.894 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -160.4 -69.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.573 -0.899 . . . . 71.15 108.573 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -81.93 98.58 8.63 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.289 -1.004 . . . . 71.43 108.289 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.98 121.84 11.56 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 124.249 0.968 . . . . 62.22 108.812 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -71.13 82.09 0.7 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.986 0.804 . . . . 71.13 109.163 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -106.6 160.81 15.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.615 1.166 . . . . 73.23 111.305 -173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -85.59 95.46 9.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.472 -0.786 . . . . 73.44 110.166 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.794 -0.817 . . . . 72.11 108.794 171.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.677 0.251 . . . . 62.03 111.677 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.97 -169.59 42.66 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 73.2 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 63.24 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 54.35 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 65.11 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.692 HG21 HG11 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 72.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 63.24 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 71.23 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 64.11 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 65.1 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 73.04 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 63.54 113.717 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 65.04 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 73.3 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 34.52 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 62.44 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.2 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 64.54 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 61.32 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 74.44 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 71.51 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HG3' HD21 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 71.5 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 71.52 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 62.34 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 63.44 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 71.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 41.44 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.629 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.72 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 63.4 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 72.44 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 53.3 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.0 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 64.34 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 74.04 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.22 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 54.34 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 64.42 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 61.24 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.62 HD21 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 71.1 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' HG22 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 74.03 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.507 HD11 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 73.24 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 73.41 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG11 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 31.44 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 71.13 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.13 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 61.12 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 61.14 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 71.15 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 73.11 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.753 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 73.12 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 61.42 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.675 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.43 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 55.24 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 61.15 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.47 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 53.33 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 63.24 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 65.23 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 64.55 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 72.42 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 64.31 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 51.01 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.12 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 72.14 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 64.23 111.502 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -64.46 102.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 54.24 111.167 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.5 mt -100.17 157.95 16.21 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.717 -0.846 . . . . 63.52 108.717 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 25' ' ' HIS . 42.4 mt-10 -64.39 119.5 10.48 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.674 -0.861 . . . . 74.13 108.674 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -58.05 -22.26 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.349 1.46 . . . . 72.01 112.865 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -86.93 20.72 2.52 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.75 0.82 . . . . 73.42 110.718 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 58.88 36.35 24.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.384 1.474 . . . . 74.44 112.036 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 62.77 30.81 16.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.247 1.019 . . . . 65.43 112.501 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -83.75 11.85 6.82 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.543 0.337 . . . . 54.45 111.391 170.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 125.126 1.37 . . . . 70.43 110.53 175.801 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.813 -0.44 . . . . 74.3 109.813 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.74 129.12 6.38 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 63.53 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD23 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 70.41 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.597 HG11 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 53.25 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 73.02 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.65 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 72.21 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.23 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 73.1 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 70.53 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.13 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 71.43 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 71.11 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 64.21 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 72.01 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 70.02 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 71.53 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 71.42 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 65.11 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 71.22 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 62.22 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 71.23 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 44.05 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 73.12 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 70.34 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 62.42 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 62' ' ' ASP . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 63.4 107.084 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 64.23 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 64.32 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 64.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 61.11 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 63.13 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.42 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 71.13 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 72.35 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 50.01 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 70.05 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 63.32 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.03 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 73.24 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.11 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 63.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.22 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 72.32 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.695 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 64.02 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 60.35 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 74.54 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 72.12 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 62.4 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.24 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 64.23 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 61.03 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 51.51 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 73.31 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 63.25 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.574 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 72.44 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.35 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 73.32 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 72.42 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 54.44 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 54.41 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 54.43 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 62.43 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 72.15 112.228 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 65.51 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m -67.44 99.49 0.75 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 61.2 109.584 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.061 0.945 . . . . 72.0 110.587 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -99.22 -72.08 0.67 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.012 -0.736 . . . . 60.15 109.012 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -89.61 115.44 27.0 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 109.568 -0.53 . . . . 74.34 109.568 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -112.55 89.9 3.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.857 0.863 . . . . 74.35 109.347 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -150.7 94.5 2.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.335 1.054 . . . . 75.41 109.651 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -72.67 114.24 10.59 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.315 -0.994 . . . . 72.35 108.315 169.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -80.35 74.0 7.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.953 0.501 . . . . 73.34 111.301 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.6 t60 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.918 1.287 . . . . 74.33 107.661 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.712 -0.477 . . . . 60.13 109.712 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.34 153.88 8.03 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 -172.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 64.15 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 63.44 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 62.4 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.479 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 54.32 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.2 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 53.41 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 43.31 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 70.41 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 65.45 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 72.32 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 71.25 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 71.42 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 44.31 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 70.1 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 71.31 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 62.45 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 63.21 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 51.12 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 64.13 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 64.21 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 72.12 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 42.32 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 72.44 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 73.22 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 64.31 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 41.34 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 72.52 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 61.44 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 73.34 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 72.43 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 22.13 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.74 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 60.34 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 73.32 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 70.04 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 52.21 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 62.32 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.12 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 71.21 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 64.34 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 72.35 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 73.54 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 65.34 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.75 ' HA ' HG11 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 70.11 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 65.42 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 71.11 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.456 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 70.11 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.32 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 63.34 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.12 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 70.32 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 54.41 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 63.21 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 73.44 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 70.0 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 71.3 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.605 ' HG2' HD21 ' A' ' 129' ' ' LEU . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 55.35 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 61.15 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 51.03 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p -77.18 80.97 3.69 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' ' 124' ' ' GLU . 32.0 mt -131.89 -67.5 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.455 1.102 . . . . 75.22 108.866 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.15 135.37 14.91 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.69 -1.141 . . . . 54.03 109.029 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -156.63 32.01 0.32 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.298 1.047 . . . . 61.04 108.31 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -81.05 74.29 8.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.648 -1.16 . . . . 72.04 109.078 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -76.74 78.73 3.36 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.103 -0.953 . . . . 75.42 110.023 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -62.51 -35.77 80.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.279 -0.873 . . . . 73.21 110.699 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -148.74 -52.13 0.17 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.806 -1.088 . . . . 75.33 108.297 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 CA--C 1.564 1.519 0 O-C-N 124.637 1.21 . . . . 72.04 109.258 -178.504 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.72 -0.474 . . . . 70.43 109.72 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.09 122.17 28.75 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.354 0.409 . . . . 61.05 112.171 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 53.02 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.32 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 72.11 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.52 HD23 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 73.43 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 64.44 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 62.31 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 54.24 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG21 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 64.23 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 71.0 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 61.33 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 74.22 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 72.13 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 63.1 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.14 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 71.31 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 61.11 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.456 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 72.34 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 70.11 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.31 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 72.12 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 60.11 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 62.51 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.76 HD11 HG23 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 64.12 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 53.12 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.23 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 71.44 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 73.35 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 54.23 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' HD23 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 52.43 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 54.44 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 64.31 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 52.4 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.14 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 63.34 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.1 112.448 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 54.3 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 74.13 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 71.1 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.469 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 61.2 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' HB2' ' A' ' 107' ' ' TYR . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 61.42 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 71.25 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 70.41 111.591 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 70.42 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 72.31 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 64.32 110.507 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' HG11 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 72.45 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' TYR . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 64.15 110.449 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 70.41 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 40.34 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 54.15 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 72.24 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.546 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 64.01 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 72.34 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.13 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 70.23 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 64.35 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 73.51 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.423 HD11 HG11 ' A' ' 55' ' ' VAL . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 74.5 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 61.33 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m -76.8 75.72 3.43 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 61.33 108.794 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.5 mt -99.59 141.08 32.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.667 -1.151 . . . . 74.42 109.891 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 132' ' ' HIS . 12.9 tt0 -109.8 148.96 30.53 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.377 -0.601 . . . . 73.5 109.377 170.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -130.4 7.03 4.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.125 0.97 . . . . 74.22 111.313 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.637 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 54.0 t60 -79.2 -60.83 2.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.629 0.371 . . . . 65.14 110.39 -173.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -86.81 66.29 9.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.036 -0.727 . . . . 74.41 109.036 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -74.61 -22.42 58.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.094 -0.957 . . . . 75.12 110.715 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -121.9 -57.69 1.78 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.053 0.941 . . . . 64.45 108.784 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.257 1.459 0 C-N-CA 123.473 0.709 . . . . 70.0 110.303 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.76 40.62 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 52.2 108.543 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.12 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 64.41 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 62.15 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.459 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.11 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 72.2 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 61.3 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 65.44 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 71.44 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 73.54 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 63.32 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 72.44 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 65.44 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 41.33 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 45.13 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.42 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 65.23 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 54.14 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 64.32 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 65.22 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 64.51 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 73.54 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 63.5 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 53.42 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.797 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.797 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 72.3 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 53.14 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.766 ' HB ' HG22 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.12 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' HG21 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 71.35 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 51.03 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 64.33 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 70.34 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 71.54 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 71.21 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 73.31 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 72.11 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.605 HD11 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 41.04 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 63.11 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 60.42 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 70.23 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 62.23 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.449 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 64.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 92' ' ' LEU . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 63.23 110.082 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 71.41 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 51.05 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 54.55 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 86' ' ' SER . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 71.12 110.59 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 73.41 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 54.25 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.449 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 63.05 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 65.41 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 62.43 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 70.42 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.24 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 62.52 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 64.14 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 70.25 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 35.15 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.13 111.246 -170.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 65.32 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 60.34 111.229 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.04 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 63.4 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 70.15 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 72.35 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 52.44 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 45.11 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.483 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 62.14 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 44.44 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -66.48 103.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.1 mt -111.5 140.5 46.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.557 0.743 . . . . 71.51 109.871 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.96 123.16 26.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.979 -0.748 . . . . 55.11 108.979 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -97.4 142.63 29.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.921 0.488 . . . . 72.5 111.008 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -146.82 137.37 23.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.465 1.106 . . . . 74.24 108.41 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -140.16 107.34 5.48 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.841 . . . . 44.51 108.731 171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -69.89 134.94 48.98 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.329 -0.989 . . . . 62.21 108.329 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -72.37 -47.08 52.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.609 0.242 . . . . 75.52 110.918 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.531 -0.914 . . . . 73.41 108.531 -178.768 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.678 -0.49 . . . . 64.4 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.77 120.28 0.91 Allowed Glycine 0 C--N 1.352 1.432 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 -172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 72.42 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 71.25 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 55.22 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.552 HD23 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 63.02 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 63.51 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG13 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 45.44 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 55.0 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 51.52 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 63.05 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 70.54 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 53.34 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 54.53 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 72.03 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 60.32 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 54.32 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.04 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 45.2 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 60.14 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 60.54 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 53.32 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 60.2 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.13 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 70.01 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 74.02 111.352 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.524 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 64.44 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 72.23 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 70.13 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 65.21 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 72.2 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 44.31 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.639 HG11 ' HB2' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.45 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 52.51 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 53.41 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 72.4 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 72.23 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 54.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 51.21 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 70.02 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 52.33 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 71.53 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 73.11 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' HG13 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 54.25 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 63.1 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 61.31 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 52.33 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.547 ' HA ' HD12 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 72.45 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 53.43 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 71.14 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 71.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 65.12 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.803 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 73.23 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 71.23 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 50.3 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 71.32 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.47 ' HB ' HD13 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 70.32 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 70.34 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 65.32 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 73.4 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 71.53 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 50.21 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 74.3 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 73.05 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 65.14 111.025 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 131' ' ' HIS . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 74.1 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 21.42 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -122.67 -68.11 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 63.41 107.446 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.36 138.19 50.41 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.889 -1.051 . . . . 72.4 109.062 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -85.95 112.6 21.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.023 -1.473 . . . . 73.33 107.023 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 22.6 p80 -61.39 -40.58 94.88 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.484 0.49 . . . . 75.04 110.588 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 47.88 82.86 0.04 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.628 1.571 . . . . 73.2 112.638 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.9 m170 62.17 36.55 14.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.345 1.058 . . . . 72.51 111.052 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 131' ' ' HIS . 8.0 t-80 -66.95 -61.2 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.334 0.654 . . . . 64.33 110.306 -174.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 64.81 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.223 1.409 . . . . 75.21 113.99 170.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.4 m80 . . . . . 0 C--O 1.245 0.852 0 C-N-CA 123.868 0.867 . . . . 72.2 108.868 169.863 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.437 -0.579 . . . . 72.33 109.437 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.06 167.23 11.04 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 73.33 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 63.33 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 73.21 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 82' ' ' VAL . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 60.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 51.43 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 64.24 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 72.42 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 65.12 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 52.4 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 71.34 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 72.41 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.04 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 73.43 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 50.03 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.22 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 63.31 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 60.2 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 61.11 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 71.14 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 72.52 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.553 HG11 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.53 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 62.32 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 74.02 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 71.04 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.0 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 73.42 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 64.11 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 53.35 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.12 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 70.11 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 62.23 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.657 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.33 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 42.44 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 HG11 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 64.54 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 44.05 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 73.4 111.234 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 53.12 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.644 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 73.51 109.138 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 64.13 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 61.53 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 63.34 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 42.01 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 72.01 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.654 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 70.41 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 64.33 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 73.01 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 52.24 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 73.05 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 52.32 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 70.32 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 62.32 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 34.01 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 71.23 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 72.22 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m -74.41 91.84 2.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 66.1 mt -90.18 151.0 21.77 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.052 0.941 . . . . 73.14 110.111 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -56.78 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.0 163.22 26.9 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.666 -1.152 . . . . 64.12 111.45 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -62.58 113.56 3.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.934 -1.03 . . . . 74.11 109.615 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -64.15 -40.65 96.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.196 0.598 . . . . 64.31 109.903 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -144.97 109.38 4.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.152 0.981 . . . . 74.22 108.653 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -113.01 83.09 1.77 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.534 0.734 . . . . 74.42 110.04 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 124.239 1.016 . . . . 70.41 108.534 170.801 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 111.423 0.157 . . . . 62.32 111.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.15 -159.82 28.76 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 64.32 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 73.44 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 72.32 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 72.42 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.12 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 73.23 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.24 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 50.15 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 61.43 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 62.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 51.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 64.41 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 72.34 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 119' ' ' LEU . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 50.23 111.193 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 64.0 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.25 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 52.1 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 74.54 113.619 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 73.24 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' NZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 70.43 113.001 -170.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 62.5 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 73.53 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 72.32 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.13 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.419 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 62.35 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 73.3 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 71.22 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HB ' HD23 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 60.41 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 53.11 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 72.1 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 63.44 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 60.21 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 31.14 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 64.2 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.404 HD11 ' NZ ' ' A' ' 37' ' ' LYS . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 44.21 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 44.34 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HA ' HH11 ' A' ' 48' ' ' ARG . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 64.33 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 65.45 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 64.45 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 65.53 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 HD13 ' A' ' 8' ' ' LEU . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 71.03 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 45.11 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 60.3 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 71.35 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.13 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 64.23 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HA ' HG11 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 73.42 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 52.13 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 62.52 111.996 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 64.15 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 54.31 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 72.42 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 64.45 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 71.35 112.268 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 70.33 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 21' ' ' GLU . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 65.41 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 63.44 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 52.0 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -69.97 89.3 0.6 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 45.13 111.323 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.642 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 94.3 mt -74.78 164.33 26.69 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.098 0.559 . . . . 74.33 111.165 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.14 133.77 53.57 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 108.082 -1.081 . . . . 62.44 108.082 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -66.32 92.1 0.18 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.277 1.031 . . . . 73.2 111.08 -171.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 82.2 t60 55.46 -91.1 0.03 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.38 1.472 . . . . 71.34 110.453 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -165.28 118.81 1.22 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.738 1.615 . . . . 65.14 107.535 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -79.47 105.64 10.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.928 0.491 . . . . 71.21 110.321 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -78.7 169.08 18.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.974 0.91 . . . . 62.14 110.802 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 124.114 0.966 . . . . 75.51 109.124 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.334 -0.617 . . . . 73.44 109.334 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.27 129.3 20.15 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.608 0.567 . . . . 72.41 112.039 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 73.55 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 63.21 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 HG13 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.13 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 44.2 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 63.32 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 71.01 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HB3' HD22 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 65.3 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 62.15 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.11 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 71.41 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 64.45 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 64.14 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.24 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 73.34 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 65.14 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 73.23 111.37 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 72.02 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 64.23 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 56' ' ' VAL . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 64.32 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 70.53 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 72.34 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 55.15 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 71.14 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 73.44 108.36 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 51.45 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 51.24 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 53.04 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 73.5 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 73.32 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 65.44 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 72.05 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 62.32 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 71.24 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 34.24 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 63.32 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 54.14 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 70.42 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 62.23 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 70.33 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 63.52 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' HD12 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 72.4 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 71.51 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.41 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 71.41 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 21.34 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.78 ' HA ' HG11 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 74.44 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.31 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 72.23 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 70.45 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 71.02 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 71.21 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 54.32 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 62.31 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 73.44 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 71.31 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 65.34 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 50.33 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 63.42 111.334 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 72.31 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 54.01 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m -117.16 -73.09 0.66 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.43 -179.16 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 65.43 109.985 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.78 132.65 37.96 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.843 -0.799 . . . . 74.42 108.843 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 19.7 t-80 -76.17 92.91 3.29 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.082 -0.711 . . . . 53.0 109.082 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -79.61 175.37 10.67 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.472 -1.24 . . . . 75.11 110.268 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -96.04 138.71 33.27 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.385 0.674 . . . . 71.33 109.974 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -89.09 94.09 9.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.086 -0.961 . . . . 75.23 108.499 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -140.25 121.67 15.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.232 -0.895 . . . . 70.41 109.928 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 23.8 p80 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.995 0.918 . . . . 61.43 109.221 173.11 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.753 -0.462 . . . . 73.13 109.753 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.16 152.56 52.77 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 109.551 -1.42 . . . . 71.22 109.551 164.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 43.2 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 74.51 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 72.24 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 71.34 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 72.41 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HG3' HG21 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 71.41 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 63.33 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 72.41 111.529 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 64.3 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 63.04 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 51.22 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.41 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 62.32 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 73.11 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 40' ' ' VAL . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.0 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 53.44 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 72.35 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 51.32 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 63.22 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 78' ' ' LEU . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 71.52 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 60.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.03 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 65.33 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 43.2 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 61.3 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 42.05 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 60.23 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 61.31 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 65.44 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 55.32 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 72.53 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 63.55 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB2' HG22 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 64.51 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 53.24 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 8' ' ' LEU . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.442 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 52.0 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 62.53 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 63.05 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 55.5 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 61.24 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.628 ' HA ' HG11 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 71.24 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 73.11 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 64.1 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 71.44 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 65.14 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 64.21 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 73.32 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 51.02 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 74.05 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.487 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 64.5 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 63.21 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 45.45 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 62.34 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 60.43 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.23 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 62.14 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m -81.08 -57.4 3.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 7.7 mp 65.98 167.81 0.21 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.957 1.303 . . . . 64.34 112.692 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.64 168.55 9.26 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.931 0.892 . . . . 72.31 108.959 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.41 86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.632 0.729 . . . . 64.52 109.633 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -116.0 -54.21 2.51 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.976 -1.12 . . . . 65.11 107.976 171.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 m80 61.75 25.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.618 -1.173 . . . . 74.22 111.711 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -130.89 166.72 20.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.752 1.221 . . . . 71.14 108.251 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -77.63 82.67 4.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.379 -0.601 . . . . 63.34 109.379 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.213 -0.662 . . . . 74.11 109.213 177.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.42 0.629 . . . . 70.22 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.15 38.74 Favored Glycine 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 62.23 109.506 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 51.41 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 64.14 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.468 HD13 HG13 ' A' ' 82' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 73.41 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 63.44 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 62.2 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 71.23 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 73.4 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 64.32 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 70.14 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 63.12 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 71.2 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 73.23 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 70.33 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 70.31 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 63.52 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 71.15 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.443 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.22 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.1 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 72.33 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 72.51 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 63.52 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 73.02 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 71.31 111.271 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 73.41 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 43.33 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 42.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 70.42 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 62.23 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 71.21 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 44.25 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 70.22 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 53.13 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 73.34 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 74.31 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 40.32 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 48' ' ' ARG . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.23 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.607 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 64.32 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 65.33 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 54.1 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 73.54 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 64.12 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.31 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 61.14 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 63.5 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.14 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 62.05 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 70.04 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.12 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 70.42 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.455 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 73.3 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.43 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 53.3 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 64.45 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 61.41 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 53.23 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 72.22 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m -72.0 85.54 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.75 -65.01 0.99 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.453 0.701 . . . . 71.53 109.446 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 63.68 12.13 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.401 1.481 . . . . 60.41 112.299 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -145.0 167.02 23.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.779 1.632 . . . . 74.35 107.982 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -76.33 113.65 14.15 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.485 -0.931 . . . . 71.33 108.485 167.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -71.02 -59.51 2.74 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.637 0.775 . . . . 51.54 109.453 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -150.83 -70.35 0.18 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 107.134 -1.432 . . . . 71.02 107.134 170.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -125.31 98.86 5.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.701 -1.963 . . . . 72.23 105.701 171.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.992 1.317 . . . . 71.34 109.23 -162.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.065 0.46 . . . . 70.23 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.66 29.44 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 55.22 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 70.0 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 54.13 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 72.2 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 73.53 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 34.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 62.11 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 60.01 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HZ2' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 71.11 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 61.22 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 71.34 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 73.12 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.02 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 63.2 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 60.44 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 72.01 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 70.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.74 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 70.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 73.55 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 73.3 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 43.41 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 74.14 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HG2' HG22 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 54.53 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 63.33 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 62.21 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 50.24 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 73.52 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 33.22 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 72.13 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 72.55 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD13 HG11 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 64.01 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 61.22 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 63.53 110.662 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 62.23 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 65.11 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.473 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.23 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 61.24 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 65.41 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 70.1 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 65.51 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 64.42 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.14 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 50.22 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 73.43 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 72.11 108.803 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.473 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 63.11 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.14 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 53.03 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 71.22 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 34.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 54.32 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 129' ' ' LEU . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 72.43 111.178 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 52.45 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p -74.41 -37.69 63.28 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 124' ' ' GLU . 18.9 mt -112.28 -178.08 3.32 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.171 0.589 . . . . 71.24 110.31 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.19 167.49 21.76 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.91 0.884 . . . . 72.34 110.639 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.22 104.39 16.4 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.787 -0.82 . . . . 75.1 108.787 174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -66.5 133.15 49.79 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.891 0.876 . . . . 74.22 110.803 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -95.35 141.67 28.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.763 0.825 . . . . 72.32 109.423 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 m80 64.64 -175.9 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.152 0.981 . . . . 54.43 111.889 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 69.26 -178.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.735 1.214 . . . . 74.44 111.064 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 CA--C 1.556 1.202 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 174.494 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.128 0.49 . . . . 70.03 109.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.77 31.74 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 63.44 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 71.44 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 63.33 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 HG23 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 43.02 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 74.33 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 64.4 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.22 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 61.21 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 64.54 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 73.54 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 54.31 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 52.34 110.784 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 53' ' ' PRO . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 41.53 109.703 176.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 61.02 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 71.31 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 71.2 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 62.5 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.42 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 55.32 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 63.32 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 65.02 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 61.23 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.01 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' HG22 ' A' ' 29' ' ' VAL . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 63.12 113.088 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 61.25 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 69' ' ' ILE . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 72.32 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB2' HG21 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 62.11 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 70.34 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.587 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 41.33 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 73.21 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 HG11 ' A' ' 56' ' ' VAL . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 65.43 109.85 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 33.35 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.2 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 72.14 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 51.03 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 63.55 107.917 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 72.42 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 71.25 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.484 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 62.44 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 70.41 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 52.14 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.21 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 63.13 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 72.25 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 62.23 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 72.45 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 24.45 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' HA ' HG11 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 74.21 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 64.22 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 73.12 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 64.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 65.41 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 61.51 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 70.04 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 63.34 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 73.13 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 64.43 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.34 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 70.3 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 73.02 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m -143.09 87.18 1.95 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.5 mt -135.87 105.51 6.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.601 0.76 . . . . 74.42 110.483 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 130.98 55.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.163 -1.792 . . . . 72.44 106.163 167.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -74.23 81.32 1.82 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.916 -0.772 . . . . 72.4 108.916 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -72.87 102.88 3.54 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.162 -0.927 . . . . 74.53 109.01 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -67.26 88.87 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.564 0.745 . . . . 71.35 109.184 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -83.81 106.34 15.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.927 0.491 . . . . 70.32 110.492 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -145.19 65.25 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.531 1.132 . . . . 72.04 108.105 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.855 1.262 . . . . 75.33 111.282 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.328 -0.619 . . . . 74.42 109.328 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.96 168.57 11.29 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 53.44 109.953 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 61.04 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 64.32 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 65.4 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 34.24 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 70.1 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.586 HG21 HG11 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 54.53 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 70.41 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 64.41 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 65.21 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 70.41 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 63.5 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 54.22 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 54.53 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 61.23 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 71.01 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 71.23 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 70.13 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 72.53 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 61.44 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 63.5 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 54.34 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 62.12 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.31 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 63.04 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 63.31 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 62.03 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 72.33 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 65.15 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 61.02 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 72.45 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 64.31 111.718 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 61.23 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 31.22 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 41.12 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 55.53 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 61.3 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 55.24 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 64.22 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 62.52 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 72.42 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 64.41 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 53.25 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 64.22 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 65.34 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 63.53 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.749 ' HA ' HG11 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 63.2 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 40.32 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 70.02 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 65.21 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 63.1 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 72.1 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 72.04 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 62.34 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 73.44 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.6 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 52.02 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 71.22 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 70.33 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 63.22 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 52.44 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 71.13 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m -75.78 104.58 6.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -141.66 115.26 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.787 0.835 . . . . 73.24 109.157 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.43 -67.56 0.85 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.259 -0.645 . . . . 72.52 109.259 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -133.27 169.62 16.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.833 0.853 . . . . 72.23 110.131 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -140.26 166.02 25.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.767 1.227 . . . . 74.2 108.729 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 52.65 94.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.213 1.005 . . . . 74.44 112.24 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -73.06 -53.23 11.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.64 0.376 . . . . 74.42 111.51 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.17 -41.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.677 0.275 . . . . 72.01 110.904 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 CA--C 1.551 0.991 0 C-N-CA 123.403 0.681 . . . . 71.42 110.124 -176.237 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mmm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.52 -0.548 . . . . 72.22 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.95 162.08 16.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 73.52 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 53.23 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 84' ' ' ILE . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 63.44 108.366 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 35.22 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 52.13 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 52.13 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 63.14 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 53.03 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 63.5 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 72.34 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 53.15 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.14 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 62.02 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 65.34 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 65.5 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 41.31 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 54.44 112.889 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.12 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 71.24 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 65.35 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 51.34 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.11 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 63.44 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 72.23 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 70.41 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 63.22 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 73.45 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HB2' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 61.32 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 53.3 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 60.43 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 52.2 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.4 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 53.11 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 52.22 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 34.02 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 8' ' ' LEU . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 63.43 109.76 -176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 61.04 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 64.53 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 73.44 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 72.23 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.13 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 53.43 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.671 ' HA ' HG11 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 74.12 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 70.31 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 64.13 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 54.12 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 45.54 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 72.4 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 70.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 71.53 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 70.23 110.738 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 62.22 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 64.3 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 72.21 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 62.51 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 64.42 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.542 ' HB2' HG21 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m -96.87 102.6 14.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.05 71.95 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.21 1.404 . . . . 73.11 110.105 -165.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.72 158.8 35.49 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.889 -1.05 . . . . 72.55 111.069 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.7 123.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.129 1.372 . . . . 62.33 110.365 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -52.65 106.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.129 0.972 . . . . 73.54 112.377 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -65.09 127.94 33.72 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.028 1.331 . . . . 74.51 109.587 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -54.7 -47.71 73.37 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.158 0.911 . . . . 65.33 112.356 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.3 t60 66.88 115.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.414 1.086 . . . . 71.23 111.729 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 109.214 -0.662 . . . . 74.43 109.214 173.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 ttm . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 120.873 0.368 . . . . 72.22 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.65 -179.31 30.85 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.601 -1.0 . . . . 73.32 110.601 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 64.4 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.25 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 54.43 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 55.02 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 64.32 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 72.35 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 65.14 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 51.24 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 72.2 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 74.53 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.455 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 54.34 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 60.21 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.635 HG22 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 72.02 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 45.12 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 64.51 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 52.54 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' HG23 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 72.14 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 55.33 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 72.54 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 71.24 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.14 110.813 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 65.21 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 60.51 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.12 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 64.42 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 50.15 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 62.42 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 72.4 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB2' HG13 ' A' ' 58' ' ' VAL . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 60.33 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 54.55 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 53.33 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 55.31 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 73.55 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 73.3 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 73.14 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 55.3 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.04 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 72.42 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 72.41 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 70.42 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 62.45 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 70.34 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 65.34 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 71.1 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 65.04 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 55.12 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.764 ' HA ' HG11 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.02 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 72.41 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 71.54 110.756 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 70.35 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 64.21 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 73.24 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.605 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 73.14 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 65.25 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 63.44 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 53.03 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 71.52 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 61.22 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 63.05 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 71.44 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 51.52 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 72.14 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p -72.28 -38.33 68.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 95.7 mt 66.07 167.5 0.21 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.847 1.259 . . . . 70.44 112.179 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.55 117.14 22.93 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.516 -0.55 . . . . 62.1 109.516 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -79.57 -33.62 41.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.549 0.69 . . . . 73.03 109.663 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.412 ' HE1' ' HA ' ' A' ' 25' ' ' HIS . 36.4 p-80 -103.7 171.01 7.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.906 1.282 . . . . 64.32 109.361 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -129.86 147.96 51.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.128 -0.693 . . . . 73.35 109.128 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -111.11 116.92 31.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.29 0.636 . . . . 75.04 109.379 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -172.22 124.37 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.432 0.693 . . . . 64.41 109.962 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 124.803 1.241 . . . . 64.22 110.759 177.766 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.925 -0.398 . . . . 74.4 109.925 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.47 133.34 25.66 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.942 -0.572 . . . . 25.24 111.857 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 71.53 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 63.33 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 73.11 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 64.13 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 73.44 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 55.35 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 55.12 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 64.25 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 71.32 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 64.14 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 52.23 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 72.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 73.13 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 54.15 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 62.33 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 63.34 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 65.23 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 74.04 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 64.22 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 64.3 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 54.24 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 65.4 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 54.52 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 63.01 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 61.33 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 51.14 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.41 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 73.32 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 64.53 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 73.41 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 71.21 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 53.43 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 70.15 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 52.21 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 64.12 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 62.31 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 42.21 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 71.23 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 61.12 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 70.53 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 63.22 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 63.42 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 64.3 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 71.43 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 65.21 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 50.33 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.35 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 74.04 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 54.0 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 62.35 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 65.01 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 62.01 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 61.34 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 64.53 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.728 ' HA ' HG11 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 54.53 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 65.52 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 51.54 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 52.23 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.31 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 63.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.31 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 72.53 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.577 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 72.21 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 72.42 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 50.34 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 72.24 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t 55.86 28.45 12.48 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 71.21 112.528 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.13 167.32 13.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.956 0.903 . . . . 71.42 111.297 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -123.62 98.62 5.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.244 1.018 . . . . 74.21 108.266 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -68.18 91.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.575 -0.898 . . . . 73.22 108.575 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -68.07 156.37 37.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.315 0.646 . . . . 62.23 110.911 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.34 -20.99 63.86 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.382 0.673 . . . . 73.4 111.233 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.52 120.64 36.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.065 0.546 . . . . 71.43 111.209 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -127.9 3.92 5.98 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.283 1.033 . . . . 75.31 109.506 168.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 124.951 1.3 . . . . 71.13 108.161 176.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.237 -0.282 . . . . 72.3 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.22 172.12 17.83 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.903 -0.59 . . . . 61.32 111.635 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 51.11 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 HG22 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 72.02 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 62.02 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 70.45 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 74.25 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 55.21 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.23 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 60.3 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 70.13 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 72.12 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 55.42 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 61.24 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 62.23 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 62.33 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 63.31 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 60.11 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 54.55 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 42.43 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 60.02 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 72.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 52.23 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.41 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.76 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 63.34 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 64.35 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 72.12 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 60.24 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 62.21 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 63.11 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 53.52 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 63.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 61.14 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 55.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 45.43 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 63.43 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 33.54 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 HG11 ' HB1' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 62.41 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 64.34 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 70.23 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 71.13 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 62.34 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.713 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 70.42 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 71.22 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 54.34 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 72.5 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 62.11 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.713 HG11 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 73.44 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 63.22 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 71.32 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 62.41 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 64.42 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 70.22 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 73.43 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 43.43 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 62.05 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 62.44 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.51 ' HB3' HD23 ' A' ' 129' ' ' LEU . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m -74.69 76.93 2.04 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 63.44 110.963 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 124' ' ' GLU . 96.7 mt -83.42 153.67 24.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.16 0.984 . . . . 62.03 110.808 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -95.64 52.36 1.35 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.118 0.967 . . . . 73.13 108.739 167.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.424 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 29.2 t-80 64.18 -161.67 0.28 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.579 1.152 . . . . 72.12 110.171 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.424 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 74.8 m80 -80.29 13.98 2.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 71.15 112.592 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -75.54 78.93 2.55 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 122.025 0.917 . . . . 71.44 109.657 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -149.61 -58.67 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 105.156 -2.164 . . . . 75.33 105.156 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -161.12 106.29 1.36 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.208 -1.36 . . . . 54.01 107.891 167.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.252 1.208 0 N-CA-C 108.581 -0.896 . . . . 71.22 108.581 172.769 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtm . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.737 -0.468 . . . . 74.42 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.62 135.7 8.06 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.684 HG22 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 50.43 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 61.23 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 61.14 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 HG23 HG12 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 55.51 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 74.34 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 74.5 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 63.31 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 61.54 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 63.51 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 72.35 110.954 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 12.9 mm100 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 72.3 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 61.22 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 62.13 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 64.03 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.435 HG21 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 52.04 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HA ' HG23 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 62.22 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 73.41 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 60.42 112.316 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.551 ' HG3' HD21 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 72.11 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 64.3 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 55.2 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.42 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 29' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 HG11 ' A' ' 29' ' ' VAL . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 73.25 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HG3' HG21 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 71.42 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 61.13 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 54.4 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 63.12 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 63.43 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 71.15 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 61.44 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 33.25 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.12 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HD13 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 61.41 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 32.44 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 64.33 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.684 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 71.1 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 63.42 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' HG22 ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 64.35 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 7' ' ' VAL . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 64.11 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 63.22 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 73.34 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 62.14 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG3' HH21 ' A' ' 110' ' ' ARG . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 55.24 112.021 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 61.52 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 72.13 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.722 ' HA ' HG11 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 71.01 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 50.04 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.553 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 73.32 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 74.24 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 89' ' ' GLU . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 64.51 110.793 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 54.31 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 72.42 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 42.41 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 64.12 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 53.34 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.645 ' HA ' HG21 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m -64.58 -47.35 79.0 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 51.12 109.496 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 26' ' ' ASP . 3.6 mm? -117.35 163.34 16.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.985 -1.007 . . . . 70.14 109.914 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.73 148.17 13.97 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.069 -1.423 . . . . 72.2 107.714 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 55.19 74.34 0.37 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.182 0.926 . . . . 65.11 110.251 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -55.38 -49.11 73.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.029 -0.73 . . . . 71.24 109.029 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 60.0 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.88 1.272 . . . . 74.11 111.741 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -116.03 145.51 42.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.488 0.715 . . . . 44.14 109.913 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -114.91 142.01 47.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.105 0.962 . . . . 73.22 108.813 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 108.898 -0.778 . . . . 72.42 108.898 172.453 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 62.33 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 54.5 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 72.35 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 73.04 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 24.35 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 61.5 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 51.5 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 63.33 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 55.24 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 65.33 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 55.22 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 44.32 111.226 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 72.33 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 64.13 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 51.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 65.03 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.445 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 62.41 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 71.22 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 71.34 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 63.31 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 63.32 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.25 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 72.2 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 64.31 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.42 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 72.32 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 45.11 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 28' ' ' ASN . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 64.34 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.568 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 64.01 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.1 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.626 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 53.42 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 71.41 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 71.13 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 51.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 53.45 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 65.52 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 54.13 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 45.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 62.51 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 71.23 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 34.41 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 54.22 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 52.45 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 63.44 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 14' ' ' ILE . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 73.33 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 63.13 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 62.54 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 60.54 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 63.14 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.702 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 64.43 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 73.15 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 71.13 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 54.22 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 74.34 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 71.54 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 52.23 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.11 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.4 HD22 ' H ' ' A' ' 113' ' ' ASP . 2.2 p-10 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 73.15 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' H ' HD22 ' A' ' 111' ' ' ASN . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 70.54 111.931 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 64.13 110.18 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 70.13 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 72.04 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 74.12 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 53.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 64.43 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 71.54 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 73.2 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 63.24 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 54.35 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 65.11 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.692 HG21 HG11 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 72.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 63.24 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 71.23 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 64.11 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 65.1 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 73.04 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 63.54 113.717 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 65.04 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 73.3 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 34.52 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 62.44 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.2 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 64.54 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 61.32 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 74.44 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 71.51 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HG3' HD21 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 71.5 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 71.52 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 62.34 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 63.44 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 71.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 41.44 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.629 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.72 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 63.4 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 72.44 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 53.3 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.0 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 64.34 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 74.04 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.22 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 54.34 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 64.42 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 61.24 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.62 HD21 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 71.1 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' HG22 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 74.03 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.507 HD11 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 73.24 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 73.41 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG11 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 31.44 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 71.13 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.13 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 61.12 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 61.14 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 71.15 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 73.11 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.753 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 73.12 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 61.42 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.675 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.43 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 55.24 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 61.15 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.47 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 53.33 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 63.24 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 65.23 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 64.55 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 72.42 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 64.31 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 51.01 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.12 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 72.14 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 64.23 111.502 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 54.24 111.167 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.831 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 63.53 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.565 HD23 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 70.41 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.597 HG11 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 53.25 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 73.02 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.65 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 72.21 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.23 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 73.1 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 70.53 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.13 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 71.43 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 71.11 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 64.21 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 72.01 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 70.02 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 71.53 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 71.42 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 65.11 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 71.22 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 62.22 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 71.23 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 44.05 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 73.12 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 70.34 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.565 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 62.42 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 62' ' ' ASP . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 63.4 107.084 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 64.23 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 64.32 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 64.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 61.11 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 63.13 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.42 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 71.13 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 72.35 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 50.01 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 70.05 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 63.32 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.03 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 73.24 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.11 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 63.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.22 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 72.32 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.695 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 64.02 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 60.35 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 74.54 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 72.12 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 62.4 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.24 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 64.23 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 61.03 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 51.51 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 73.31 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.547 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 63.25 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.574 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 72.44 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.35 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 73.32 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 72.42 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 54.44 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 54.41 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 54.43 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 62.43 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 72.15 112.228 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 65.51 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 61.2 109.584 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 64.15 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 63.44 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 62.4 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.479 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 54.32 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.2 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 53.41 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 43.31 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 70.41 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 65.45 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 72.32 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 71.25 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 71.42 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 44.31 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 70.1 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 71.31 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 62.45 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 63.21 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 51.12 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 64.13 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 64.21 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 72.12 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 42.32 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 72.44 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 73.22 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 64.31 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 41.34 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 72.52 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 61.44 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 73.34 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 72.43 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 22.13 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.74 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 60.34 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 73.32 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 70.04 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 52.21 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 62.32 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.12 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 71.21 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 64.34 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 72.35 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 73.54 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 65.34 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.75 ' HA ' HG11 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 70.11 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 65.42 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 71.11 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.456 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 70.11 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.32 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 63.34 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.12 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 70.32 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 54.41 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 63.21 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 73.44 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 70.0 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 71.3 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 55.35 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 61.15 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 51.03 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.171 -0.372 . . . . 61.05 112.171 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 53.02 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.32 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 72.11 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.52 HD23 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 73.43 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 64.44 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 62.31 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 54.24 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG21 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 64.23 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 71.0 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 61.33 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 74.22 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 72.13 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 63.1 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.14 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 71.31 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 61.11 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.456 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 72.34 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 70.11 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.31 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 72.12 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 60.11 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 62.51 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.76 HD11 HG23 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 64.12 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 53.12 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.23 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 71.44 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 73.35 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 54.23 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' HD23 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 52.43 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 54.44 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 64.31 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 52.4 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.14 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 63.34 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.1 112.448 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 54.3 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 74.13 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 71.1 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.469 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 61.2 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' HB2' ' A' ' 107' ' ' TYR . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 61.42 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 71.25 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 70.41 111.591 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 70.42 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 72.31 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 64.32 110.507 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' HG11 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 72.45 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' TYR . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 64.15 110.449 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 70.41 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 40.34 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 54.15 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 72.24 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.546 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 64.01 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 72.34 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.13 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 70.23 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 64.35 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 73.51 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.423 HD11 HG11 ' A' ' 55' ' ' VAL . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 74.5 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 61.33 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 61.33 108.794 168.635 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 52.2 108.543 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.12 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 64.41 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 62.15 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.459 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.11 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 72.2 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 61.3 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 65.44 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 71.44 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 73.54 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 63.32 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 72.44 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 65.44 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 41.33 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 45.13 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.42 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 65.23 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 54.14 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 64.32 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 65.22 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 64.51 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 73.54 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 63.5 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 53.42 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.797 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.797 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 72.3 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 53.14 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.766 ' HB ' HG22 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.12 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' HG21 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 71.35 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 51.03 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 64.33 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 70.34 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 71.54 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 71.21 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 73.31 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 72.11 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.605 HD11 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 41.04 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 63.11 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 60.42 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 70.23 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 62.23 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.449 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 64.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 92' ' ' LEU . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 63.23 110.082 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 71.41 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 51.05 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 54.55 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 86' ' ' SER . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 71.12 110.59 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 73.41 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 54.25 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.449 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 63.05 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 65.41 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 62.43 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 70.42 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.24 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 62.52 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 64.14 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 70.25 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 35.15 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.42 HD22 ' H ' ' A' ' 113' ' ' ASP . 2.4 p-10 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.13 111.246 -170.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 65.32 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' ASN . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 60.34 111.229 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.04 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 63.4 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 70.15 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 72.35 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 52.44 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 45.11 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.483 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 62.14 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 44.44 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 72.42 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 71.25 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 55.22 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.552 HD23 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 63.02 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 63.51 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG13 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 45.44 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 55.0 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 51.52 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 63.05 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 70.54 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 53.34 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 54.53 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 72.03 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 60.32 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 54.32 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.04 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 45.2 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 60.14 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 60.54 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 53.32 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 60.2 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.13 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 70.01 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 74.02 111.352 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.524 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 64.44 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 72.23 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 70.13 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 65.21 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 72.2 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 44.31 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.639 HG11 ' HB2' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.45 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 52.51 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 53.41 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 72.4 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 72.23 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 54.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 51.21 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 70.02 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 52.33 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 71.53 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 73.11 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' HG13 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 54.25 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 63.1 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 61.31 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 52.33 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.547 ' HA ' HD12 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 72.45 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 53.43 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 71.14 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 71.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 65.12 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.803 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 73.23 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 71.23 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 50.3 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 71.32 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.47 ' HB ' HD13 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 70.32 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 70.34 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 65.32 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 73.4 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 71.53 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 50.21 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 74.3 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 73.05 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 65.14 111.025 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 74.1 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 21.42 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 63.41 107.446 173.241 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 73.33 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 63.33 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 73.21 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 82' ' ' VAL . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 60.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 51.43 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 64.24 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 72.42 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 65.12 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 52.4 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 71.34 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.723 ' HA ' HE21 ' A' ' 23' ' ' GLN . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.723 HE21 ' HA ' ' A' ' 20' ' ' LYS . 47.6 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 72.41 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.04 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 73.43 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 50.03 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.22 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 63.31 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 60.2 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 61.11 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 71.14 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 72.52 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.553 HG11 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.53 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 62.32 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 74.02 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 71.04 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.0 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 73.42 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 64.11 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 53.35 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.12 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 70.11 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 62.23 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.657 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.33 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 42.44 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 HG11 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 64.54 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 44.05 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 73.4 111.234 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 53.12 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.644 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 73.51 109.138 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 64.13 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 61.53 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 63.34 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 42.01 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 72.01 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.654 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 70.41 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 64.33 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 73.01 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 52.24 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 73.05 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 52.32 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 70.32 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 62.32 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 34.01 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 71.23 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 72.22 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 64.32 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 73.44 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 72.32 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 72.42 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.12 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 73.23 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.24 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 50.15 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 61.43 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 62.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 51.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 64.41 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 72.34 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 119' ' ' LEU . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 50.23 111.193 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 64.0 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.25 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 52.1 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 74.54 113.619 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 73.24 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' NZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 70.43 113.001 -170.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 62.5 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 73.53 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 72.32 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.13 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.419 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 62.35 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 73.3 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 71.22 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HB ' HD23 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 60.41 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 53.11 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 72.1 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 63.44 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 60.21 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 31.14 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 64.2 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.404 HD11 ' NZ ' ' A' ' 37' ' ' LYS . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 44.21 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 44.34 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HA ' HH11 ' A' ' 48' ' ' ARG . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 64.33 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 65.45 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 64.45 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 65.53 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 HD13 ' A' ' 8' ' ' LEU . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 71.03 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 45.11 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 60.3 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 71.35 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.13 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 64.23 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HA ' HG11 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 73.42 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 52.13 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 62.52 111.996 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 64.15 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 54.31 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 72.42 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 64.45 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 113' ' ' ASP . 2.0 p-10 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 71.35 112.268 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 111' ' ' ASN . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 70.33 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 21' ' ' GLU . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 65.41 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 63.44 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 52.0 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 45.13 111.323 -174.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 112.039 -0.424 . . . . 72.41 112.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 73.55 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 63.21 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 HG13 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.13 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 44.2 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 63.32 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 71.01 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HB3' HD22 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 65.3 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 62.15 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.11 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 71.41 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 64.45 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 64.14 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.24 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 73.34 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 65.14 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 73.23 111.37 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 72.02 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 64.23 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 56' ' ' VAL . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 64.32 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 70.53 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 72.34 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 55.15 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 71.14 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 73.44 108.36 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 51.45 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 51.24 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 53.04 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 73.5 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 73.32 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 65.44 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 72.05 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 62.32 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 71.24 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 34.24 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 63.32 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 54.14 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 70.42 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 62.23 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 70.33 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 63.52 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' HD12 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 72.4 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 71.51 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.41 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 71.41 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 21.34 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.78 ' HA ' HG11 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 74.44 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.31 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 72.23 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 70.45 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 71.02 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 71.21 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 54.32 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 62.31 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 73.44 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 71.31 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 65.34 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 50.33 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 63.42 111.334 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 72.31 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 54.01 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.519 0 N-CA-C 109.551 -1.42 . . . . 71.22 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 43.2 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 74.51 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 72.24 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 71.34 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 72.41 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HG3' HG21 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 71.41 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 63.33 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 72.41 111.529 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 64.3 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 63.04 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 51.22 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.41 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 62.32 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 73.11 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 40' ' ' VAL . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.0 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 53.44 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 72.35 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 51.32 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 63.22 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 78' ' ' LEU . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 71.52 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 60.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.03 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 65.33 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 43.2 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 61.3 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 42.05 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 60.23 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 61.31 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 65.44 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 55.32 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 72.53 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 63.55 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB2' HG22 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 64.51 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 53.24 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 8' ' ' LEU . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.442 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 52.0 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 62.53 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 63.05 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 55.5 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 61.24 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.628 ' HA ' HG11 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 71.24 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 73.11 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 64.1 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 71.44 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 65.14 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 64.21 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 73.32 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 51.02 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 74.05 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.487 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 64.5 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 63.21 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 45.45 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 62.34 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 60.43 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.23 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 62.14 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 62.23 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 51.41 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 64.14 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.468 HD13 HG13 ' A' ' 82' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 73.41 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 63.44 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 62.2 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 71.23 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 73.4 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 64.32 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 70.14 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 63.12 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 71.2 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 73.23 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 70.33 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 70.31 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 63.52 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 71.15 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.443 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.22 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.1 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 72.33 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 72.51 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 63.52 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 73.02 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 71.31 111.271 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 73.41 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 43.33 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 42.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 70.42 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 62.23 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 71.21 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 44.25 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 70.22 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 53.13 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 73.34 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 74.31 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 40.32 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 48' ' ' ARG . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.23 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.607 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 64.32 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 65.33 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 54.1 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 73.54 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 64.12 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.31 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 61.14 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 63.5 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.14 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 62.05 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 70.04 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.12 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 70.42 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.455 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 73.3 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.43 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 53.3 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 64.45 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 61.41 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 53.23 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 72.22 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.531 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 55.22 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 70.0 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 54.13 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 72.2 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 73.53 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 34.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 62.11 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 60.01 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HZ2' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 71.11 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 61.22 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 71.34 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 73.12 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.02 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 63.2 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 60.44 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 72.01 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 70.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.74 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 70.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 73.55 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 73.3 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 43.41 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 74.14 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HG2' HG22 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 54.53 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 63.33 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 62.21 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 50.24 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 73.52 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 33.22 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 72.13 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 72.55 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD13 HG11 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 64.01 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 61.22 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.607 HE21 ' HE1' ' A' ' 104' ' ' TYR . 7.3 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 63.53 110.662 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 62.23 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 65.11 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.473 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.23 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 61.24 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 65.41 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 70.1 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 65.51 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 64.42 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.14 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 50.22 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 73.43 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.607 ' HE1' HE21 ' A' ' 74' ' ' GLN . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 72.11 108.803 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.473 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 63.11 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.14 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 53.03 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 71.22 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 34.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 54.32 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 72.43 111.178 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 52.45 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.523 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 63.44 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 71.44 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 63.33 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 HG23 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 43.02 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 74.33 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 64.4 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.22 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 61.21 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 64.54 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 73.54 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 54.31 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 52.34 110.784 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 53' ' ' PRO . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 41.53 109.703 176.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 61.02 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 71.31 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 71.2 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 62.5 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.42 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 55.32 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 63.32 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 65.02 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 61.23 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.01 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' HG22 ' A' ' 29' ' ' VAL . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 63.12 113.088 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 61.25 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 69' ' ' ILE . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 72.32 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB2' HG21 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 62.11 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 70.34 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.587 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 41.33 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 73.21 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 HG11 ' A' ' 56' ' ' VAL . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 65.43 109.85 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 33.35 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.2 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 72.14 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 51.03 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 63.55 107.917 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 72.42 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 71.25 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.484 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 62.44 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 70.41 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 52.14 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.21 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 63.13 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 72.25 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 62.23 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 72.45 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 24.45 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' HA ' HG11 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 74.21 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 64.22 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 73.12 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 64.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 65.41 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 61.51 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 70.04 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 63.34 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 73.13 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 64.43 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.34 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 70.3 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 73.02 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 53.44 109.953 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 61.04 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 64.32 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 65.4 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 34.24 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 70.1 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.586 HG21 HG11 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 54.53 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 70.41 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 64.41 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 65.21 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 70.41 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 63.5 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 54.22 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 54.53 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 61.23 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 71.01 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 71.23 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 70.13 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 72.53 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 61.44 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 63.5 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 54.34 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 62.12 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.31 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 63.04 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 63.31 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 62.03 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 72.33 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 65.15 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 61.02 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 72.45 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 64.31 111.718 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 61.23 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 31.22 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 41.12 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 55.53 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 61.3 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 55.24 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 64.22 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 62.52 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 72.42 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 64.41 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 53.25 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 64.22 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 65.34 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 63.53 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.749 ' HA ' HG11 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 63.2 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 40.32 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 70.02 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 65.21 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 63.1 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 72.1 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 72.04 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 62.34 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 73.44 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.6 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 52.02 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 71.22 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 70.33 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 63.22 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 52.44 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 71.13 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 73.52 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 53.23 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 84' ' ' ILE . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 63.44 108.366 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 35.22 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 52.13 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 52.13 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 63.14 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 53.03 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 63.5 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 72.34 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 53.15 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.14 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 62.02 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 65.34 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 65.5 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 41.31 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 54.44 112.889 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.12 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 71.24 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 65.35 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 51.34 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.11 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 63.44 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 72.23 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 70.41 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 63.22 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 73.45 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HB2' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 61.32 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 53.3 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 60.43 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 52.2 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.4 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 53.11 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 52.22 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 34.02 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 8' ' ' LEU . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 63.43 109.76 -176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 61.04 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 64.53 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 73.44 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 72.23 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.13 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 53.43 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.671 ' HA ' HG11 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 74.12 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 70.31 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 64.13 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 54.12 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 45.54 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 72.4 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 70.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 71.53 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 70.23 110.738 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 62.22 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 64.3 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 72.21 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 62.51 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 64.42 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.542 ' HB2' HG21 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 110.601 -1.0 . . . . 73.32 110.601 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 64.4 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.25 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 54.43 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 55.02 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 64.32 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 72.35 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 65.14 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 51.24 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 72.2 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 74.53 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.455 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 54.34 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 60.21 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.635 HG22 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 72.02 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 45.12 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 64.51 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 52.54 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' HG23 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 72.14 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 55.33 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 72.54 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 71.24 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.14 110.813 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 65.21 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 60.51 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.12 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 64.42 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 50.15 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 62.42 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 72.4 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB2' HG13 ' A' ' 58' ' ' VAL . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 60.33 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 54.55 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 53.33 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 55.31 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 73.55 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 73.3 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 73.14 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 55.3 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.04 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 72.42 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 72.41 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 70.42 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 62.45 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 70.34 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 65.34 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 71.1 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 65.04 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 55.12 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.764 ' HA ' HG11 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.02 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 72.41 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 71.54 110.756 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 70.35 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 64.21 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 73.24 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.605 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 73.14 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 65.25 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 63.44 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 53.03 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 71.52 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 61.22 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 63.05 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 71.44 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 51.52 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 72.14 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.852 0 N-CA-C 111.857 -0.497 . . . . 25.24 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 71.53 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 63.33 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 73.11 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 64.13 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 73.44 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 55.35 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 55.12 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 64.25 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 71.32 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 64.14 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 52.23 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 72.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 73.13 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 54.15 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 62.33 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 63.34 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 65.23 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 74.04 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 64.22 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 64.3 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 54.24 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 65.4 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 54.52 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 63.01 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 61.33 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 51.14 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.41 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 73.32 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 64.53 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 73.41 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 71.21 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 53.43 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 70.15 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 52.21 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 64.12 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 62.31 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 42.21 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 71.23 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 61.12 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 70.53 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 63.22 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 63.42 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 64.3 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 71.43 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 65.21 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 50.33 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.35 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 74.04 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 54.0 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 62.35 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 65.01 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 62.01 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 61.34 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 64.53 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.728 ' HA ' HG11 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 54.53 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 65.52 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 51.54 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 52.23 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.31 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 63.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.31 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 72.53 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.577 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 72.21 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 72.42 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 50.34 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 72.24 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 71.21 112.528 170.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 111.635 -0.586 . . . . 61.32 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 51.11 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 HG22 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 72.02 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 62.02 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 70.45 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 74.25 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 55.21 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.23 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 60.3 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 70.13 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 72.12 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 55.42 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 61.24 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 62.23 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 62.33 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 63.31 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 60.11 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 54.55 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 42.43 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 60.02 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 72.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 52.23 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.41 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.76 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 63.34 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 64.35 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 72.12 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 60.24 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 62.21 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 63.11 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 53.52 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 63.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 61.14 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 55.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 45.43 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 63.43 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 33.54 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.508 HG11 ' HB1' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 62.41 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 64.34 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 70.23 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 71.13 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 62.34 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.713 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 70.42 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 71.22 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 54.34 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 72.5 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 62.11 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.713 HG11 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 73.44 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 63.22 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 71.32 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 62.41 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 64.42 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 70.22 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 73.43 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 43.43 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 62.05 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 62.44 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 63.44 110.963 -177.282 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.684 HG22 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 50.43 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 61.23 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 61.14 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.463 HG23 HG12 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 55.51 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 74.34 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 74.5 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 63.31 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 61.54 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 63.51 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 72.35 110.954 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 21.4 mm-40 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 72.3 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 61.22 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 62.13 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 64.03 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.435 HG21 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 52.04 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HA ' HG23 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 62.22 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 73.41 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 60.42 112.316 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.551 ' HG3' HD21 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 72.11 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 64.3 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 55.2 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.42 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 29' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 HG11 ' A' ' 29' ' ' VAL . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 73.25 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HG3' HG21 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 71.42 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 61.13 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 54.4 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 63.12 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 63.43 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 71.15 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 61.44 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 33.25 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.12 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HD13 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 61.41 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 32.44 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 64.33 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.684 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 71.1 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 63.42 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' HG22 ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 64.35 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 7' ' ' VAL . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 64.11 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 63.22 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 73.34 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 62.14 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG3' HH21 ' A' ' 110' ' ' ARG . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 55.24 112.021 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 61.52 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 72.13 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.722 ' HA ' HG11 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 71.01 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 50.04 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.553 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 73.32 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 74.24 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 89' ' ' GLU . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 64.51 110.793 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 54.31 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 72.42 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 42.41 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 64.12 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 53.34 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.645 ' HA ' HG21 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 51.12 109.496 176.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.257 -0.275 . . . . 54.41 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.36 148.47 5.84 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 110.835 -0.906 . . . . 62.33 110.835 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 84.0 t -133.28 141.61 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.383 1.073 . . . . 54.5 108.322 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.78 112.41 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.172 -0.677 . . . . 73.44 109.172 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 60.7 mt -102.71 109.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.597 1.159 . . . . 72.35 109.369 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 82' ' ' VAL . 29.6 mt -99.77 103.91 15.58 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.259 -0.645 . . . . 73.04 109.259 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 t -95.35 103.05 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 109.389 -0.597 . . . . 24.35 109.389 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.76 104.85 17.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.575 1.15 . . . . 61.5 108.527 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 54.9 p -106.11 138.79 41.68 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.43 0.692 . . . . 51.5 109.758 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.69 -16.89 68.47 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.995 0.809 . . . . 64.25 113.298 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.96 126.31 28.36 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.605 1.162 . . . . 74.41 108.498 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.68 -26.4 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.21 1.004 . . . . 72.24 111.836 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -67.58 -35.22 78.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.406 0.682 . . . . 63.33 110.658 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.456 HG21 HG11 ' A' ' 85' ' ' VAL . 62.6 mt -61.19 -44.62 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 109.503 -0.555 . . . . 73.35 109.503 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -56.64 -40.02 74.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 55.24 111.894 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 2.3 tm-20 -75.77 -40.5 55.18 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.643 -0.708 . . . . 65.33 110.552 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.18 -32.86 65.1 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.961 -0.462 . . . . 74.14 110.904 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.2 mt -67.55 -28.42 67.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.242 0.617 . . . . 75.33 110.932 174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 23.6 ttp180 -57.85 -49.16 77.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.029 0.531 . . . . 55.22 110.783 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.96 -37.29 76.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.194 0.934 . . . . 73.42 110.627 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 14.6 tp10 -66.52 -38.67 87.7 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.462 -0.79 . . . . 44.32 111.226 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 18' ' ' LEU . 72.0 t -64.97 -44.81 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.751 0.42 . . . . 72.22 110.439 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 25.1 mm-40 -66.2 -33.27 75.37 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.9 0.75 . . . . 75.44 111.026 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -26.95 57.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.056 0.542 . . . . 72.33 111.498 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -79.02 -31.59 44.72 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.536 0.522 . . . . 75.02 109.864 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.84 120.37 0.38 Allowed Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 123.723 0.809 . . . . 72.43 109.766 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.34 -18.89 20.12 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.66 2.24 . . . . 64.13 113.302 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -77.84 -22.77 49.41 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.157 0.583 . . . . 74.24 110.624 -175.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 127.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 108.936 -0.764 . . . . 73.51 108.936 170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -92.06 127.72 37.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.107 0.479 . . . . 51.21 110.48 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.568 HG22 ' HB ' ' A' ' 55' ' ' VAL . 22.2 p -113.38 131.26 56.05 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.209 1.004 . . . . 71.34 109.156 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.5 121.55 25.88 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.293 -1.003 . . . . 65.03 108.293 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 66.9 Cg_endo -71.53 -178.18 2.86 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.75 2.3 . . . . 62.22 112.929 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.445 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 63.5 p -67.43 -17.99 64.92 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.097 -0.956 . . . . 62.41 111.464 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -73.66 -48.87 29.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.442 1.097 . . . . 71.22 111.234 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -91.7 64.49 4.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.717 -0.674 . . . . 71.34 110.38 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -64.61 -35.85 82.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.914 1.285 . . . . 63.31 111.683 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -74.74 -40.55 61.2 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.411 -1.268 . . . . 63.32 109.975 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -76.84 -15.41 59.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.934 -1.03 . . . . 64.25 112.478 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 69' ' ' ILE . 99.2 t -54.83 -55.05 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.625 0.77 . . . . 75.21 111.656 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -62.42 -30.82 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.826 0.704 . . . . 72.2 112.326 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -70.34 -42.96 71.2 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.346 0.658 . . . . 72.03 109.825 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -66.59 -26.36 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.993 -1.003 . . . . 64.31 112.483 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 69' ' ' ILE . 70.8 mt -67.31 -42.98 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.636 0.775 . . . . 74.42 109.921 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -58.01 -44.83 87.48 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.806 0.691 . . . . 63.12 110.529 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 26.9 mtpp -73.97 -34.02 64.08 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.122 -1.399 . . . . 71.35 111.896 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.25 79.61 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.517 0.727 . . . . 73.11 111.799 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -64.25 -40.68 96.49 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.585 -0.734 . . . . 72.32 109.918 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.49 -31.35 70.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.696 -1.138 . . . . 74.01 109.618 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 23.7 mm-40 -77.58 -16.38 58.65 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.932 0.493 . . . . 45.11 110.218 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.43 68.57 Favored Glycine 0 C--N 1.362 1.978 0 O-C-N 124.006 0.816 . . . . 74.4 112.357 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 28' ' ' ASN . 15.2 mmt180 -120.59 160.48 43.99 Favored Pre-proline 0 C--O 1.242 0.691 0 C-N-CA 125.176 1.391 . . . . 75.3 109.591 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 56.6 Cg_endo -69.97 161.91 44.19 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.337 1.358 . . . . 74.12 112.31 169.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.78 121.58 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 64.34 107.499 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.568 ' HB ' HG22 ' A' ' 31' ' ' THR . 48.6 t -97.03 105.72 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.874 -0.788 . . . . 64.01 108.874 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 69' ' ' ILE . 42.9 t -96.26 113.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.443 1.097 . . . . 71.1 109.627 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.626 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 82.3 m-85 -86.21 119.78 26.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.411 0.684 . . . . 72.34 109.464 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.1 t -117.83 150.57 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.676 1.59 . . . . 74.51 108.34 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -90.69 154.82 19.28 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.113 0.565 . . . . 53.42 109.545 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.69 91.16 0.49 Allowed Glycine 0 C--N 1.352 1.444 0 C-N-CA 123.496 0.569 . . . . 71.24 111.699 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.22 -24.96 3.36 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 110.733 -0.947 . . . . 71.41 110.733 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -86.82 21.56 2.21 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.737 1.615 . . . . 65.02 109.649 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.23 -25.88 68.26 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 73.23 113.298 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.44 -41.52 72.97 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.296 0.57 . . . . 71.13 110.138 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 34' ' ' THR . 33.8 ttt-85 -65.03 -47.6 76.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.716 -1.129 . . . . 73.12 110.44 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -55.9 -51.5 67.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.018 0.747 . . . . 51.34 113.018 -176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -64.11 -37.99 89.43 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 123.804 0.69 . . . . 53.45 112.381 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.66 -35.02 67.63 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.055 0.391 . . . . 72.31 112.055 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 40' ' ' VAL . 91.7 mt -67.84 -40.02 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.662 0.785 . . . . 65.52 109.83 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.66 92.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.643 -1.162 . . . . 54.13 111.189 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.41 -32.65 66.54 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.933 -1.031 . . . . 75.44 110.733 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.73 -41.57 83.26 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.34 1.056 . . . . 75.34 110.464 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.85 -46.49 68.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.146 -0.934 . . . . 45.23 110.691 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -27.4 68.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.897 1.279 . . . . 62.51 110.024 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -62.85 -32.35 73.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.773 0.829 . . . . 71.23 111.697 174.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 8.4 mm-40 -86.59 7.1 27.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.165 0.586 . . . . 74.41 111.098 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.39 30.29 71.41 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 123.595 0.56 . . . . 34.41 112.871 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 46.1 mt -89.2 150.51 22.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.122 0.569 . . . . 54.22 110.501 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -72.94 101.41 3.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.68 115.21 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.174 -0.676 . . . . 70.3 109.174 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.95 143.97 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 107.266 -1.383 . . . . 74.41 107.266 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 6' ' ' LEU . 87.6 t -131.57 113.07 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 108.478 -0.934 . . . . 52.45 108.478 176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -108.29 108.12 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.865 0.866 . . . . 63.44 109.478 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.71 114.98 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.435 0.694 . . . . 72.1 109.474 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 14' ' ' ILE . 16.5 t -98.14 100.53 10.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.653 1.181 . . . . 73.33 108.333 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -150.0 135.18 18.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.432 1.093 . . . . 74.32 109.079 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -77.91 -15.69 58.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.261 0.624 . . . . 75.04 110.185 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.73 121.71 31.39 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.793 0.837 . . . . 73.13 109.283 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.41 -25.0 63.92 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.491 0.716 . . . . 63.13 112.593 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 6.1 mm-40 -73.21 -40.77 64.46 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.364 0.415 . . . . 72.12 110.79 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.7 -33.54 76.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.023 0.529 . . . . 62.54 110.815 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.94 -53.91 33.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.08 -0.964 . . . . 60.54 110.344 172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -70.8 -41.81 71.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.865 0.866 . . . . 75.11 112.94 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 64.3 mttm -66.55 -46.34 76.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.917 0.487 . . . . 63.14 110.381 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' A' ' 99' ' ' LYS . . . -65.76 -38.81 94.81 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.646 -0.707 . . . . 64.1 112.191 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.702 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.6 t80 -56.29 -57.49 12.01 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.87 0.868 . . . . 74.15 110.548 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.1 -36.97 78.13 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.07 0.856 . . . . 64.43 111.592 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.8 t70 -61.88 -48.85 78.66 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.197 0.599 . . . . 72.55 111.214 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 95' ' ' GLY . 1.4 mppt? -78.07 -31.59 50.3 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.054 0.542 . . . . 73.15 111.437 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -64.92 -40.22 94.72 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.315 0.646 . . . . 75.23 111.766 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -70.53 -18.51 62.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.336 0.655 . . . . 71.13 111.64 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 62.6 mttm -85.28 0.14 52.92 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.59 0.756 . . . . 75.11 111.217 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.87 10.85 48.43 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 119.713 -0.493 . . . . 54.22 113.874 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.0 143.76 28.23 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.645 0.723 . . . . 74.2 109.633 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -87.17 101.59 13.64 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 96' ' ' TYR . 23.0 t -103.49 127.36 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 122.88 0.472 . . . . 71.33 110.974 -169.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -105.59 145.92 30.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.088 0.955 . . . . 74.34 109.19 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 p -108.53 143.9 36.93 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.885 0.874 . . . . 71.54 109.037 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 p -143.61 137.44 28.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.036 0.534 . . . . 52.23 111.226 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -69.0 -41.51 77.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.597 1.159 . . . . 73.11 111.212 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.4 HD22 ' H ' ' A' ' 113' ' ' ASP . 2.2 p-10 -166.62 -168.36 1.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.7 -1.137 . . . . 71.41 108.549 -170.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -37.86 67.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.813 0.845 . . . . 73.15 112.971 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' H ' HD22 ' A' ' 111' ' ' ASN . 11.2 m-20 -61.52 -51.73 67.38 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 123.552 0.532 . . . . 70.54 111.931 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -70.58 -36.08 73.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.315 0.646 . . . . 72.25 110.142 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.5 94.95 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.348 1.03 . . . . 52.42 110.858 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.5 ttmt -68.77 -44.23 74.1 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.597 1.185 . . . . 64.13 110.18 -176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.42 -51.48 69.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.706 0.629 . . . . 74.53 110.102 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.3 -28.03 66.82 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.381 0.673 . . . . 74.13 112.35 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.77 -52.03 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.066 0.946 . . . . 70.13 110.226 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 27.7 mtpp -71.4 -30.23 65.85 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 114.888 -1.051 . . . . 72.04 110.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -64.55 -41.35 96.39 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.545 0.738 . . . . 75.32 110.362 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.47 -30.56 69.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.255 0.622 . . . . 74.12 110.908 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.02 -36.44 69.68 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.903 0.881 . . . . 53.3 111.028 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.7 mt-10 -68.73 -38.02 79.86 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.305 0.642 . . . . 61.54 110.155 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -74.15 -18.48 60.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.949 0.9 . . . . 64.43 112.076 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.9 p -90.97 -17.42 26.38 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.864 0.466 . . . . 63.13 111.461 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.38 -17.3 11.41 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.584 0.552 . . . . 71.54 113.437 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.1 m -71.67 118.63 14.74 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.222 0.609 . . . . 74.45 110.273 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.98 138.94 48.48 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.054 0.942 . . . . 54.32 109.894 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -160.4 -69.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.573 -0.899 . . . . 71.15 108.573 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -81.93 98.58 8.63 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.289 -1.004 . . . . 71.43 108.289 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -57.98 121.84 11.56 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 124.249 0.968 . . . . 62.22 108.812 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -71.13 82.09 0.7 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.986 0.804 . . . . 71.13 109.163 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -106.6 160.81 15.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.615 1.166 . . . . 73.23 111.305 -173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -85.59 95.46 9.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.472 -0.786 . . . . 73.44 110.166 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.794 -0.817 . . . . 72.11 108.794 171.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.677 0.251 . . . . 62.03 111.677 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.97 -169.59 42.66 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.142 -0.783 . . . . 72.25 111.142 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 79' ' ' ARG . 67.2 t -142.74 145.46 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 117.953 0.876 . . . . 61.11 111.059 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.7 t -126.96 113.1 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.204 1.002 . . . . 75.04 108.647 171.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -94.67 107.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.694 0.798 . . . . 73.2 109.726 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 27.3 mt -96.91 104.18 16.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.906 0.882 . . . . 75.32 108.813 174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 9' ' ' THR . 44.9 t -92.74 106.41 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.221 0.608 . . . . 74.45 109.7 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.594 HD13 HG13 ' A' ' 82' ' ' VAL . 9.0 mp -87.21 103.69 15.67 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.043 0.937 . . . . 74.41 108.655 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 7' ' ' VAL . 28.1 p -107.22 137.95 44.32 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.17 0.588 . . . . 63.24 110.12 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.64 27.08 17.16 Favored Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.24 -0.744 . . . . 54.35 111.24 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -165.39 137.02 4.06 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.079 0.952 . . . . 72.2 108.766 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -71.26 -45.69 62.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.034 0.934 . . . . 71.14 111.482 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 35.5 mmt180 -67.53 -34.01 76.22 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.901 -0.59 . . . . 65.11 111.384 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.692 HG21 HG11 ' A' ' 85' ' ' VAL . 64.8 mt -60.87 -46.71 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.728 -0.471 . . . . 72.24 109.728 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.66 71.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.424 0.69 . . . . 54.33 111.782 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG2' ' HE3' ' A' ' 20' ' ' LYS . 33.8 tt0 -69.16 -41.37 77.33 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.776 0.83 . . . . 75.01 111.049 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 31.3 mm-40 -69.81 -33.34 72.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.797 0.439 . . . . 75.24 111.103 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.4 mt -72.04 -33.81 68.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.148 -0.933 . . . . 72.24 110.383 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 57.2 ttp180 -59.09 -46.38 88.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.598 0.759 . . . . 63.24 110.426 174.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HE3' ' HG2' ' A' ' 16' ' ' GLU . 92.6 mttt -62.38 -33.56 74.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.546 -1.206 . . . . 74.54 110.865 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 15.6 tp10 -71.33 -38.83 71.65 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.558 -0.746 . . . . 71.23 111.507 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -60.04 -34.17 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.323 0.649 . . . . 64.11 110.77 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -65.2 -32.59 74.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.091 0.556 . . . . 65.1 111.85 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -85.47 -30.53 23.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.084 0.554 . . . . 73.04 111.616 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 20.0 t60 -74.61 -56.72 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.487 0.66 . . . . 75.23 109.444 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -154.05 100.19 2.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.187 -0.915 . . . . 72.12 109.324 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD2' ' HE1' ' A' ' 131' ' ' HIS . 59.0 Cg_endo -68.42 -8.57 23.44 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.024 2.483 . . . . 63.54 113.717 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -80.77 -20.45 42.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.944 0.498 . . . . 75.45 110.426 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.77 111.29 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 108.445 -0.946 . . . . 65.04 108.445 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -85.48 158.95 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.689 0.756 . . . . 73.3 111.039 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.0 p -118.1 121.71 41.25 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.371 -1.286 . . . . 73.51 110.756 -172.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.77 112.26 65.5 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 123.781 0.832 . . . . 75.34 109.895 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.97 176.57 8.81 Favored 'Trans proline' 0 C--N 1.362 1.27 0 C-N-CA 122.459 2.106 . . . . 74.44 112.634 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 59' ' ' ARG . 73.5 p -64.81 -30.7 71.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.899 0.88 . . . . 34.52 112.565 -173.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -6.4 47.54 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.362 0.504 . . . . 74.53 112.362 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 38.4 m-20 -107.34 35.28 3.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.299 0.639 . . . . 62.44 109.657 169.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HD3' ' HD3' ' A' ' 65' ' ' ARG . 1.1 tptm -50.45 -47.66 56.74 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.902 1.281 . . . . 70.23 112.457 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.49 -34.19 77.37 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.996 0.903 . . . . 74.2 110.026 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 44.1 tttm -82.88 -18.68 39.38 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.541 -1.663 . . . . 64.54 111.444 -170.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.8 t -53.28 -49.71 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 123.898 0.879 . . . . 61.32 111.553 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.04 -43.14 77.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.314 1.046 . . . . 74.53 112.126 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -64.8 -48.57 73.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.509 -0.769 . . . . 74.44 110.9 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 24.8 mm-40 -60.98 -37.1 81.25 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.155 0.582 . . . . 74.01 111.41 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mt -63.37 -42.56 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.635 1.174 . . . . 71.51 110.202 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -58.94 -39.4 81.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.969 . . . . 72.45 111.29 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -71.14 -46.64 61.15 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.303 -0.629 . . . . 73.43 109.303 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.08 -30.46 70.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.994 -1.003 . . . . 62.42 111.863 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HG3' HD21 ' A' ' 78' ' ' LEU . 76.6 ttt180 -58.72 -49.55 77.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.264 1.026 . . . . 71.5 110.265 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -65.01 -40.73 95.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.615 -1.175 . . . . 71.52 111.169 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -81.35 -12.42 59.01 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.275 -0.875 . . . . 70.34 111.646 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.94 13.34 80.91 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 114.591 0.596 . . . . 73.31 114.591 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -92.19 153.63 43.09 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 123.112 0.565 . . . . 62.34 110.924 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 48.1 Cg_endo -66.73 145.49 75.54 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.177 1.918 . . . . 60.23 110.371 165.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -127.71 125.42 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.39 -0.967 . . . . 74.52 108.39 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' THR . 58.4 t -95.33 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.012 -0.736 . . . . 63.44 109.012 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.9 t -96.79 109.55 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.086 0.954 . . . . 74.13 108.632 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -76.09 107.58 8.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.591 0.71 . . . . 71.43 109.66 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -100.77 150.54 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-N 113.769 -1.56 . . . . 41.44 107.444 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.629 ' HB2' HG21 ' A' ' 34' ' ' THR . 48.1 ttt180 -94.97 163.1 13.46 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.044 -0.724 . . . . 75.23 109.044 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.13 -29.93 75.93 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.194 0.309 . . . . 65.25 113.807 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 13.84 66.45 Favored Glycine 0 C--N 1.347 1.172 0 C-N-CA 122.609 0.147 . . . . 72.4 113.08 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.78 28.9 8.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.185 0.994 . . . . 74.44 109.232 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.58 -40.03 71.48 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.328 1.051 . . . . 63.41 112.499 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.72 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.5 mp0 -64.31 -47.42 79.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.124 -0.943 . . . . 63.4 110.631 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 92.6 mtt180 -62.76 -36.19 82.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.739 -0.664 . . . . 72.44 110.529 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.7 -51.91 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.478 0.711 . . . . 53.3 111.503 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.5 pttt -73.41 -27.01 61.21 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.603 0.564 . . . . 73.0 111.971 -174.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -74.61 -48.46 26.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.59 0.356 . . . . 64.34 111.048 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.39 -31.17 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.684 0.793 . . . . 74.04 110.013 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.36 -46.9 75.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.93 0.892 . . . . 73.13 111.572 174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.14 -39.09 91.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.075 0.55 . . . . 75.1 110.144 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.5 t80 -60.8 -55.06 37.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.821 -1.082 . . . . 73.22 110.117 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.45 75.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.945 0.778 . . . . 54.34 111.525 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -66.47 -37.26 84.73 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.157 0.583 . . . . 74.34 110.752 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -24.25 61.75 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.845 0.458 . . . . 64.42 110.869 174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 7.9 mm-40 -77.08 -0.12 23.55 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.132 0.573 . . . . 61.24 111.353 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.98 37.27 60.52 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.492 0.495 . . . . 74.14 112.1 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.62 HD21 ' HG3' ' A' ' 48' ' ' ARG . 43.5 mt -116.9 136.98 52.53 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.976 0.91 . . . . 71.1 108.823 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.796 ' HB2' HG22 ' A' ' 3' ' ' VAL . 22.9 mmm180 -67.26 119.08 11.55 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.215 -0.661 . . . . 74.03 109.215 173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 51.9 t -95.91 118.46 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 75.53 109.558 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.507 HD11 ' HE3' ' A' ' 125' ' ' LYS . 1.8 mp -106.92 118.48 54.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 N-CA-C 107.981 -1.118 . . . . 73.24 107.981 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG13 HD13 ' A' ' 8' ' ' LEU . 93.3 t -105.21 112.05 37.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 N-CA-C 108.094 -1.076 . . . . 64.55 108.094 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -109.77 104.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 108.824 -0.806 . . . . 73.41 108.824 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mt -93.63 122.41 45.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 109.099 -0.704 . . . . 72.53 109.099 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG11 HG21 ' A' ' 14' ' ' ILE . 4.1 t -112.88 102.58 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.53 -0.915 . . . . 31.44 108.53 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -150.7 140.24 21.54 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.365 0.666 . . . . 71.13 109.975 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.98 -29.92 69.9 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.205 -0.665 . . . . 75.13 109.205 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.58 94.82 1.02 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.799 -1.092 . . . . 61.12 108.948 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.41 -22.18 64.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.359 0.663 . . . . 75.32 111.953 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.1 -38.36 82.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.081 0.552 . . . . 61.14 109.929 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.75 -34.39 71.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.037 0.535 . . . . 64.14 110.753 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.01 -46.79 89.32 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.432 0.458 . . . . 71.15 109.806 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.99 -47.71 67.8 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.642 1.177 . . . . 74.34 111.538 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.67 -50.22 70.11 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.524 0.515 . . . . 73.11 110.419 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.83 -29.51 75.21 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.708 -0.678 . . . . 72.52 113.087 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.753 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.6 t80 -61.82 -58.38 8.21 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.562 0.345 . . . . 73.11 110.252 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -73.74 -37.48 65.07 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 123.96 0.787 . . . . 73.12 111.126 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.59 -45.72 92.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.751 0.821 . . . . 61.42 111.192 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.675 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.0 mptt -79.1 -33.98 43.94 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.973 0.509 . . . . 74.43 111.035 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -68.43 -36.52 79.18 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.152 0.581 . . . . 75.0 111.702 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.074 0.55 . . . . 55.24 111.172 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -81.84 -10.54 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.649 0.78 . . . . 61.15 111.112 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.94 8.45 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 116.322 -0.399 . . . . 71.01 113.513 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 10.9 m-85 -104.7 138.31 41.21 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.974 -0.75 . . . . 72.02 108.974 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' HG13 ' A' ' 81' ' ' ILE . 15.9 m-20 -76.05 100.73 5.02 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.251 -1.018 . . . . 72.42 108.251 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 96' ' ' TYR . 11.5 t -101.09 139.16 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 110.035 -0.357 . . . . 75.01 110.035 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.47 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 86.3 m-85 -127.14 131.81 50.7 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.454 -1.313 . . . . 72.33 107.454 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 p -106.91 136.63 46.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 p -144.43 138.07 27.45 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.826 0.851 . . . . 75.44 109.257 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.16 -35.19 36.91 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.385 -0.598 . . . . 53.33 109.385 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.77 -171.53 3.96 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 111.658 0.244 . . . . 73.35 111.658 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -53.66 -44.89 70.02 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.387 1.075 . . . . 63.24 111.847 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -54.8 -47.69 73.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 123.873 0.733 . . . . 74.31 112.242 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.47 -49.03 62.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.972 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.58 71.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.974 -1.012 . . . . 63.22 111.976 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.6 ttmt -65.39 -37.5 87.16 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.766 1.226 . . . . 65.23 110.676 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.48 -51.4 13.08 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.911 -1.04 . . . . 64.55 109.605 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.54 -31.47 72.27 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.972 0.909 . . . . 72.42 112.167 -174.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.0 tp -70.47 -50.25 40.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.815 0.846 . . . . 73.23 110.658 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 36.4 mtmm -67.55 -32.41 73.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.805 -0.634 . . . . 64.31 111.109 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.27 -39.16 93.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.499 0.72 . . . . 75.42 111.45 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.07 -30.78 68.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.676 0.79 . . . . 51.01 111.249 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.01 -34.66 69.03 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.406 0.683 . . . . 73.12 110.698 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 40.4 mt-10 -69.95 -50.88 37.53 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.399 0.679 . . . . 63.23 111.803 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.57 -20.85 63.65 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.519 0.512 . . . . 72.14 112.025 -175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.1 p -79.16 -26.56 42.74 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.266 0.627 . . . . 64.23 111.502 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.04 -41.31 1.31 Allowed Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.318 -0.401 . . . . 61.33 112.328 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -64.46 102.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.498 0.719 . . . . 54.24 111.167 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.5 mt -100.17 157.95 16.21 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.717 -0.846 . . . . 63.52 108.717 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 25' ' ' HIS . 42.4 mt-10 -64.39 119.5 10.48 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.674 -0.861 . . . . 74.13 108.674 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.449 ' HE1' ' HD2' ' A' ' 27' ' ' PRO . 46.6 m80 -58.05 -22.26 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.349 1.46 . . . . 72.01 112.865 -171.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -86.93 20.72 2.52 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.75 0.82 . . . . 73.42 110.718 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 58.88 36.35 24.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.384 1.474 . . . . 74.44 112.036 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 62.77 30.81 16.73 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.247 1.019 . . . . 65.43 112.501 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -83.75 11.85 6.82 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.543 0.337 . . . . 54.45 111.391 170.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 125.126 1.37 . . . . 70.43 110.53 175.801 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.813 -0.44 . . . . 74.3 109.813 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.74 129.12 6.38 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.131 -0.787 . . . . 74.53 111.131 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 79' ' ' ARG . 61.1 t -141.98 130.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.125 0.97 . . . . 63.53 108.478 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 t -109.25 113.52 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.861 0.464 . . . . 72.23 110.29 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 108.89 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.905 0.882 . . . . 74.12 109.176 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.565 HD23 ' HB ' ' A' ' 56' ' ' VAL . 29.0 mt -98.99 105.21 17.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.003 0.921 . . . . 70.41 110.036 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.597 HG11 HD13 ' A' ' 18' ' ' LEU . 21.6 t -100.71 109.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 122.371 0.269 . . . . 75.42 110.604 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 mp -87.52 103.85 15.93 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.472 -0.936 . . . . 73.45 108.472 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -105.66 136.16 45.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.697 -0.483 . . . . 53.25 109.697 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.3 -6.3 88.86 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.613 -0.721 . . . . 74.52 112.382 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -140.19 132.97 29.07 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.176 0.991 . . . . 72.03 109.649 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.72 -31.85 65.29 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.35 1.06 . . . . 74.1 111.961 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttp-105 -69.06 -35.06 76.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.921 -0.4 . . . . 73.02 109.921 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.65 HG21 HG11 ' A' ' 85' ' ' VAL . 58.5 mt -60.73 -46.08 96.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 O-C-N 124.109 0.88 . . . . 72.21 109.632 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.44 -33.82 70.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.306 0.642 . . . . 72.23 111.914 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -72.45 -46.24 55.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.747 0.419 . . . . 73.1 110.352 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.21 -39.02 74.61 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.96 0.904 . . . . 72.24 111.547 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 7' ' ' VAL . 96.3 mt -67.96 -42.32 81.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.404 -0.816 . . . . 70.53 110.791 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.5 ttm-85 -57.68 -54.59 45.1 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.849 0.718 . . . . 74.35 111.632 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 8.5 ptmm? -64.27 -31.17 72.27 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.941 0.776 . . . . 72.13 111.798 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 26.9 mm-40 -66.85 -37.85 85.27 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.922 0.489 . . . . 71.43 111.843 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 123' ' ' LEU . 69.6 t -64.3 -42.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 O-C-N 124.033 0.833 . . . . 71.11 109.939 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 15.8 mm100 -66.25 -33.09 74.95 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.022 0.826 . . . . 74.14 111.27 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 39.4 mmtm -74.97 -36.84 62.04 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.91 0.484 . . . . 72.22 110.771 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -73.35 -35.18 65.94 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.317 0.647 . . . . 72.24 110.214 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -162.4 120.4 1.33 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.102 -1.073 . . . . 74.54 108.102 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -87.19 4.1 6.26 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.873 2.382 . . . . 73.13 114.253 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -117.87 6.46 12.26 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.389 0.676 . . . . 64.21 111.909 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.58 143.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.339 0.256 . . . . 72.01 110.317 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.58 140.1 37.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.424 0.69 . . . . 75.2 109.892 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 p -141.97 124.72 15.98 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 82.1 t -134.31 128.01 19.13 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.883 0.873 . . . . 74.24 110.199 -171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -88.42 -178.47 2.06 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.897 2.398 . . . . 75.54 113.395 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 59' ' ' ARG . 52.9 p -63.21 -38.74 92.35 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.701 1.2 . . . . 70.02 112.749 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -1.02 14.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.268 0.627 . . . . 74.52 112.479 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 40' ' ' VAL . 32.5 m-20 -115.33 38.47 3.22 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.507 0.723 . . . . 71.53 109.524 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -45.66 82.91 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.03 0.932 . . . . 71.42 111.4 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -67.82 -22.93 65.13 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.682 -1.144 . . . . 74.42 111.147 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.0 mmtt -91.22 -21.39 21.13 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.133 0.973 . . . . 65.11 111.966 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 69' ' ' ILE . 69.0 t -52.85 -49.69 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.8 0.84 . . . . 63.01 112.297 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.97 -37.35 84.46 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.698 0.799 . . . . 71.22 111.881 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.85 -39.26 93.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.881 0.472 . . . . 71.24 110.422 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 14.7 mm-40 -78.51 -26.78 45.96 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.028 -0.533 . . . . 75.4 111.263 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.18 -42.8 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.392 0.677 . . . . 75.53 109.252 170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.3 -39.31 86.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.206 -0.906 . . . . 73.12 110.317 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.19 -49.85 68.17 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.004 0.815 . . . . 62.22 110.846 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.81 83.37 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.871 0.732 . . . . 74.34 110.508 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -62.24 -51.72 66.6 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.572 -0.74 . . . . 71.23 111.71 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' A' ' 50' ' ' GLN . 16.6 ptpt -69.55 -26.55 64.55 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 123.421 0.451 . . . . 44.05 112.193 -172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 49' ' ' LYS . 72.1 mt-30 -93.8 -9.19 38.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.493 0.717 . . . . 74.23 111.596 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.57 54.67 7.32 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.501 -0.64 . . . . 71.25 111.501 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -136.48 151.77 73.58 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.148 1.379 . . . . 75.33 109.419 -170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -81.48 165.37 18.46 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 121.664 1.576 . . . . 75.34 112.456 166.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.8 tt -138.88 121.98 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.237 -0.892 . . . . 73.12 108.649 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -99.12 105.31 17.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.614 -0.884 . . . . 70.34 108.614 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.5 t -95.17 112.62 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.772 0.829 . . . . 62.42 109.449 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -81.74 106.62 13.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.615 -0.721 . . . . 75.21 109.127 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 62' ' ' ASP . 86.6 t -101.41 149.36 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.381 1.472 . . . . 63.4 107.084 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 34' ' ' THR . 15.3 ttt180 -95.52 158.01 15.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.487 -0.56 . . . . 64.23 109.487 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 81.01 0.24 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.298 -0.721 . . . . 64.32 111.298 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.54 -26.56 0.26 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.303 -0.719 . . . . 72.13 111.303 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 31.2 m-20 -94.58 42.76 1.09 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.38 0.672 . . . . 64.44 109.69 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.05 -29.21 70.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 65.11 111.638 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -68.64 -43.44 76.25 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.924 -0.58 . . . . 73.43 110.519 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -59.39 -37.8 78.88 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.522 0.329 . . . . 61.11 110.392 175.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.66 -51.01 71.27 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.866 0.729 . . . . 63.13 111.188 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -73.67 -31.19 63.34 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.076 0.399 . . . . 74.42 112.076 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.41 -41.94 60.07 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.1 110.95 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 40' ' ' VAL . 85.0 mt -71.82 -32.53 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.285 0.634 . . . . 71.13 109.493 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.04 -39.55 93.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.641 0.776 . . . . 75.4 111.095 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 29.7 tt0 -65.14 -43.31 92.27 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.154 0.909 . . . . 72.35 109.554 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 63.2 t80 -63.23 -45.18 92.82 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.26 0.975 . . . . 74.31 110.727 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.49 94.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.485 0.714 . . . . 50.01 110.903 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -68.34 -32.54 72.72 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.593 -0.73 . . . . 73.45 110.667 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 17.8 ttmm -66.02 -34.19 77.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.763 1.225 . . . . 74.44 110.877 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 9.7 mm-40 -74.66 -13.61 60.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.122 0.969 . . . . 72.24 111.328 175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.64 32.98 28.91 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.694 -0.562 . . . . 70.43 111.694 -174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 28.5 mt -106.97 150.59 26.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.505 0.722 . . . . 70.05 109.923 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.41 126.54 29.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.213 -0.662 . . . . 73.53 109.213 176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.4 116.07 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.409 -0.589 . . . . 75.41 109.409 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.6 mp -112.55 114.12 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.357 -0.979 . . . . 63.32 108.357 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.91 112.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 109.082 -0.71 . . . . 74.5 109.082 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.94 107.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 118.633 0.652 . . . . 74.24 109.91 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.9 mt -90.62 111.02 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.301 -0.629 . . . . 73.03 109.301 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.65 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -95.65 101.91 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.002 -0.74 . . . . 75.53 109.002 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 m -148.54 130.72 15.48 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.473 -0.936 . . . . 73.24 108.473 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.56 -25.97 66.9 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.049 0.539 . . . . 71.11 110.549 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.22 104.26 6.66 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.413 -0.812 . . . . 75.24 108.855 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 41.3 mt-10 -64.83 -23.16 67.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.906 -0.588 . . . . 63.21 111.805 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 5.0 mp0 -58.67 -44.5 90.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.382 0.673 . . . . 72.52 109.81 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.44 76.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.608 0.763 . . . . 63.12 111.23 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.79 -54.07 31.89 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.411 0.684 . . . . 62.22 111.409 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 15.3 mmt180 -70.39 -35.49 73.52 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.701 0.626 . . . . 75.42 110.473 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -66.19 -52.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.616 -0.72 . . . . 72.32 110.166 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 -31.54 75.99 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.844 -0.616 . . . . 63.23 112.808 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.695 ' HA ' HG11 ' A' ' 106' ' ' VAL . 90.3 t80 -60.81 -58.09 9.91 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.243 0.617 . . . . 64.02 110.21 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.68 -41.11 92.81 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.331 1.019 . . . . 60.35 111.936 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.9 -44.43 96.12 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.923 0.765 . . . . 74.54 112.307 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.51 -33.36 48.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.383 0.273 . . . . 72.12 110.947 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -68.37 -34.8 76.71 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.262 0.625 . . . . 62.4 111.912 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -74.03 -15.46 61.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.24 111.231 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -87.98 -6.85 57.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.8 0.84 . . . . 74.51 110.747 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.95 38.15 6.56 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.302 0.376 . . . . 71.24 113.156 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -112.67 140.11 47.72 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.879 -0.786 . . . . 64.23 108.879 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -82.34 102.06 10.99 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.295 -0.632 . . . . 72.53 109.295 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.1 t -101.3 145.98 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.732 0.301 . . . . 61.03 110.525 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -121.96 145.39 48.17 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.901 1.28 . . . . 72.11 109.301 172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.6 p -115.66 127.28 55.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.625 0.77 . . . . 74.01 109.229 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -137.66 132.87 33.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.311 0.644 . . . . 51.51 109.739 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -77.37 -28.62 52.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.388 0.675 . . . . 73.31 110.386 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -152.99 -179.63 7.85 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.599 -0.728 . . . . 74.53 111.43 -166.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -64.65 -45.16 87.93 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.682 1.193 . . . . 73.22 111.675 -176.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.97 -44.63 70.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 124.233 0.958 . . . . 64.01 111.158 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 11.8 tp10 -67.42 -48.37 67.5 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.382 -1.281 . . . . 63.25 110.541 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.68 -34.94 79.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.436 -0.802 . . . . 75.03 111.922 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.574 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 35.2 ttmt -62.45 -34.31 76.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.604 1.162 . . . . 72.44 111.811 -175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 114' ' ' GLU . 44.2 mtmt -75.37 -50.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.251 0.621 . . . . 64.35 110.072 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 30.3 mmtp -64.58 -27.99 69.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.31 1.044 . . . . 73.32 112.078 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 18' ' ' LEU . 49.8 tp -70.23 -42.26 72.49 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.725 -1.125 . . . . 72.42 110.642 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 99.6 mttt -72.46 -29.5 63.73 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.075 -0.511 . . . . 64.24 111.26 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 54.1 mt-10 -62.78 -37.39 86.47 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.733 0.646 . . . . 54.44 110.435 170.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -71.41 -33.91 69.87 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.899 0.879 . . . . 54.41 110.908 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 HG22 ' A' ' 22' ' ' VAL . 93.0 mt -67.53 -37.0 82.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.277 0.631 . . . . 75.44 110.711 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 57.8 mt-10 -60.4 -42.88 96.83 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.995 0.518 . . . . 54.43 110.683 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 61.9 mttm -69.74 -25.28 63.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.701 0.801 . . . . 62.43 111.607 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 p -93.43 2.32 56.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.294 0.638 . . . . 72.15 112.228 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.57 -17.6 58.18 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-O 119.397 -0.668 . . . . 65.51 113.491 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 66.6 m -67.44 99.49 0.75 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.494 0.647 . . . . 61.2 109.584 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.061 0.945 . . . . 72.0 110.587 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -99.22 -72.08 0.67 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.012 -0.736 . . . . 60.15 109.012 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -89.61 115.44 27.0 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 109.568 -0.53 . . . . 74.34 109.568 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -112.55 89.9 3.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.857 0.863 . . . . 74.35 109.347 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -150.7 94.5 2.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.335 1.054 . . . . 75.41 109.651 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -72.67 114.24 10.59 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.315 -0.994 . . . . 72.35 108.315 169.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -80.35 74.0 7.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.953 0.501 . . . . 73.34 111.301 -172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.6 t60 . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 124.918 1.287 . . . . 74.33 107.661 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.712 -0.477 . . . . 60.13 109.712 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.34 153.88 8.03 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.227 -1.149 . . . . 74.24 110.227 -172.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 126' ' ' SER . 47.8 t -142.45 135.0 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.898 0.879 . . . . 64.15 109.58 -174.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.3 t -117.06 113.84 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.072 0.549 . . . . 63.44 109.995 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.35 109.41 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.685 0.794 . . . . 62.4 109.101 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.06 104.38 16.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.059 0.944 . . . . 74.1 109.487 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.2 t -94.33 105.41 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.572 -0.529 . . . . 72.43 109.572 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.479 HD13 HG13 ' A' ' 82' ' ' VAL . 7.6 mp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.088 -1.078 . . . . 73.35 108.088 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.8 p -107.24 136.56 46.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.312 0.645 . . . . 74.45 109.764 -174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.14 -9.12 59.79 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.19 -0.459 . . . . 73.53 112.74 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -148.62 124.61 10.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.932 1.293 . . . . 54.32 108.307 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.37 -26.02 68.28 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.102 0.961 . . . . 75.52 111.998 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -57.42 -43.09 83.52 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.252 0.621 . . . . 74.2 109.919 173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 85' ' ' VAL . 64.5 mt -61.41 -39.22 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.322 0.649 . . . . 64.33 110.425 176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -58.79 -37.59 76.68 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.35 0.66 . . . . 53.41 112.111 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.56 -37.47 74.01 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.667 0.387 . . . . 72.53 110.456 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 52.3 mt-10 -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.765 -0.652 . . . . 43.31 110.993 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 88.5 mt -78.55 -31.15 47.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.552 0.741 . . . . 70.41 111.248 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -62.66 -48.39 79.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.37 0.668 . . . . 74.0 111.393 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -61.89 -29.06 69.95 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.089 -0.959 . . . . 65.45 111.137 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 28.4 mm-40 -66.49 -43.14 86.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.347 0.659 . . . . 72.32 111.063 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.42 -39.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 123.994 0.809 . . . . 73.35 110.254 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.15 -29.89 64.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.313 -0.858 . . . . 71.25 111.62 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.07 -33.42 57.12 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.716 0.407 . . . . 73.44 110.336 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -69.32 -52.45 27.19 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.031 0.932 . . . . 73.45 110.014 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 33.9 t70 -155.98 117.09 2.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.475 1.11 . . . . 71.21 108.648 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 17.2 Cg_exo -67.15 -17.94 50.77 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.956 2.437 . . . . 72.24 113.494 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -86.29 -16.85 36.25 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.581 0.752 . . . . 71.42 111.321 -170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.09 120.8 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.472 -0.566 . . . . 44.31 109.472 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -70.13 142.67 52.52 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.68 0.613 . . . . 70.1 110.658 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -131.22 121.49 24.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.635 0.774 . . . . 64.53 109.15 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 40' ' ' VAL . 20.6 t -114.37 122.54 34.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.883 0.873 . . . . 63.43 109.671 -173.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.0 176.49 8.88 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.735 2.29 . . . . 62.34 112.672 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 59' ' ' ARG . 49.7 p -69.1 -30.06 68.27 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.506 0.723 . . . . 71.31 111.913 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -59.29 -30.53 68.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 62.45 111.509 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 85.4 m-20 -97.26 33.71 1.92 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.335 1.054 . . . . 71.0 111.041 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 12.5 tmtt? -55.17 -44.23 75.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.725 0.81 . . . . 74.32 112.199 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.14 -39.28 89.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.121 0.486 . . . . 63.21 110.227 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 68.8 mttm -67.97 -25.57 65.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.282 -0.872 . . . . 75.34 111.842 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 32' ' ' VAL . 91.9 t -53.88 -45.22 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 123.777 0.673 . . . . 51.12 111.263 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -53.55 -44.34 69.18 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.17 0.988 . . . . 64.13 110.99 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 10.6 mm-40 -69.98 -41.33 74.59 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 115.526 -0.761 . . . . 64.21 110.157 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.06 -34.53 78.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.088 0.955 . . . . 73.13 111.723 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 73' ' ' ALA . 76.1 mt -71.3 -38.03 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.814 0.846 . . . . 73.14 109.318 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 27.7 tt0 -59.58 -41.96 91.43 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.53 -0.759 . . . . 72.42 110.126 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 61.9 mmtt -68.18 -43.51 78.0 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.854 -0.424 . . . . 72.12 109.854 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.14 77.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.565 0.746 . . . . 42.32 111.347 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 77.0 ttt180 -69.07 -46.45 67.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.21 0.604 . . . . 72.44 110.335 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -69.06 -34.25 74.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.148 0.979 . . . . 73.22 110.142 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -90.87 -13.02 34.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.178 0.991 . . . . 64.31 110.838 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.11 39.76 92.78 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 123.582 0.551 . . . . 41.34 114.091 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -139.52 161.56 56.22 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.262 1.025 . . . . 75.24 110.478 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.73 168.08 22.54 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.492 2.128 . . . . 75.31 114.749 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.1 tt -155.35 139.64 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 113.473 -1.694 . . . . 72.52 108.141 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.57 117.69 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.114 -0.698 . . . . 61.44 109.114 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.82 131.91 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.702 -0.851 . . . . 72.22 108.702 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 86.2 m-85 -104.06 111.78 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.948 0.899 . . . . 73.34 109.245 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG11 ' HB2' ' A' ' 66' ' ' ALA . 61.8 t -111.61 153.35 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.002 1.721 . . . . 72.43 108.005 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 34' ' ' THR . 53.8 mtm180 -90.67 166.61 13.06 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.638 0.653 . . . . 75.43 110.593 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.73 65.14 4.18 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 110.9 -0.88 . . . . 22.13 110.9 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.33 -35.55 0.07 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 109.199 -1.561 . . . . 65.13 109.199 -172.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.22 25.09 0.62 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.577 1.151 . . . . 65.21 110.917 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.36 -36.4 75.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.938 1.295 . . . . 74.52 111.32 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.0 -32.39 73.74 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.789 0.836 . . . . 75.13 111.346 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 83.4 mtt180 -78.98 -37.46 39.35 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.375 0.67 . . . . 74.33 109.934 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.74 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.44 -36.27 80.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.787 0.835 . . . . 60.34 112.841 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.75 -36.14 80.0 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.036 0.534 . . . . 73.32 111.096 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.11 -36.74 64.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.859 0.864 . . . . 70.45 111.159 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.27 -41.7 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.894 0.878 . . . . 75.14 109.895 172.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -65.65 -42.75 91.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.03 -0.986 . . . . 70.04 110.838 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.21 -37.1 77.91 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.177 -0.92 . . . . 74.21 110.536 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.8 t80 -62.77 -50.58 70.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.587 -0.523 . . . . 75.33 109.587 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 44' ' ' ILE . . . -59.8 -32.64 70.81 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.808 0.843 . . . . 52.21 111.74 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.26 -43.83 85.37 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.646 0.779 . . . . 73.43 110.091 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -33.51 73.7 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.969 0.908 . . . . 72.35 111.133 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 16.0 mm-40 -72.83 -13.45 61.3 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.896 0.478 . . . . 73.11 111.9 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.56 25.28 65.72 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.877 -0.489 . . . . 53.13 111.877 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 48' ' ' ARG . 30.4 mt -96.98 138.92 33.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.876 -0.787 . . . . 74.3 108.876 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.86 115.45 8.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.305 -0.998 . . . . 71.24 108.305 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.79 127.2 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 109.383 -0.599 . . . . 62.32 109.383 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.99 138.14 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.441 -1.689 . . . . 73.52 106.441 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 8' ' ' LEU . 95.0 t -123.19 125.78 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.178 -1.045 . . . . 72.12 108.178 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -122.5 106.12 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 109.344 -0.613 . . . . 71.21 109.344 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -91.26 131.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 14' ' ' ILE . 13.0 t -117.27 103.0 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.89 0.876 . . . . 73.15 109.16 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.0 t -162.21 155.95 21.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.621 0.768 . . . . 64.34 109.871 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.22 -24.83 34.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.654 -0.703 . . . . 75.31 110.54 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -78.12 108.55 11.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.319 0.647 . . . . 72.35 109.788 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -52.8 -37.12 59.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.051 0.94 . . . . 65.33 110.45 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 7.1 mt-10 -58.65 -54.23 49.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.673 -1.148 . . . . 73.54 110.391 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.42 82.28 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.666 0.786 . . . . 73.51 111.45 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.6 -54.01 48.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.33 -0.85 . . . . 74.44 110.855 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 79.3 mtp180 -68.92 -28.09 66.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.559 0.948 . . . . 65.34 113.559 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.3 mmtt -64.46 -51.51 62.72 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.649 0.658 . . . . 74.54 110.469 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.92 -32.35 61.03 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.188 -0.915 . . . . 72.23 111.97 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.75 ' HA ' HG11 ' A' ' 106' ' ' VAL . 66.4 t80 -59.95 -56.97 15.08 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.389 0.676 . . . . 70.11 110.288 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.01 -48.46 81.72 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.218 0.948 . . . . 74.1 110.83 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -56.83 -51.58 68.42 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.695 0.622 . . . . 73.02 111.698 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.95 -31.41 61.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.788 0.435 . . . . 73.24 110.996 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.51 -35.09 79.84 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.03 0.532 . . . . 65.42 110.969 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -74.7 -12.26 60.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.245 1.018 . . . . 71.11 111.708 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -87.81 2.33 51.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.77 0.428 . . . . 73.42 110.177 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.37 34.7 11.69 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.436 0.541 . . . . 41.51 112.881 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.456 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 8.9 m-30 -111.61 149.19 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.483 0.713 . . . . 74.21 110.25 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -79.27 104.2 9.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 170.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -105.75 138.47 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.878 -0.415 . . . . 70.11 109.878 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' CD1' ' HD2' ' A' ' 118' ' ' LYS . 92.2 m-85 -117.36 143.11 46.31 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.523 1.129 . . . . 74.32 109.955 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.4 p -108.77 129.43 55.37 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.381 -0.97 . . . . 63.34 108.381 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -126.04 132.13 52.04 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.436 -0.579 . . . . 70.41 109.436 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -82.68 -18.47 40.83 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.84 0.713 . . . . 72.12 111.563 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.48 -178.52 7.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.255 0.622 . . . . 72.1 110.44 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -38.31 88.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.069 0.948 . . . . 61.44 112.191 -175.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -66.24 -37.04 84.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.898 0.479 . . . . 75.11 111.191 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.74 -43.09 90.05 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.352 -0.84 . . . . 74.33 110.465 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.83 76.78 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.265 0.626 . . . . 72.52 110.884 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 38.4 ttmt -68.61 -45.5 71.75 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.392 1.477 . . . . 70.32 111.292 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -69.99 -43.2 71.91 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.332 0.395 . . . . 54.41 110.244 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 72.7 mmtt -69.58 -27.61 65.26 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.565 0.746 . . . . 63.21 111.772 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.07 -43.9 77.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.413 0.685 . . . . 73.44 110.69 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 56.5 mtmt -73.43 -28.84 62.19 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.922 -0.581 . . . . 65.0 111.147 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.88 -32.3 73.95 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.684 0.793 . . . . 70.0 111.122 169.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.68 -31.79 65.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.372 0.669 . . . . 71.3 110.757 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.31 -26.7 58.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.449 0.7 . . . . 74.53 110.612 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.605 ' HG2' HD21 ' A' ' 129' ' ' LEU . 50.3 mt-10 -65.94 -30.9 71.55 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.137 0.575 . . . . 70.31 110.52 171.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -72.91 -32.2 65.17 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.553 0.741 . . . . 55.35 111.479 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 3' ' ' VAL . 62.7 p -81.73 -11.83 58.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.972 0.509 . . . . 61.15 111.899 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.75 3.72 90.38 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.638 -0.534 . . . . 51.03 112.635 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.2 p -77.18 80.97 3.69 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.062 -0.718 . . . . 71.22 109.062 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' ' 124' ' ' GLU . 32.0 mt -131.89 -67.5 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.455 1.102 . . . . 75.22 108.866 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.15 135.37 14.91 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.69 -1.141 . . . . 54.03 109.029 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -156.63 32.01 0.32 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.298 1.047 . . . . 61.04 108.31 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -81.05 74.29 8.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.648 -1.16 . . . . 72.04 109.078 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -76.74 78.73 3.36 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.103 -0.953 . . . . 75.42 110.023 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -62.51 -35.77 80.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.279 -0.873 . . . . 73.21 110.699 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -148.74 -52.13 0.17 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.806 -1.088 . . . . 75.33 108.297 169.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 CA--C 1.564 1.519 0 O-C-N 124.637 1.21 . . . . 72.04 109.258 -178.504 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.72 -0.474 . . . . 70.43 109.72 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.09 122.17 28.75 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.354 0.409 . . . . 61.05 112.171 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.3 t -122.64 118.85 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.984 -1.117 . . . . 53.02 107.984 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.1 t -95.52 112.14 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.494 0.664 . . . . 64.32 109.49 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 55' ' ' VAL . 49.3 mt -97.67 132.69 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.942 1.297 . . . . 72.11 107.507 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.52 HD23 ' HB ' ' A' ' 56' ' ' VAL . 67.9 mt -126.93 100.55 6.19 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.368 -0.975 . . . . 73.43 108.368 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 103.41 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 109.062 -0.718 . . . . 75.41 109.062 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mp -88.71 109.72 20.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.844 -1.169 . . . . 64.44 107.844 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 62.9 p -106.7 136.3 46.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.824 0.45 . . . . 62.31 110.258 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.72 90.66 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.823 0.702 . . . . 54.24 111.933 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.83 129.95 56.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.267 . . . . 74.43 108.486 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.8 -26.66 60.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 72.05 111.575 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -64.27 -33.68 76.37 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 122.243 -0.286 . . . . 74.55 110.54 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG21 HG11 ' A' ' 85' ' ' VAL . 52.3 mt -57.12 -43.39 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.438 0.695 . . . . 64.23 110.204 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -59.82 -34.26 72.83 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.566 0.746 . . . . 71.0 112.249 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -70.73 -36.7 73.31 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.745 -0.662 . . . . 74.31 111.836 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 55.9 mm-40 -66.33 -39.48 89.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.002 0.521 . . . . 71.31 111.192 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 78.1 mt -68.99 -36.19 77.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.145 -0.934 . . . . 74.11 110.38 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 65.7 ttp85 -60.45 -44.68 95.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.158 0.983 . . . . 61.33 110.635 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 47.4 mtpt -57.62 -40.59 79.52 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.897 -1.047 . . . . 74.22 110.761 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 56.6 mm-40 -64.95 -45.76 84.39 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.387 0.675 . . . . 72.13 112.119 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 18' ' ' LEU . 61.8 t -64.37 -41.55 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.929 0.768 . . . . 63.1 110.803 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.77 -33.15 73.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.189 0.596 . . . . 61.42 111.239 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.18 -32.89 61.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.081 0.552 . . . . 74.51 110.733 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.76 -48.45 38.25 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.952 0.901 . . . . 75.14 110.283 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -158.04 104.94 1.73 Allowed Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.708 1.203 . . . . 64.44 107.785 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.47 -13.29 35.15 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.044 2.496 . . . . 71.42 113.433 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -76.5 -22.7 54.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.32 0.648 . . . . 71.32 111.399 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.96 125.64 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.027 0.531 . . . . 71.31 109.732 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -78.53 118.96 21.16 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 121.06 0.457 . . . . 61.11 110.884 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.456 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 4.4 p -104.14 118.71 37.3 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.237 -1.023 . . . . 71.14 108.237 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 36' ' ' ASP . 47.9 t -130.33 104.73 16.25 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.415 0.686 . . . . 72.34 109.386 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 96.3 Cg_endo -80.65 -172.34 1.49 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.585 2.19 . . . . 71.23 113.579 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ARG . 35.6 p -68.31 -7.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.191 -0.913 . . . . 73.31 112.225 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -71.62 -39.81 70.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.079 0.951 . . . . 70.11 108.949 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 32' ' ' VAL . 5.8 m-20 -104.67 32.25 4.23 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.348 1.059 . . . . 72.31 109.037 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 2.0 ttmp? -53.26 -45.01 68.63 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.414 1.486 . . . . 73.55 112.085 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -72.5 -37.79 68.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.375 -1.284 . . . . 74.01 109.144 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.66 -5.07 56.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.821 1.249 . . . . 72.12 112.54 -171.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 69' ' ' ILE . 86.9 t -58.08 -41.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.902 0.881 . . . . 60.11 111.075 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.13 -36.87 66.22 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.576 1.15 . . . . 62.51 112.036 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -75.6 -39.32 58.15 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 64.3 110.716 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 39.7 mm-40 -64.82 -25.29 67.85 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.892 0.877 . . . . 74.45 112.663 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.76 HD11 HG23 ' A' ' 69' ' ' ILE . 87.2 mt -62.05 -47.32 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.103 0.961 . . . . 64.12 109.434 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.13 -40.17 80.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.75 1.22 . . . . 70.32 111.031 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 63.0 mmtt -66.22 -43.89 85.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.326 -0.852 . . . . 73.34 109.839 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.09 87.35 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.992 0.917 . . . . 73.42 111.623 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 81.1 mtp180 -62.31 -51.09 69.04 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.942 0.497 . . . . 74.4 110.753 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -33.09 74.89 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.458 -0.792 . . . . 53.12 110.285 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -83.45 -16.5 45.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.728 0.811 . . . . 73.23 111.545 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.61 78.52 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 122.946 0.308 . . . . 65.23 113.475 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -124.29 163.82 33.79 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.338 1.055 . . . . 71.44 110.417 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.55 166.48 29.73 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.56 1.506 . . . . 73.35 113.598 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.67 122.11 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.929 -1.508 . . . . 75.43 106.929 171.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 HD12 ' A' ' 5' ' ' ILE . 24.0 t -100.04 105.54 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.002 -0.74 . . . . 54.23 109.002 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' HD23 ' A' ' 6' ' ' LEU . 38.2 t -90.55 138.97 18.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.599 1.16 . . . . 52.43 108.935 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 87.4 m-85 -114.0 108.44 17.02 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.08 143.36 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.882 1.273 . . . . 72.32 108.891 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB2' HG21 ' A' ' 34' ' ' THR . 42.9 ttm180 -79.24 142.78 35.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.994 -0.743 . . . . 74.14 108.994 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.34 93.06 0.19 Allowed Glycine 0 C--N 1.348 1.222 0 O-C-N 123.728 0.643 . . . . 54.44 111.648 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.78 -30.91 1.01 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.415 -1.074 . . . . 64.31 110.415 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -81.66 55.34 2.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.878 1.271 . . . . 52.4 110.423 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.89 -33.41 75.95 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.114 0.966 . . . . 72.43 111.716 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.34 -33.72 76.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.933 -0.576 . . . . 73.32 111.392 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 2.9 mpt_? -65.74 -37.1 85.46 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.524 -0.547 . . . . 70.34 109.524 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.21 -53.78 52.62 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.577 -0.283 . . . . 71.14 111.512 176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -72.51 -33.96 67.28 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.903 0.705 . . . . 73.53 112.903 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.5 -49.27 42.71 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.797 0.439 . . . . 75.11 111.477 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 44' ' ' ILE . 89.5 mt -62.89 -39.58 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.612 -0.514 . . . . 63.34 109.612 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -42.91 83.19 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.808 0.843 . . . . 73.1 112.448 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.69 -42.9 94.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.248 0.619 . . . . 74.34 110.373 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 86.7 t80 -62.65 -51.36 67.55 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.168 -0.924 . . . . 72.43 109.543 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.07 87.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.03 0.932 . . . . 71.4 112.472 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.9 -38.5 85.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.595 0.758 . . . . 54.3 110.208 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -74.45 -20.02 60.18 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.471 -0.786 . . . . 74.13 110.978 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 6.7 mm-40 -81.74 2.52 29.52 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.096 0.558 . . . . 71.21 110.807 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.72 25.47 53.22 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.097 0.379 . . . . 72.25 112.645 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 mt -105.23 164.83 11.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.224 0.61 . . . . 71.1 110.938 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.469 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.01 128.64 35.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.776 -0.824 . . . . 75.32 108.776 172.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.66 121.71 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.382 0.673 . . . . 75.04 109.304 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 122' ' ' ALA . 2.1 mp -116.3 116.25 51.7 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 107.81 -1.182 . . . . 70.43 107.81 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 106' ' ' VAL . 84.2 t -104.12 116.53 48.08 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.25 0 N-CA-C 109.001 -0.74 . . . . 61.2 109.001 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' HB2' ' A' ' 107' ' ' TYR . 61.0 mt -108.35 116.53 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.545 -0.722 . . . . 74.45 109.697 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -97.94 125.78 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.902 -0.777 . . . . 71.41 108.902 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 18.0 t -111.53 100.64 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.618 -1.253 . . . . 61.42 107.618 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -153.09 134.33 14.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.123 0.969 . . . . 73.22 108.512 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -91.19 56.36 3.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.254 1.026 . . . . 75.5 109.907 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -154.67 130.35 9.97 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.593 -1.262 . . . . 73.24 107.593 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -68.72 -35.97 77.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.994 0.809 . . . . 71.25 110.954 -170.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -76.34 -33.5 58.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.843 0.857 . . . . 70.41 111.591 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.27 -38.19 84.7 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.286 0.565 . . . . 70.42 110.597 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -71.85 -52.96 14.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.756 -1.111 . . . . 73.14 110.272 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -64.71 -47.75 77.18 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.87 0.692 . . . . 72.31 112.87 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -59.08 -49.73 76.75 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.497 0.498 . . . . 64.32 110.507 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.14 79.33 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 123.553 0.533 . . . . 63.03 112.629 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' HG11 ' A' ' 106' ' ' VAL . 75.7 t80 -63.29 -59.98 4.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.301 0.641 . . . . 73.33 110.596 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -71.51 -30.76 66.3 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.749 0.655 . . . . 74.44 111.314 -175.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.11 -51.4 61.5 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.832 0.853 . . . . 72.45 112.457 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -74.97 -34.1 61.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.731 0.412 . . . . 73.51 110.193 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' TYR . 45.9 tttm -67.92 -29.79 68.95 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.269 0.628 . . . . 64.15 110.449 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 34.3 ttmt -68.79 -33.06 73.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.358 1.063 . . . . 70.41 110.215 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.32 -4.97 53.38 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.133 0.973 . . . . 73.31 111.461 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.85 26.15 27.62 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.302 0.477 . . . . 40.34 113.079 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -102.54 121.78 43.06 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.992 -1.484 . . . . 54.15 106.992 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 31.8 t70 -69.91 103.81 2.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.022 0.529 . . . . 74.34 110.383 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 96' ' ' TYR . 36.7 t -99.53 137.9 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 122.194 -0.316 . . . . 72.24 111.618 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.546 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 82.9 m-85 -111.46 145.81 38.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 64.01 108.952 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -109.14 143.24 38.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.732 0.813 . . . . 72.34 109.465 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -148.75 134.48 18.84 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 70.44 109.902 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -68.89 -37.29 78.92 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.428 0.691 . . . . 75.04 111.107 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.95 -179.83 8.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.928 -1.033 . . . . 74.13 110.34 -165.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -43.53 93.98 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.118 1.367 . . . . 72.44 113.166 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -57.42 -42.17 81.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.928 0.491 . . . . 71.0 111.863 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -71.84 -45.82 60.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.564 -0.744 . . . . 60.44 111.157 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -61.17 -32.16 71.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.931 0.893 . . . . 73.21 111.684 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 37.9 ttmt -61.88 -44.37 96.95 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.119 1.367 . . . . 70.23 111.125 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -75.56 -43.74 47.02 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.978 -1.01 . . . . 64.35 110.293 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 42.3 mmtm -67.84 -25.17 65.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.462 1.105 . . . . 73.51 112.114 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.423 HD11 HG11 ' A' ' 55' ' ' VAL . 2.2 tt -71.9 -45.19 62.13 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.172 0.589 . . . . 74.13 109.516 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.29 -28.46 70.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.854 -0.612 . . . . 72.05 112.033 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -53.54 -46.32 70.14 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.169 0.509 . . . . 74.55 111.198 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -72.19 -34.36 68.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.031 -0.986 . . . . 73.21 111.648 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.31 -38.34 90.77 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.972 0.509 . . . . 75.31 110.49 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.33 -36.05 76.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.742 0.817 . . . . 73.3 111.53 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.91 -33.36 74.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.901 0.48 . . . . 74.5 111.464 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.7 p -84.47 -12.79 53.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.556 0.742 . . . . 61.33 112.405 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.63 40.25 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.782 -0.454 . . . . 74.3 114.024 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.5 m -76.8 75.72 3.43 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.833 0.825 . . . . 61.33 108.794 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.5 mt -99.59 141.08 32.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.667 -1.151 . . . . 74.42 109.891 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 132' ' ' HIS . 12.9 tt0 -109.8 148.96 30.53 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.377 -0.601 . . . . 73.5 109.377 170.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -130.4 7.03 4.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.125 0.97 . . . . 74.22 111.313 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.637 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 54.0 t60 -79.2 -60.83 2.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.629 0.371 . . . . 65.14 110.39 -173.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -86.81 66.29 9.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.036 -0.727 . . . . 74.41 109.036 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -74.61 -22.42 58.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.094 -0.957 . . . . 75.12 110.715 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -121.9 -57.69 1.78 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.053 0.941 . . . . 64.45 108.784 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.257 1.459 0 C-N-CA 123.473 0.709 . . . . 70.0 110.303 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.76 40.62 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.734 -0.546 . . . . 75.1 111.734 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 71.8 t -135.94 139.8 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.543 -0.91 . . . . 52.2 108.543 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.9 113.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.12 108.695 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.02 107.3 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.875 0.87 . . . . 64.41 108.704 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.8 mt -95.99 104.03 15.95 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.428 0.691 . . . . 73.12 109.323 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.9 t -99.64 105.17 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 109.278 -0.638 . . . . 62.15 109.278 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.459 ' HG ' ' HB ' ' A' ' 58' ' ' VAL . 6.9 mp -86.12 107.8 18.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 107.178 -1.415 . . . . 73.11 107.178 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 42.5 p -105.33 138.18 41.94 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.933 0.493 . . . . 74.34 110.118 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.96 -13.89 72.85 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 115.333 -0.849 . . . . 54.01 113.041 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -134.46 140.41 46.21 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.295 1.038 . . . . 73.44 109.509 173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.58 -40.18 95.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.179 0.992 . . . . 72.35 112.119 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -77.01 -29.53 55.47 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.071 0.549 . . . . 74.01 110.729 -173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.08 -35.3 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.029 0.532 . . . . 72.2 110.28 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.71 74.92 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.374 0.67 . . . . 74.02 111.684 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.3 -39.5 71.43 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.886 0.874 . . . . 62.15 111.407 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.04 -42.18 97.16 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.271 0.628 . . . . 61.3 110.821 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.4 mt -64.93 -43.25 93.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.146 -0.934 . . . . 65.44 109.868 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -54.48 -48.57 71.66 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 124.596 1.185 . . . . 71.44 111.735 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -56.74 -39.4 73.89 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.509 1.131 . . . . 73.54 110.677 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.96 -36.82 62.05 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 123.97 0.794 . . . . 73.52 110.15 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.5 t -56.73 -38.31 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.322 0.649 . . . . 63.32 110.598 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.4 -30.28 68.22 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.025 -0.989 . . . . 72.44 111.093 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -76.98 -37.32 55.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.739 0.816 . . . . 75.43 110.81 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.12 -49.3 52.15 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.459 0.703 . . . . 65.44 109.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -148.31 126.6 5.97 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.111 -0.495 . . . . 41.33 109.76 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -84.04 -11.87 8.55 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.79 2.327 . . . . 45.13 113.358 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -83.41 -32.75 25.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.548 0.739 . . . . 52.54 110.033 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 53' ' ' PRO . 49.0 t -62.69 134.83 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.241 0.616 . . . . 73.25 109.876 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -112.31 159.86 18.24 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.291 0.636 . . . . 75.55 110.45 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 55' ' ' VAL . 16.6 p -134.49 143.89 47.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.807 -1.088 . . . . 74.12 109.806 -170.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -126.49 112.86 23.11 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.42 109.563 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.16 172.31 13.26 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.726 2.284 . . . . 75.22 113.038 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 59' ' ' ARG . 59.4 p -67.28 -32.36 73.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.929 0.891 . . . . 73.01 112.606 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -21.94 66.06 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.25 0.62 . . . . 74.25 111.329 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 70.2 m-20 -92.0 38.9 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.515 0.726 . . . . 65.23 110.292 174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -56.71 -48.41 77.77 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.253 1.021 . . . . 54.14 112.546 -175.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.21 -35.5 78.07 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.692 0.758 . . . . 73.02 109.536 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 36.1 tttp -72.56 -23.74 61.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.605 -1.634 . . . . 64.32 111.88 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.67 -56.36 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.715 0.806 . . . . 65.22 111.559 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.01 -37.87 86.48 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.993 0.917 . . . . 70.54 111.559 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -63.3 -38.99 93.3 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.754 -1.112 . . . . 64.51 110.576 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 35.0 mm-40 -72.39 -34.52 67.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.857 0.463 . . . . 55.53 111.19 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.82 -32.86 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.918 0.887 . . . . 74.31 110.801 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG2' HH12 ' A' ' 48' ' ' ARG . 6.1 tm-20 -56.49 -55.9 27.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.523 0.729 . . . . 73.54 111.321 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -76.95 -30.7 56.15 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.911 -0.566 . . . . 63.5 111.716 178.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -34.1 73.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.267 0.485 . . . . 53.42 111.307 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 78' ' ' LEU . 30.3 ttp-105 -63.55 -51.22 66.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.973 1.309 . . . . 75.41 110.116 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.91 -36.19 80.61 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.895 -1.502 . . . . 65.04 111.467 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.797 ' HB3' HH11 ' A' ' 52' ' ' ARG . 29.7 mm-40 -80.49 -17.52 51.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.525 -0.761 . . . . 73.14 110.917 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 36.41 93.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.757 0.661 . . . . 72.34 113.399 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.797 HH11 ' HB3' ' A' ' 50' ' ' GLN . 84.8 mtt85 -118.56 149.13 45.62 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.628 0.771 . . . . 72.3 110.85 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 29' ' ' VAL . 36.2 Cg_endo -64.72 136.43 49.48 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.763 2.309 . . . . 63.15 112.476 171.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.04 120.91 50.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.915 -1.143 . . . . 53.14 107.915 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.766 ' HB ' HG22 ' A' ' 31' ' ' THR . 42.0 t -97.84 105.33 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.463 -0.569 . . . . 74.24 109.463 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 6' ' ' LEU . 61.1 t -94.13 114.79 31.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 123.772 0.829 . . . . 74.5 109.158 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.77 119.22 25.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.349 -0.612 . . . . 73.43 109.349 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 66' ' ' ALA . 64.3 t -105.34 144.67 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.347 1.059 . . . . 55.12 108.208 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB2' HG21 ' A' ' 34' ' ' THR . 30.5 ttp180 -83.76 144.12 29.53 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.658 0.783 . . . . 71.35 109.255 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 82.8 0.13 Allowed Glycine 0 C--N 1.346 1.104 0 O-C-N 123.938 0.774 . . . . 51.03 112.425 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.68 -25.74 0.58 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.15 -0.78 . . . . 64.33 111.15 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.78 36.78 0.67 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.047 0.939 . . . . 64.23 110.278 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.23 -35.15 80.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.872 1.669 . . . . 70.34 110.725 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -55.99 -43.17 77.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.144 1.378 . . . . 71.54 111.543 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HD3' ' A' ' 37' ' ' LYS . 87.9 mtt180 -80.18 -32.07 38.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.439 1.096 . . . . 71.21 111.306 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -60.8 -33.73 73.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.734 0.814 . . . . 75.12 111.674 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -67.67 -32.68 73.51 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 123.833 0.708 . . . . 73.31 111.169 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.84 -43.13 72.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.133 0.973 . . . . 72.11 110.671 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.605 HD11 ' HE3' ' A' ' 37' ' ' LYS . 40.0 mt -65.58 -44.46 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.196 -0.911 . . . . 41.04 109.323 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.53 -41.89 98.01 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.854 -1.067 . . . . 73.52 111.382 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.64 -45.25 79.63 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.013 0.821 . . . . 74.43 110.344 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.3 t80 -62.95 -43.93 97.44 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.028 0.83 . . . . 75.22 110.493 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.06 82.85 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.907 0.754 . . . . 72.04 110.46 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -66.23 -31.18 71.85 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.417 -0.81 . . . . 74.3 110.92 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -68.7 -34.1 75.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.394 1.078 . . . . 63.11 110.571 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 6.9 mm-40 -79.17 -7.14 57.97 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.458 -0.792 . . . . 73.54 110.706 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.84 12.17 72.21 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.219 0.438 . . . . 60.42 112.796 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 48' ' ' ARG . 33.0 mt -84.17 143.94 29.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.084 0.954 . . . . 73.44 110.229 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 113.7 9.46 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.904 0.753 . . . . 70.23 109.147 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.69 120.69 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.745 . . . . 72.55 110.206 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.38 113.91 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.738 -1.208 . . . . 62.23 107.738 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.67 115.85 48.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.876 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 107' ' ' TYR . 58.9 mt -117.27 109.95 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.767 0.712 . . . . 74.3 109.967 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.449 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.9 mp -91.14 130.7 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.176 -1.046 . . . . 75.34 108.176 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 22.5 t -118.4 102.32 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.918 1.287 . . . . 64.44 107.593 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 92' ' ' LEU . 71.1 m -151.12 139.11 19.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.796 0.439 . . . . 63.23 110.082 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.67 -36.41 74.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.132 0.973 . . . . 71.42 111.42 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.73 122.61 27.87 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.816 0.846 . . . . 71.41 110.074 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -69.33 -21.71 63.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.074 0.949 . . . . 73.41 111.397 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -69.45 -38.81 77.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.72 0.408 . . . . 51.05 111.659 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.88 78.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.979 0.418 . . . . 54.55 110.376 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 86' ' ' SER . 81.9 mt -64.21 -45.97 85.96 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.139 -0.937 . . . . 71.12 110.59 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -61.87 -45.02 95.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.283 1.433 . . . . 73.41 111.742 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -61.45 -53.35 57.7 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.709 0.631 . . . . 54.25 110.075 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.449 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -66.48 -28.63 73.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.966 0.791 . . . . 61.43 112.937 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.704 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.3 t80 -69.17 -59.4 3.04 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 122.729 0.412 . . . . 72.4 110.276 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.83 -34.64 64.64 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.612 0.57 . . . . 63.05 111.905 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 33.0 t70 -64.47 -52.09 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.861 0.726 . . . . 72.45 111.14 -175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.02 -30.04 55.6 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.448 0.699 . . . . 74.12 111.382 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -65.54 -29.44 70.07 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.747 0.819 . . . . 74.34 111.534 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.89 -26.38 56.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.543 0.737 . . . . 65.41 111.354 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 38.0 mttm -84.58 1.53 45.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.127 0.571 . . . . 62.43 111.456 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.02 29.65 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.997 -0.335 . . . . 70.42 113.112 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -106.53 137.41 44.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.844 -0.799 . . . . 75.24 108.844 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -84.04 108.69 17.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.094 -0.706 . . . . 74.23 109.094 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -107.48 135.15 47.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.053 0.454 . . . . 62.52 111.747 -169.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB2' HG12 ' A' ' 83' ' ' ILE . 79.6 m-85 -115.05 145.78 41.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.295 1.038 . . . . 73.45 109.235 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.3 p -109.57 151.66 26.5 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.015 0.926 . . . . 64.14 109.11 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.9 p -153.15 131.52 12.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.635 0.374 . . . . 70.25 110.194 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.0 mmm-85 -68.67 -29.82 68.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.645 0.778 . . . . 35.15 112.042 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.42 HD22 ' H ' ' A' ' 113' ' ' ASP . 2.4 p-10 -165.77 -176.93 4.07 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.757 -0.656 . . . . 63.13 111.246 -170.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 -43.54 66.19 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.468 1.507 . . . . 65.32 112.745 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' ASN . 1.9 m-20 -59.17 -49.16 78.91 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.981 0.912 . . . . 60.34 111.229 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.33 -37.81 71.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.412 -0.813 . . . . 74.04 110.701 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.35 80.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.993 0.917 . . . . 63.4 110.777 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 120' ' ' LYS . 36.4 ttmt -65.88 -54.47 26.2 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.963 -1.471 . . . . 70.15 110.137 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -65.66 -34.2 77.66 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.576 0.547 . . . . 74.1 111.442 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.38 -41.77 93.38 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.799 0.44 . . . . 71.11 110.728 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 1.2 tt -66.37 -41.77 88.95 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.156 -0.929 . . . . 72.35 109.603 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 116' ' ' LYS . 28.2 mtpp -67.75 -40.12 84.15 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.638 0.775 . . . . 74.45 111.182 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 45.6 mt-10 -62.41 -42.07 99.16 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.994 0.809 . . . . 72.53 110.121 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.07 73.62 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.519 0.728 . . . . 74.31 111.307 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 29' ' ' VAL . 88.9 mt -68.41 -43.59 76.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.537 0.735 . . . . 52.44 109.852 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 49.7 mt-10 -68.18 -31.8 71.59 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 45.11 111.455 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.483 ' HE3' ' OH ' ' A' ' 107' ' ' TYR . 65.3 mttm -70.84 -30.22 66.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.454 0.702 . . . . 62.14 110.756 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.5 p -87.7 2.06 52.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.352 0.661 . . . . 44.44 111.631 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.18 -17.45 58.6 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.984 -0.342 . . . . 71.24 113.248 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -66.48 103.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.805 0.842 . . . . 71.44 110.838 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.1 mt -111.5 140.5 46.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.557 0.743 . . . . 71.51 109.871 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.96 123.16 26.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.979 -0.748 . . . . 55.11 108.979 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -97.4 142.63 29.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.921 0.488 . . . . 72.5 111.008 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -146.82 137.37 23.75 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.465 1.106 . . . . 74.24 108.41 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -140.16 107.34 5.48 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.841 . . . . 44.51 108.731 171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -69.89 134.94 48.98 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.329 -0.989 . . . . 62.21 108.329 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -72.37 -47.08 52.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.609 0.242 . . . . 75.52 110.918 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.531 -0.914 . . . . 73.41 108.531 -178.768 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.678 -0.49 . . . . 64.4 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.77 120.28 0.91 Allowed Glycine 0 C--N 1.352 1.432 0 N-CA-C 110.806 -0.918 . . . . 71.11 110.806 -172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 86.0 t -142.23 142.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 107.643 -1.243 . . . . 72.42 107.643 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.37 111.94 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.462 0.574 . . . . 71.25 109.464 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.4 108.86 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.169 -1.049 . . . . 55.22 108.169 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.552 HD23 ' HB ' ' A' ' 56' ' ' VAL . 56.4 mt -95.56 102.38 14.18 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.596 -0.891 . . . . 63.02 108.596 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.0 t -92.55 103.56 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.082 -1.081 . . . . 63.51 108.082 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.42 HD13 HG13 ' A' ' 82' ' ' VAL . 8.0 mp -89.22 104.19 16.76 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 107.799 -1.186 . . . . 45.44 107.799 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 85' ' ' VAL . 70.5 p -105.92 139.41 40.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.359 0.663 . . . . 55.0 109.255 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.21 -0.59 45.89 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.37 0.419 . . . . 51.52 113.832 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -152.48 134.45 14.84 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.699 1.2 . . . . 74.02 109.259 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 43.7 tt0 -74.35 -27.68 60.79 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.379 1.072 . . . . 75.11 112.072 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -64.65 -38.01 89.53 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.966 -0.753 . . . . 75.41 108.966 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.05 -41.63 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.707 0.803 . . . . 73.31 110.233 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -61.96 -42.45 99.13 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.179 0.592 . . . . 63.05 111.706 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.53 -40.49 61.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.126 0.417 . . . . 70.54 112.126 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.96 -30.75 70.12 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.696 0.225 . . . . 74.43 110.773 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' VAL . 90.4 mt -70.4 -29.25 65.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.149 0.58 . . . . 53.34 111.193 172.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -64.83 -47.55 77.57 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.8 0.44 . . . . 71.11 110.306 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -58.4 -36.47 73.63 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.918 -1.037 . . . . 74.41 110.303 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -62.87 -51.05 68.5 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.384 1.052 . . . . 72.24 109.925 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' LEU . 86.1 t -58.64 -39.25 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 123.958 0.786 . . . . 54.53 110.84 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -66.1 -36.49 83.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.338 0.655 . . . . 73.23 111.961 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -79.14 -30.35 43.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.671 0.388 . . . . 72.03 110.639 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -72.96 -39.89 65.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.966 0.906 . . . . 60.32 109.729 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -170.09 107.96 0.45 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.09 1.356 . . . . 62.1 108.297 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.14 9.33 4.18 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.036 2.491 . . . . 54.32 113.878 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -101.7 -18.77 15.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.496 0.718 . . . . 74.11 110.518 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 53' ' ' PRO . 95.4 t -69.11 134.37 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.229 -0.656 . . . . 71.04 109.229 171.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.44 145.66 53.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.525 0.73 . . . . 72.21 109.849 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 p -141.92 135.95 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -137.68 126.41 14.68 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.455 -0.942 . . . . 45.2 108.455 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 76.1 Cg_endo -76.5 -177.01 3.42 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.229 1.952 . . . . 75.11 113.262 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 59' ' ' ARG . 81.7 p -65.05 -43.52 92.03 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 75.42 113.335 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -81.6 4.81 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.996 -1.002 . . . . 75.0 112.957 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.39 34.38 4.55 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.724 0.81 . . . . 63.1 109.526 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.2 tmtt? -53.92 -46.52 71.51 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.427 1.091 . . . . 60.14 112.465 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.96 -34.13 77.08 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.193 0.597 . . . . 60.54 110.855 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.4 mtpt -76.5 -23.59 53.74 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.077 -0.965 . . . . 70.1 111.514 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.5 t -54.56 -43.48 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 53.32 110.214 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -54.9 -42.1 71.76 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.517 1.127 . . . . 60.2 110.922 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -61.88 -52.17 65.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.289 -0.869 . . . . 73.12 110.64 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 6.1 mm-40 -69.74 -26.04 64.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.613 -1.176 . . . . 73.11 112.495 -171.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.22 -50.0 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.769 0.828 . . . . 74.13 109.702 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HG3' HH21 ' A' ' 48' ' ' ARG . 37.0 tt0 -65.0 -41.32 95.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.431 -0.804 . . . . 70.01 111.026 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -69.15 -32.78 72.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.842 0.857 . . . . 74.02 111.352 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.73 -45.48 61.63 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.248 0.619 . . . . 74.42 110.01 176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.524 HH21 ' HG3' ' A' ' 45' ' ' GLU . 53.8 ttp85 -58.95 -39.13 80.72 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.614 1.166 . . . . 64.44 111.08 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.06 -37.63 86.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.239 -0.891 . . . . 63.54 109.874 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.47 -10.37 35.27 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.265 0.626 . . . . 74.12 112.328 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.23 -27.91 17.98 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.514 0.566 . . . . 75.44 114.514 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -89.75 157.53 46.31 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-N 117.259 0.529 . . . . 72.23 112.069 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 90.4 Cg_endo -75.41 -177.81 3.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.444 2.096 . . . . 70.13 114.587 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -141.4 122.98 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 113.77 -1.559 . . . . 65.21 108.334 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.64 106.07 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.827 -1.175 . . . . 72.2 107.827 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 6' ' ' LEU . 48.1 t -89.54 140.61 15.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.16 1.384 . . . . 44.31 109.076 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.529 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 85.8 m-85 -111.78 130.35 55.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.639 HG11 ' HB2' ' A' ' 66' ' ' ALA . 75.2 t -129.61 127.8 64.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 125.181 1.392 . . . . 73.54 107.483 -174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD2' ' HB2' ' A' ' 12' ' ' GLU . 58.6 ttt180 -95.88 87.49 4.64 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.442 0.564 . . . . 73.45 110.796 -173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.54 -85.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.507 0 C-N-CA 124.485 1.041 . . . . 52.51 115.551 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.65 -10.71 50.96 Favored Glycine 0 C--N 1.36 1.883 0 C-N-CA 123.55 0.595 . . . . 74.44 114.227 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.57 10.65 5.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.636 0.774 . . . . 70.21 111.569 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.0 -35.51 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.761 1.224 . . . . 53.41 111.242 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.71 -35.51 79.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.429 1.092 . . . . 72.4 111.396 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' ' HE3' ' A' ' 37' ' ' LYS . 94.7 mtt180 -81.07 -31.8 34.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.929 0.892 . . . . 72.23 111.582 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.639 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.65 -33.57 75.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.953 0.901 . . . . 54.12 111.643 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -65.2 -33.47 76.07 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.786 0.679 . . . . 51.21 110.721 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -74.58 -41.41 60.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.221 1.008 . . . . 72.41 110.48 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 37' ' ' LYS . 73.0 mt -63.63 -36.93 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.494 0.718 . . . . 70.02 109.774 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.12 -43.99 73.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.442 1.097 . . . . 72.2 111.717 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.31 -37.0 80.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.719 -0.673 . . . . 60.35 110.429 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -65.92 -42.8 89.66 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.881 0.738 . . . . 73.41 110.277 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.32 92.8 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.143 0.977 . . . . 52.33 110.775 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.08 -29.41 62.92 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.84 -1.073 . . . . 71.53 111.186 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 1.1 tpmt? -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.209 0.604 . . . . 75.41 110.183 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 48' ' ' ARG . 7.0 mm-40 -74.03 -11.29 60.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.061 0.944 . . . . 75.34 110.998 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.04 26.51 48.61 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.77 0.669 . . . . 73.11 112.555 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 48' ' ' ARG . 31.5 mt -99.52 158.79 15.49 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.335 0.654 . . . . 74.12 111.411 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HB2' HG13 ' A' ' 3' ' ' VAL . 91.9 mtt180 -71.01 118.84 14.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.595 -1.184 . . . . 74.31 107.999 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.88 116.56 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.916 -0.772 . . . . 73.41 108.916 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.64 112.78 41.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 C-N-CA 124.051 0.94 . . . . 54.25 108.474 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 106' ' ' VAL . 92.1 t -104.7 116.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 109.471 -0.566 . . . . 73.42 109.471 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.2 mt -112.26 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.427 0.691 . . . . 63.1 109.294 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.14 131.84 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.632 -0.877 . . . . 61.31 108.632 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 9' ' ' THR . 32.8 t -116.46 102.03 13.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.616 1.167 . . . . 74.42 108.541 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.9 t -163.06 147.35 11.22 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.372 1.069 . . . . 52.33 108.867 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.37 -25.89 51.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.761 0.824 . . . . 74.21 110.763 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.64 115.19 22.04 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.175 0.59 . . . . 74.53 109.575 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.547 ' HA ' HD12 ' A' ' 92' ' ' LEU . 40.3 mt-10 -66.06 -26.16 67.36 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.83 0.706 . . . . 72.45 111.378 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.37 -33.07 75.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.025 0.53 . . . . 53.43 111.058 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.17 -41.61 49.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.373 0.669 . . . . 72.12 110.716 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 89' ' ' GLU . 84.4 mt -61.2 -51.53 68.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.879 0.872 . . . . 71.14 111.245 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 94.9 mtt180 -63.5 -30.21 71.36 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.871 1.268 . . . . 74.24 113.373 -169.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -64.26 -50.67 67.02 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 110.194 -0.298 . . . . 71.44 110.194 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.9 -33.0 56.2 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.786 0.679 . . . . 65.12 112.506 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.803 ' HA ' HG11 ' A' ' 106' ' ' VAL . 53.0 t80 -61.68 -57.75 10.74 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.964 0.906 . . . . 73.23 109.986 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.64 -36.51 68.01 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 124.407 1.067 . . . . 74.4 110.493 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 26.8 t70 -60.93 -56.2 23.97 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.13 0.269 . . . . 65.51 110.503 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.49 -33.19 72.5 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.702 -0.681 . . . . 74.52 110.83 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.67 -40.05 94.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.098 0.559 . . . . 71.23 110.936 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -72.1 -20.61 61.61 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.53 0.732 . . . . 75.41 111.742 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 28.0 mtpp -81.59 -11.67 59.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.139 0.576 . . . . 50.3 110.697 172.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.35 24.98 7.23 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 123.285 0.469 . . . . 70.42 113.146 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -107.76 141.19 39.68 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.994 -0.743 . . . . 73.44 108.994 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -81.45 103.04 10.91 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.9 -0.778 . . . . 73.02 108.9 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 96' ' ' TYR . 16.3 t -101.6 129.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.513 -0.312 . . . . 72.41 110.8 -175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -103.46 140.66 37.19 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.262 1.025 . . . . 71.32 109.381 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.47 ' HB ' HD13 ' A' ' 92' ' ' LEU . 20.7 p -108.72 142.2 39.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.644 1.177 . . . . 70.32 108.797 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 114' ' ' GLU . 81.0 p -127.32 178.65 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.334 0.653 . . . . 70.34 110.273 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -107.76 -28.6 9.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.738 0.415 . . . . 65.32 110.081 170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -168.8 -163.26 0.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.91 -36.39 59.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.271 1.428 . . . . 73.4 112.518 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -53.69 -52.05 61.27 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.427 0.691 . . . . 75.52 111.888 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' SER . 14.7 mp0 -74.37 -37.8 63.36 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.221 -0.9 . . . . 75.51 110.129 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.07 74.36 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.233 0.958 . . . . 71.53 111.317 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 34.3 ttmt -72.02 -47.22 53.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.38 1.072 . . . . 50.21 111.584 -175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -72.87 -32.01 65.11 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.805 -0.14 . . . . 74.3 111.212 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -72.88 -28.26 62.38 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.089 0.556 . . . . 73.05 110.982 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.54 -40.03 77.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.694 0.798 . . . . 75.02 109.826 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -65.9 -43.03 89.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.705 -0.679 . . . . 71.51 111.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -31.48 72.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.929 0.768 . . . . 74.12 111.151 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.87 75.45 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.707 0.803 . . . . 74.24 110.989 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.26 -32.32 64.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 65.14 111.025 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 131' ' ' HIS . 48.5 mt-10 -79.1 -27.76 42.95 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.974 0.91 . . . . 74.25 111.928 174.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.87 -26.64 43.97 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.846 0.858 . . . . 74.1 109.816 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.3 p -89.76 176.82 6.7 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.764 0.826 . . . . 71.31 110.651 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -81.22 61.29 4.61 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.322 -0.399 . . . . 21.42 112.576 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 m -122.67 -68.11 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.446 -1.316 . . . . 63.41 107.446 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 mp -113.36 138.19 50.41 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.889 -1.051 . . . . 72.4 109.062 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -85.95 112.6 21.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.023 -1.473 . . . . 73.33 107.023 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 22.6 p80 -61.39 -40.58 94.88 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.484 0.49 . . . . 75.04 110.588 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 47.88 82.86 0.04 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.628 1.571 . . . . 73.2 112.638 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.9 m170 62.17 36.55 14.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.345 1.058 . . . . 72.51 111.052 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 131' ' ' HIS . 8.0 t-80 -66.95 -61.2 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.334 0.654 . . . . 64.33 110.306 -174.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 64.81 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.223 1.409 . . . . 75.21 113.99 170.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 27.4 m80 . . . . . 0 C--O 1.245 0.852 0 C-N-CA 123.868 0.867 . . . . 72.2 108.868 169.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.437 -0.579 . . . . 72.33 109.437 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.06 167.23 11.04 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.347 -1.101 . . . . 51.44 110.347 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.1 t -137.28 133.68 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 117.691 0.745 . . . . 73.33 109.51 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.5 113.69 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.911 -0.774 . . . . 71.33 108.911 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 107.56 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.855 -0.795 . . . . 63.33 108.855 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 56' ' ' VAL . 60.7 mt -97.94 103.89 15.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.714 0.806 . . . . 75.42 109.334 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.47 HG12 HG23 ' A' ' 9' ' ' THR . 30.7 t -95.61 105.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 109.599 -0.519 . . . . 73.21 109.599 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD13 HG13 ' A' ' 82' ' ' VAL . 8.6 mp -87.39 102.25 14.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.333 -0.988 . . . . 74.21 108.333 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 7' ' ' VAL . 41.3 p -107.43 138.23 44.01 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.397 0.679 . . . . 60.12 109.232 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -24.38 75.84 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.94 -0.464 . . . . 51.43 111.94 169.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -130.09 127.2 39.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.45 1.1 . . . . 64.24 109.793 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.91 -23.16 67.24 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.288 0.635 . . . . 72.42 111.392 173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -58.46 -45.14 89.17 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.354 0.662 . . . . 75.32 110.555 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 90.4 mt -60.57 -46.22 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.657 -0.497 . . . . 74.44 109.657 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.28 75.77 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.289 0.993 . . . . 65.12 111.84 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.95 -41.53 74.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.32 0.648 . . . . 71.31 111.762 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 33.3 mm-40 -68.92 -30.94 69.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.048 0.451 . . . . 74.13 110.996 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.4 mt -74.82 -34.15 62.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.369 0.667 . . . . 52.4 110.556 173.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -62.8 -44.91 94.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.892 0.877 . . . . 71.34 110.32 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.723 ' HA ' HE21 ' A' ' 23' ' ' GLN . 11.4 ptmt -67.59 -31.41 71.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.424 -0.807 . . . . 72.31 109.936 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.783 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 19.5 tp10 -75.17 -36.95 61.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.131 0.973 . . . . 74.44 112.263 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.8 t -59.86 -38.58 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.536 0.334 . . . . 73.5 110.171 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.723 HE21 ' HA ' ' A' ' 20' ' ' LYS . 47.6 mt-30 -63.81 -31.13 72.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.408 0.683 . . . . 72.13 111.105 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -71.85 -43.86 64.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.841 0.456 . . . . 72.41 109.975 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.49 -55.71 9.47 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.558 -0.746 . . . . 71.04 110.481 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -150.65 117.91 3.44 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.811 0.845 . . . . 65.12 108.743 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.57 -15.16 22.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.874 2.383 . . . . 73.43 113.693 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.89 -22.8 21.84 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.585 0.754 . . . . 50.03 111.516 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.95 118.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.451 -0.574 . . . . 75.12 109.451 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -78.21 128.97 34.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.031 -0.531 . . . . 70.4 111.458 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HB ' ' A' ' 55' ' ' VAL . 21.1 p -107.18 129.2 54.88 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.173 0.989 . . . . 74.22 109.12 175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.73 117.34 27.52 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.812 0.845 . . . . 63.31 108.941 -175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.41 177.3 8.53 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.254 1.969 . . . . 75.23 113.286 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 p -64.01 -35.07 79.51 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.661 1.184 . . . . 60.2 111.418 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -68.76 -25.25 64.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.106 -1.407 . . . . 73.55 111.252 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.16 37.65 1.62 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 61.11 110.799 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -57.88 -38.69 76.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.996 0.919 . . . . 71.14 111.923 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.91 -34.82 76.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.18 0.592 . . . . 63.51 110.436 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -77.54 -18.71 56.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.272 -0.876 . . . . 72.52 110.78 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.553 HG11 HD13 ' A' ' 69' ' ' ILE . 67.7 t -54.95 -53.85 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.68 0.792 . . . . 73.53 111.265 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -56.94 -40.68 76.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.013 0.925 . . . . 72.51 111.181 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -59.27 -51.03 71.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.026 -0.988 . . . . 62.32 110.577 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.228 1.011 . . . . 62.24 112.681 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.3 mt -72.18 -50.09 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.612 . . . . 64.24 109.534 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.72 -30.39 70.61 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.896 0.748 . . . . 72.3 110.046 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -69.22 -46.69 66.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.552 1.141 . . . . 75.25 111.049 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.08 -37.03 86.19 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.243 0.617 . . . . 70.12 110.415 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 74.0 ttt180 -58.27 -46.96 85.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.352 1.061 . . . . 74.02 110.069 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -66.84 -40.21 87.87 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.174 0.921 . . . . 71.04 110.221 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -82.1 -16.66 49.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.368 0.667 . . . . 73.41 112.011 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.41 49.51 25.23 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.13 -0.388 . . . . 54.54 112.13 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -132.47 157.28 78.71 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 124.968 1.307 . . . . 75.23 110.681 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 97.9 Cg_endo -77.67 157.45 31.9 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.953 1.769 . . . . 71.0 112.188 165.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.52 125.24 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.784 -1.191 . . . . 71.24 107.784 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 31' ' ' THR . 59.4 t -96.8 106.31 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.364 -0.606 . . . . 73.42 109.364 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.6 ' HB ' HD23 ' A' ' 6' ' ' LEU . 46.8 t -92.16 141.24 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.391 1.076 . . . . 64.11 109.502 174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -111.75 114.02 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.399 -0.963 . . . . 72.22 108.399 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.2 151.86 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.154 1.382 . . . . 53.35 107.659 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.47 161.7 21.19 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.841 -0.537 . . . . 74.12 109.927 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.11 -31.79 81.93 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.72 -0.552 . . . . 74.04 111.72 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.06 -21.23 79.99 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.768 0.334 . . . . 70.11 113.657 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.67 58.12 2.65 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.7 0.762 . . . . 75.52 109.576 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.92 -44.7 95.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.323 1.049 . . . . 62.23 111.474 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.657 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 2.9 mp0 -63.06 -49.62 73.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HD3' ' HG3' ' A' ' 37' ' ' LYS . 79.2 mtt180 -58.09 -36.68 73.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.66 0.6 . . . . 73.33 111.017 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -60.7 -53.19 60.42 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.203 0.601 . . . . 42.44 111.838 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 42.9 pttt -78.34 -26.99 46.96 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.993 0.738 . . . . 75.41 112.993 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -75.24 -39.29 60.08 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.597 0.759 . . . . 74.02 110.8 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 HG11 ' A' ' 40' ' ' VAL . 93.0 mt -71.42 -32.45 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.233 0.613 . . . . 60.25 109.542 173.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.99 88.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.695 0.798 . . . . 74.01 111.311 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.24 -49.17 68.1 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.838 -1.074 . . . . 73.34 109.293 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 93.1 t80 -55.31 -47.21 75.94 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.587 1.179 . . . . 64.54 110.571 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.85 95.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.971 0.908 . . . . 44.05 111.797 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -72.1 -32.76 67.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.214 -0.448 . . . . 71.14 110.253 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 8.8 mmpt? -66.3 -31.67 72.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.708 0.803 . . . . 73.4 111.234 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 17.3 mm-40 -72.39 -14.77 61.79 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.245 0.618 . . . . 75.04 111.14 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.18 36.14 13.52 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.825 -0.51 . . . . 53.12 111.825 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 48' ' ' ARG . 37.4 mt -115.37 150.28 36.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 63.4 109.974 -176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.644 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.84 117.76 12.77 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.01 0.524 . . . . 74.44 109.83 174.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.5 112.93 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.138 -0.69 . . . . 73.51 109.138 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.99 113.0 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.113 -1.44 . . . . 71.34 107.113 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG13 HD13 ' A' ' 8' ' ' LEU . 87.2 t -101.83 110.88 29.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 108.794 -0.817 . . . . 73.42 108.794 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.3 mt -105.38 104.1 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.506 -0.553 . . . . 75.45 109.506 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.2 mt -88.45 118.61 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 14' ' ' ILE . 3.2 t -106.95 103.05 14.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.586 -0.894 . . . . 75.01 108.586 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.5 m -145.99 135.09 22.72 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.124 0.97 . . . . 74.03 108.965 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -71.09 -24.57 62.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.674 0.389 . . . . 64.13 110.235 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.64 102.99 6.38 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.669 -0.863 . . . . 61.53 108.669 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' HD12 ' A' ' 92' ' ' LEU . 51.6 mt-10 -69.25 -22.11 63.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.882 0.873 . . . . 71.33 111.195 176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.36 -40.89 85.82 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.648 1.179 . . . . 63.34 109.463 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.81 -34.05 64.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.424 0.69 . . . . 42.01 111.072 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 89' ' ' GLU . 54.9 mt -55.4 -47.49 75.82 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 123.98 0.8 . . . . 75.31 110.379 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -66.69 -38.21 86.31 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 124.04 0.837 . . . . 72.01 112.0 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -57.14 -53.08 62.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.584 0.552 . . . . 75.31 110.771 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.04 -30.61 62.93 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.701 -0.681 . . . . 70.2 112.283 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.654 ' HA ' HG11 ' A' ' 106' ' ' VAL . 70.4 t80 -60.28 -58.71 7.33 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.209 0.604 . . . . 74.01 110.444 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.64 -32.7 64.15 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.895 0.747 . . . . 75.53 111.204 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.11 -42.22 89.53 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.954 0.502 . . . . 71.43 111.818 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 12.3 mptt -80.88 -36.2 31.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.157 0.583 . . . . 73.54 111.196 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -70.37 -31.95 69.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.953 0.501 . . . . 70.41 111.855 -174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.19 -22.71 66.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.003 0.43 . . . . 73.31 110.91 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -85.61 6.61 26.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.047 0.939 . . . . 74.11 111.322 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 27.65 39.81 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.097 0.379 . . . . 71.14 113.784 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.66 142.41 32.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.253 0.621 . . . . 74.23 109.743 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.54 100.63 7.84 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.49 -0.93 . . . . 72.3 108.49 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 96' ' ' TYR . 24.1 t -101.87 133.55 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.32 -0.622 . . . . 64.33 109.32 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -115.98 137.14 52.38 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.362 1.065 . . . . 73.32 108.751 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 92' ' ' LEU . 47.2 p -107.19 135.79 48.12 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.515 -0.92 . . . . 73.42 108.515 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 p -140.54 133.82 29.7 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.109 0.564 . . . . 61.02 109.665 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -61.28 -42.4 98.58 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.113 0.965 . . . . 73.01 111.497 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -156.63 179.33 9.38 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.201 -0.909 . . . . 52.24 110.281 -167.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 17' ' ' GLU . 12.8 tm-20 -67.04 -27.08 67.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.07 0.948 . . . . 71.33 112.154 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.4 -48.99 79.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.027 0.376 . . . . 73.05 110.337 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -69.52 -40.57 76.84 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.446 -0.797 . . . . 73.42 111.059 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.1 80.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.283 -0.871 . . . . 52.32 111.253 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.783 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 3.5 ttmp? -60.84 -42.48 97.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.949 1.299 . . . . 70.32 110.357 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.05 -53.92 48.73 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 124.042 0.839 . . . . 73.34 109.6 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.06 -34.52 76.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 62.32 111.835 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 32.0 tp -70.8 -48.78 52.36 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.146 0.904 . . . . 74.53 111.24 -174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -74.33 -28.74 61.28 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.842 -0.617 . . . . 74.53 110.892 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.21 -37.18 79.51 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.243 0.617 . . . . 75.24 110.685 167.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.36 -29.06 63.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.868 0.867 . . . . 34.01 111.659 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.24 -35.88 66.33 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.962 0.505 . . . . 73.01 110.22 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.04 -28.4 63.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.536 0.734 . . . . 72.25 110.593 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 79' ' ' ARG . 6.8 tmtm? -66.62 -32.45 73.79 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.068 1.347 . . . . 73.13 110.104 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p -80.13 -47.38 14.85 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.618 -0.719 . . . . 71.23 109.989 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 135.81 -6.15 4.1 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.773 -1.103 . . . . 72.22 113.081 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.9 m -74.41 91.84 2.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.156 0.582 . . . . 72.23 109.712 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 66.1 mt -90.18 151.0 21.77 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.052 0.941 . . . . 73.14 110.111 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -56.78 4.49 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.0 163.22 26.9 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.666 -1.152 . . . . 64.12 111.45 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -62.58 113.56 3.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.934 -1.03 . . . . 74.11 109.615 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -64.15 -40.65 96.59 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.196 0.598 . . . . 64.31 109.903 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -144.97 109.38 4.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.152 0.981 . . . . 74.22 108.653 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -113.01 83.09 1.77 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.534 0.734 . . . . 74.42 110.04 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 124.239 1.016 . . . . 70.41 108.534 170.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 111.423 0.157 . . . . 62.32 111.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.15 -159.82 28.76 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.919 -0.472 . . . . 71.51 111.919 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 79' ' ' ARG . 25.6 t -141.11 135.41 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.879 0.872 . . . . 64.32 110.073 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.26 111.6 35.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 109.033 -0.728 . . . . 73.24 109.033 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.73 108.35 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.701 1.2 . . . . 73.44 108.444 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 56' ' ' VAL . 58.0 mt -98.14 101.98 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.034 0.934 . . . . 72.32 109.128 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.79 105.34 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.035 -0.728 . . . . 72.42 109.035 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.7 mp -88.59 102.62 15.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.834 0.854 . . . . 72.11 108.971 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.0 p -106.41 154.99 20.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.485 0.714 . . . . 74.12 109.93 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 -11.8 84.22 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.085 -0.507 . . . . 71.12 113.267 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -167.48 156.07 9.62 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 117.093 0.447 . . . . 71.23 111.741 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -68.23 -33.01 73.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.431 1.092 . . . . 73.23 111.446 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -57.48 -36.92 72.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.909 0.884 . . . . 75.33 110.978 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG21 HG11 ' A' ' 85' ' ' VAL . 28.5 mt -72.52 -51.9 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.274 -0.639 . . . . 74.24 109.274 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.02 71.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.629 -1.169 . . . . 50.15 112.99 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.35 -38.76 65.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.542 0.737 . . . . 61.43 110.637 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.93 -30.13 63.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.005 -0.543 . . . . 62.22 110.571 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.1 mt -72.96 -27.01 61.58 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.764 -0.653 . . . . 51.42 110.62 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -66.89 -45.06 79.21 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.376 -0.601 . . . . 64.41 109.376 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -68.91 -30.51 69.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.069 -0.969 . . . . 72.34 111.497 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 119' ' ' LEU . 10.7 tp10 -53.45 -50.82 64.47 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.883 1.273 . . . . 50.23 111.193 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' LEU . 58.3 t -61.96 -39.95 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.192 -1.367 . . . . 64.0 110.78 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.76 -32.33 65.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.015 0.526 . . . . 75.31 111.129 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -83.32 -40.81 19.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.279 0.632 . . . . 74.44 111.896 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -77.18 -55.83 5.09 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.093 -0.336 . . . . 75.25 110.093 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.4 114.17 3.05 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.276 0.63 . . . . 73.12 109.455 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.03 -3.62 11.09 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.948 2.432 . . . . 64.52 113.429 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -89.36 -20.96 23.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.266 0.626 . . . . 75.02 110.062 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 53' ' ' PRO . 95.8 t -66.43 130.91 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 115.681 -0.691 . . . . 72.44 109.818 174.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -72.35 141.54 48.79 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.666 0.786 . . . . 52.1 110.507 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -127.26 122.07 32.91 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.399 0.679 . . . . 71.55 109.895 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG11 ' HA ' ' A' ' 40' ' ' VAL . 2.7 t -118.11 113.42 37.44 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.538 -0.744 . . . . 75.35 109.063 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 56.9 Cg_endo -71.78 172.2 14.97 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.281 1.987 . . . . 74.54 113.619 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 p -63.69 -35.48 80.68 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 74.22 111.623 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -65.48 -25.65 67.58 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.005 -0.998 . . . . 73.24 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 1.7 m-20 -95.67 50.07 1.2 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.005 0.922 . . . . 53.32 109.385 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' NZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -62.43 -45.16 94.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.213 1.005 . . . . 70.43 113.001 -170.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.68 -38.71 58.51 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.637 0.732 . . . . 71.31 109.34 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 36' ' ' ASP . 1.3 tmtp? -61.51 -20.74 63.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.401 -1.727 . . . . 74.11 111.647 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.563 ' HA ' HG11 ' A' ' 32' ' ' VAL . 88.5 t -50.91 -47.58 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.577 1.151 . . . . 62.5 111.2 177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.5 tmpt? -59.8 -38.46 82.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.502 1.121 . . . . 73.53 110.98 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -44.31 80.55 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.659 -0.701 . . . . 73.21 110.224 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.08 -31.65 70.54 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.621 0.769 . . . . 72.32 111.985 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.49 -40.79 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.391 0.676 . . . . 64.14 110.354 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.46 -36.95 85.45 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.093 -0.958 . . . . 75.32 110.438 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.98 -40.47 78.77 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.737 . . . . 74.13 110.655 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.39 85.71 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 74.11 111.06 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.419 HH11 ' HA ' ' A' ' 76' ' ' GLU . 28.0 ttt180 -62.47 -43.69 98.2 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 115.656 -0.702 . . . . 62.35 109.796 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.31 -38.61 91.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.571 0.748 . . . . 73.3 110.125 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -77.4 -17.9 57.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.947 0.499 . . . . 72.15 110.346 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.97 78.23 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.145 -0.479 . . . . 71.43 112.58 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.0 mtp-105 -129.71 163.91 43.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.709 0.804 . . . . 73.14 110.248 -173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HG2' HG22 ' A' ' 29' ' ' VAL . 24.3 Cg_endo -62.81 162.32 25.71 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.446 2.097 . . . . 71.22 113.608 170.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.9 tt -140.64 129.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.717 1.207 . . . . 73.12 108.328 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.79 133.06 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.15 -0.685 . . . . 74.31 109.15 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HB ' HD23 ' A' ' 6' ' ' LEU . 83.8 t -127.53 140.89 47.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 125.45 1.5 . . . . 60.41 107.922 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 63.9 m-85 -114.4 116.37 28.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.507 -0.923 . . . . 74.23 108.507 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -124.8 151.71 30.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.053 -1.832 . . . . 53.11 106.053 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.12 153.43 39.57 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.029 0.832 . . . . 72.1 110.398 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -62.88 -32.52 84.17 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.775 -0.648 . . . . 64.42 112.294 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.53 -5.32 89.32 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-O 120.032 -0.316 . . . . 63.44 113.255 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.35 39.09 1.97 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.185 0.994 . . . . 75.34 109.519 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.91 -21.84 64.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.26 0.624 . . . . 70.01 110.998 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 45.8 mt-10 -72.61 -26.27 61.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.503 0.721 . . . . 64.05 111.083 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? -75.21 -46.78 31.72 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.259 -0.645 . . . . 60.21 109.259 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.6 77.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.402 1.081 . . . . 31.14 112.837 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . 22.3 pttp -68.94 -33.47 73.77 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.285 0.366 . . . . 64.2 111.881 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.86 -39.17 64.16 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.769 0.827 . . . . 72.41 110.982 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.404 HD11 ' NZ ' ' A' ' 37' ' ' LYS . 92.2 mt -63.38 -41.7 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.301 -0.863 . . . . 72.02 109.752 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.73 -30.41 69.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.764 -1.107 . . . . 44.21 111.399 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.54 -33.04 62.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.297 0.639 . . . . 70.33 110.545 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 85.1 t80 -72.4 -36.43 68.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.749 -0.659 . . . . 44.34 110.031 171.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.02 -48.05 72.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.763 0.825 . . . . 74.45 111.808 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.39 -30.72 71.57 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 116.001 -0.545 . . . . 63.4 110.297 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 24.0 ttmm -64.05 -37.59 87.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.376 1.07 . . . . 72.22 110.947 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HA ' HH11 ' A' ' 48' ' ' ARG . 15.9 mm-40 -73.82 -0.29 15.4 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.642 0.777 . . . . 64.44 112.007 176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.98 69.4 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.795 -0.522 . . . . 64.33 111.795 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.21 129.22 55.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.004 0.922 . . . . 65.45 108.647 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.7 ttt180 -65.6 131.17 45.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.534 0.734 . . . . 64.45 109.662 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -96.49 124.72 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.337 0.255 . . . . 74.51 110.562 -175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.17 124.53 70.91 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 N-CA-C 107.278 -1.379 . . . . 65.53 107.278 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 HD13 ' A' ' 8' ' ' LEU . 90.0 t -111.2 114.03 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.352 -0.61 . . . . 71.03 109.352 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -106.36 105.74 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.414 0.552 . . . . 45.11 109.712 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.9 mt -90.74 110.58 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.34 -0.615 . . . . 60.3 109.34 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 HG21 ' A' ' 14' ' ' ILE . 8.3 t -98.0 103.09 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 74.43 109.386 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.3 t -155.24 138.8 15.97 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.178 0.991 . . . . 75.51 108.894 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -70.65 -20.33 62.73 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.468 0.707 . . . . 71.35 111.757 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.93 107.88 14.12 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.098 0.559 . . . . 72.31 109.809 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 37.3 mt-10 -61.44 -28.72 69.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.218 1.007 . . . . 75.01 111.825 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.61 -47.36 60.53 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.824 -0.626 . . . . 73.14 110.194 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.26 -31.86 73.12 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.576 0.751 . . . . 53.13 111.034 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 89' ' ' GLU . 82.7 mt -58.57 -52.78 64.21 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.317 -0.856 . . . . 64.23 110.116 172.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -64.55 -34.74 78.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.549 0.74 . . . . 74.01 112.725 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -59.9 -49.44 77.68 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.551 0.532 . . . . 73.2 110.966 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.84 -31.92 54.76 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 123.437 0.461 . . . . 73.25 112.831 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HA ' HG11 ' A' ' 106' ' ' VAL . 76.9 t80 -61.68 -60.82 3.1 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.507 0.723 . . . . 73.42 111.018 -173.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 42.2 mt-10 -70.89 -37.54 73.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.466 -0.788 . . . . 75.12 109.95 -173.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.8 -50.88 69.26 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.352 1.061 . . . . 73.55 112.167 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -70.27 -26.93 64.04 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.312 0.645 . . . . 52.13 111.111 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -72.22 -27.93 62.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.947 0.499 . . . . 62.52 111.996 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 58.0 mttm -63.32 -27.81 69.58 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.4 0.619 . . . . 64.15 109.962 173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 27.2 mtpp -88.32 -12.58 43.06 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.763 1.225 . . . . 75.05 111.246 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.72 6.61 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 116.185 -0.461 . . . . 73.33 113.687 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.2 140.77 37.86 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.39 100.43 9.25 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.012 -0.736 . . . . 74.04 109.012 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.1 t -101.2 139.11 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 110.204 -0.295 . . . . 54.31 110.204 -173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.01 137.81 54.47 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.065 1.346 . . . . 72.42 107.465 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.3 p -107.03 128.13 54.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.127 -0.694 . . . . 64.45 109.127 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 p -126.32 128.91 47.86 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.922 -0.769 . . . . 74.13 108.922 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.31 -31.59 43.25 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.254 -0.885 . . . . 74.52 109.747 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 113' ' ' ASP . 2.0 p-10 -153.66 167.83 28.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.916 -1.038 . . . . 63.32 109.733 -171.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 36.8 tt0 -61.69 -28.36 69.35 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.149 0.906 . . . . 71.35 112.268 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 111' ' ' ASN . 5.2 m-20 -59.24 -44.73 92.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.881 0.473 . . . . 73.11 109.955 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -75.47 -35.16 60.92 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.877 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . . . -62.13 -34.58 76.63 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.288 0.635 . . . . 75.35 111.33 177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 1.6 ttmp? -62.48 -46.72 87.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.77 1.228 . . . . 74.23 110.148 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -63.92 -53.03 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.966 -1.015 . . . . 70.33 110.454 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -67.91 -30.62 70.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.675 0.79 . . . . 72.4 112.085 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 21' ' ' GLU . 26.6 tp -68.32 -49.25 61.65 Favored 'General case' 0 C--N 1.344 0.365 0 O-C-N 123.801 0.688 . . . . 74.22 110.086 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 10.0 mtmp? -68.57 -31.23 70.27 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.683 0.614 . . . . 65.41 111.075 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.86 -42.99 94.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.328 0.651 . . . . 63.44 110.238 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.52 75.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.802 0.841 . . . . 72.24 110.606 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.66 -38.05 76.95 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.507 0.723 . . . . 71.2 110.692 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 47.3 mt-10 -74.03 -32.09 63.18 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.895 0.478 . . . . 75.22 111.429 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -80.31 -12.95 59.55 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.322 0.649 . . . . 73.43 111.792 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.4 p -96.31 -20.95 18.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.114 0.566 . . . . 52.0 111.711 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.61 -45.66 0.77 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.428 -0.351 . . . . 64.22 112.225 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -69.97 89.3 0.6 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.566 0.746 . . . . 45.13 111.323 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.642 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 94.3 mt -74.78 164.33 26.69 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.098 0.559 . . . . 74.33 111.165 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.14 133.77 53.57 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 108.082 -1.081 . . . . 62.44 108.082 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -66.32 92.1 0.18 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.277 1.031 . . . . 73.2 111.08 -171.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 82.2 t60 55.46 -91.1 0.03 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.38 1.472 . . . . 71.34 110.453 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -165.28 118.81 1.22 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.738 1.615 . . . . 65.14 107.535 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -79.47 105.64 10.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.928 0.491 . . . . 71.21 110.321 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -78.7 169.08 18.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.974 0.91 . . . . 62.14 110.802 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 N--CA 1.481 1.081 0 C-N-CA 124.114 0.966 . . . . 75.51 109.124 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.334 -0.617 . . . . 73.44 109.334 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.27 129.3 20.15 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.608 0.567 . . . . 72.41 112.039 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 91.5 t -141.15 128.93 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.779 -1.193 . . . . 73.55 107.779 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.83 112.69 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.613 0.642 . . . . 71.42 110.709 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.35 108.92 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.897 1.279 . . . . 71.12 109.025 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -100.18 104.04 15.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 74.24 110.113 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 83' ' ' ILE . 21.8 t -90.2 105.03 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.143 0.577 . . . . 63.21 109.954 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 HG13 ' A' ' 82' ' ' VAL . 9.2 mp -87.13 103.08 15.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.649 -0.871 . . . . 64.13 108.649 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -106.45 133.35 51.28 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.283 -0.636 . . . . 73.22 109.283 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.61 -14.78 80.93 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.037 -0.529 . . . . 44.2 112.103 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -127.98 131.89 49.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.44 1.096 . . . . 74.2 109.437 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.55 -27.99 67.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.376 1.071 . . . . 74.13 111.883 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -74.16 -31.37 62.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.721 0.408 . . . . 63.32 111.601 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 85' ' ' VAL . 79.5 mt -64.87 -46.21 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.309 -0.626 . . . . 72.33 109.309 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.95 -34.11 71.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.57 0.748 . . . . 74.05 111.822 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.66 -41.67 83.41 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.114 0.966 . . . . 74.51 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -68.58 -37.9 80.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.311 0.644 . . . . 71.01 111.244 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HB3' HD22 ' A' ' 119' ' ' LEU . 83.5 mt -69.5 -29.52 67.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.143 0.577 . . . . 72.14 110.944 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.1 -39.5 92.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.12 0.568 . . . . 75.1 109.977 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.98 -38.3 88.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.322 -0.854 . . . . 65.3 110.697 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -62.41 -41.29 98.57 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.686 0.616 . . . . 62.15 111.246 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.69 -45.96 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 123.829 0.705 . . . . 75.4 110.477 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -62.84 -29.04 70.43 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.496 0.498 . . . . 73.43 112.106 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -88.08 -29.24 20.79 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.972 0.509 . . . . 72.11 111.889 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -79.79 -50.8 10.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.407 0.683 . . . . 72.34 109.927 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -162.06 101.82 1.14 Allowed Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 124.673 1.189 . . . . 71.41 109.028 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.76 -2.0 11.59 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.909 2.406 . . . . 64.45 113.747 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -75.75 -22.88 56.07 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.969 0.508 . . . . 74.25 110.099 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 43.7 t -78.89 118.77 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.862 -0.792 . . . . 64.14 108.862 170.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -76.57 160.28 29.57 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.282 0.563 . . . . 73.24 112.049 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 20.0 p -129.7 122.58 29.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.894 -1.048 . . . . 73.04 110.095 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -119.41 117.61 32.91 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 73.23 110.035 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.46 176.51 9.59 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.032 2.488 . . . . 73.34 113.662 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.7 p -66.94 -31.63 72.34 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.848 -1.069 . . . . 65.14 112.291 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -22.62 67.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.742 0.817 . . . . 73.23 111.37 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 97.4 m-20 -97.34 38.26 1.28 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 71.31 110.577 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -51.73 -43.35 62.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.232 1.413 . . . . 72.02 113.159 -174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.91 -43.62 57.79 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.534 1.159 . . . . 71.32 109.69 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.576 ' HD2' ' HB3' ' A' ' 36' ' ' ASP . 1.7 tmtp? -63.56 -26.5 68.73 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.235 -2.257 . . . . 64.23 111.282 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 56' ' ' VAL . 57.4 t -55.78 -52.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.879 0.872 . . . . 64.32 110.936 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.6 -36.46 74.04 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.812 -1.086 . . . . 70.53 111.031 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.93 -45.6 73.84 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.047 -0.978 . . . . 71.32 110.002 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 63.6 mm-40 -66.9 -24.2 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.387 0.675 . . . . 70.33 112.777 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 69' ' ' ILE . 70.6 mt -58.37 -47.08 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 122.805 0.442 . . . . 72.34 109.98 174.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 32.8 tt0 -69.21 -34.75 75.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.695 . . . . 74.15 110.899 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -74.37 -31.18 62.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.711 0.804 . . . . 55.15 111.764 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -35.49 73.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.354 0.662 . . . . 73.14 109.476 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 47.0 mtp85 -62.76 -40.99 98.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.769 0.827 . . . . 73.41 110.906 171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.2 -38.08 84.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.801 0.841 . . . . 71.14 109.584 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -86.95 -9.23 56.14 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 71.32 111.705 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.97 35.62 90.93 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.737 0.648 . . . . 54.33 113.73 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -136.84 158.54 72.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.937 0.895 . . . . 74.23 110.528 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.624 ' HB3' ' HB ' ' A' ' 3' ' ' VAL . 56.4 Cg_endo -70.31 175.74 8.15 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.613 2.209 . . . . 64.24 113.73 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 tt -151.87 128.47 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 114.892 -1.049 . . . . 73.24 109.47 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' THR . 87.1 t -99.56 106.56 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.384 0.611 . . . . 72.32 110.031 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 6' ' ' LEU . 57.9 t -96.98 126.69 49.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.519 1.128 . . . . 73.25 109.918 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -91.5 112.74 24.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.593 0.757 . . . . 71.3 109.421 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.38 150.68 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.072 1.349 . . . . 73.44 108.36 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -82.57 148.85 27.8 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 122.021 -0.424 . . . . 71.12 110.176 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.65 87.61 0.53 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.174 -1.17 . . . . 51.45 110.174 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.77 -21.56 1.3 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.021 -0.831 . . . . 51.24 111.021 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.01 47.16 1.46 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.858 0.863 . . . . 64.44 109.677 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.07 -29.4 68.35 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.229 1.012 . . . . 53.04 110.211 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 28.1 tt0 -54.79 -54.4 42.6 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.01 1.324 . . . . 73.5 110.298 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -68.79 -33.12 73.34 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.508 -0.769 . . . . 73.32 110.477 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.95 87.35 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.358 0.663 . . . . 65.44 111.224 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -74.3 -28.87 61.38 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 118.786 -0.626 . . . . 72.05 111.652 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -67.98 -53.17 28.1 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.194 0.521 . . . . 75.43 110.835 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 44' ' ' ILE . 95.9 mt -64.14 -41.34 92.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.789 -1.096 . . . . 62.32 110.355 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.75 -36.62 84.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.62 0.768 . . . . 64.12 111.409 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.28 -44.73 78.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.295 0.638 . . . . 74.33 110.522 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 90.3 t80 -66.87 -37.18 83.93 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.528 0.517 . . . . 74.33 110.313 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.62 -49.15 77.73 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.404 0.682 . . . . 73.25 110.819 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.77 -28.34 66.7 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 71.24 110.601 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -64.65 -34.19 77.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.253 1.021 . . . . 73.55 110.59 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 11.8 mm-40 -77.05 -4.99 47.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.111 0.565 . . . . 74.25 111.232 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.45 20.42 60.28 Favored Glycine 0 C--N 1.346 1.131 0 C-N-CA 123.143 0.401 . . . . 34.24 112.403 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 20.0 mt -91.68 157.43 16.95 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.041 0.536 . . . . 75.35 110.128 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -77.41 128.91 35.04 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.109 -1.071 . . . . 63.32 108.109 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 70' ' ' ALA . 36.8 t -106.09 132.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.909 -0.775 . . . . 54.14 108.909 177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 105' ' ' ASP . 2.8 mp -121.97 135.32 62.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 8' ' ' LEU . 88.3 t -122.18 113.27 38.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.975 0 N-CA-C 108.409 -0.96 . . . . 70.42 108.409 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 7' ' ' VAL . 47.5 mt -104.41 103.98 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.992 -0.744 . . . . 62.23 108.992 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -91.29 105.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.625 -0.88 . . . . 62.02 108.625 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 14' ' ' ILE . 21.3 t -94.68 101.69 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.302 -0.999 . . . . 70.33 108.302 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -148.63 133.08 17.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.59 -27.72 67.94 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 109.189 -0.671 . . . . 63.52 109.189 168.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.72 96.91 0.76 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.003 0.921 . . . . 74.11 109.543 172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' HD12 ' A' ' 92' ' ' LEU . 34.6 mt-10 -70.27 -21.88 62.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.148 0.579 . . . . 74.12 111.656 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.2 -53.39 58.32 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.07 -0.715 . . . . 72.4 109.07 168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -30.43 71.05 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.905 0.882 . . . . 74.14 111.633 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 89' ' ' GLU . 80.5 mt -59.53 -54.22 49.03 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 123.829 0.706 . . . . 71.51 110.237 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -72.13 -34.68 68.73 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.81 0.694 . . . . 70.41 112.425 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.5 -48.37 81.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.789 0.68 . . . . 71.41 110.111 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.92 -34.12 53.58 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.859 0.725 . . . . 21.34 112.709 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.78 ' HA ' HG11 ' A' ' 106' ' ' VAL . 93.3 t80 -61.39 -58.77 6.86 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 122.878 0.471 . . . . 74.44 110.293 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -74.09 -32.81 63.39 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.308 1.005 . . . . 64.22 111.157 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -43.73 80.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.808 . . . . 73.42 111.744 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.987 -0.551 . . . . 73.31 110.484 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.11 -35.04 78.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.299 0.64 . . . . 72.23 111.54 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.7 -27.34 62.02 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.587 0.355 . . . . 74.45 110.776 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -74.25 -17.36 60.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.131 0.572 . . . . 70.45 110.347 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.34 16.15 14.0 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.957 -0.565 . . . . 45.23 113.411 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -91.98 135.56 33.85 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.797 -0.816 . . . . 75.43 108.797 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 81' ' ' ILE . 15.6 t70 -80.35 102.19 9.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.204 -0.665 . . . . 74.31 109.204 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 96' ' ' TYR . 17.5 t -102.96 146.29 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.891 0.377 . . . . 71.02 111.191 -170.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 125' ' ' LYS . 91.7 m-85 -123.35 143.81 49.86 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.864 1.266 . . . . 70.13 109.371 174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.4 p -109.2 147.01 33.22 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.03 0.932 . . . . 65.44 109.915 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 p -158.13 132.76 8.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.519 0.728 . . . . 73.34 110.111 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.59 -31.15 16.8 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.496 0.718 . . . . 71.21 110.799 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -136.67 179.03 6.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.572 0.349 . . . . 74.25 111.009 -173.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -65.99 -40.36 91.11 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.085 0.866 . . . . 54.32 112.245 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.97 -44.49 97.26 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.739 0.304 . . . . 64.31 110.702 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 48.2 mt-10 -63.61 -46.33 86.25 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.557 -0.747 . . . . 74.14 110.249 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.12 75.75 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.337 1.055 . . . . 62.31 111.748 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -71.61 -42.52 67.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.052 -1.431 . . . . 73.44 111.041 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -72.69 -37.54 67.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.177 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 33.2 mmtp -70.71 -27.94 64.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.523 0.729 . . . . 71.31 110.827 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 18' ' ' LEU . 58.7 tp -66.07 -44.99 82.89 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.844 0.715 . . . . 65.34 110.425 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 120' ' ' LYS . 10.0 mtpm? -60.55 -40.89 93.25 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.769 0.668 . . . . 73.31 110.893 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 6.2 mm-40 -57.68 -41.64 82.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.814 0.696 . . . . 70.1 110.231 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 83' ' ' ILE . . . -63.18 -44.31 95.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.643 0.777 . . . . 50.33 111.651 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.5 -36.05 76.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.121 0.968 . . . . 75.21 111.368 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 64.8 mt-10 -78.8 -29.07 44.67 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.436 1.094 . . . . 63.42 111.334 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 107' ' ' TYR . 4.8 mmmm -80.51 -20.83 42.7 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.635 0.774 . . . . 72.31 111.415 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.2 p -92.48 -173.03 3.26 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.003 0.521 . . . . 72.35 110.144 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -83.71 49.81 4.29 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.563 -0.289 . . . . 54.01 113.621 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.7 m -117.16 -73.09 0.66 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.526 -0.916 . . . . 73.23 108.526 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.43 -179.16 3.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.877 0.871 . . . . 65.43 109.985 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -93.78 132.65 37.96 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.843 -0.799 . . . . 74.42 108.843 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 19.7 t-80 -76.17 92.91 3.29 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.082 -0.711 . . . . 53.0 109.082 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -79.61 175.37 10.67 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.472 -1.24 . . . . 75.11 110.268 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -96.04 138.71 33.27 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.385 0.674 . . . . 71.33 109.974 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -89.09 94.09 9.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.086 -0.961 . . . . 75.23 108.499 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -140.25 121.67 15.05 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.232 -0.895 . . . . 70.41 109.928 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 23.8 p80 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.995 0.918 . . . . 61.43 109.221 173.11 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.753 -0.462 . . . . 73.13 109.753 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.16 152.56 52.77 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 109.551 -1.42 . . . . 71.22 109.551 164.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 79' ' ' ARG . 80.4 t -133.15 121.08 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.657 -0.868 . . . . 43.2 108.657 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -106.66 109.72 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.064 -1.087 . . . . 74.51 108.064 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.73 105.56 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.635 -1.246 . . . . 72.24 107.635 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.0 mt -97.48 102.45 14.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.673 -0.862 . . . . 74.25 108.673 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.31 104.75 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.248 -1.019 . . . . 70.14 108.248 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 10.5 mp -85.78 102.07 13.35 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 107.912 -1.144 . . . . 71.34 107.912 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -106.04 136.36 45.84 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.345 -0.613 . . . . 72.12 109.345 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.64 -20.77 72.34 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.532 0.52 . . . . 74.42 112.519 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -136.64 139.05 41.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.712 0.805 . . . . 72.41 111.046 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.03 -34.92 76.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.0 1.32 . . . . 75.0 112.163 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -67.37 -43.04 82.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.474 0.309 . . . . 71.03 110.595 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 68.4 mt -57.57 -43.0 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.847 0.717 . . . . 75.13 109.676 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.93 72.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.74 0.816 . . . . 72.21 111.582 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -71.3 -27.9 63.73 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.315 0.646 . . . . 73.5 112.179 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 32.4 mm-40 -74.06 -27.41 60.9 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.446 0.699 . . . . 73.14 111.599 175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' ILE . 62.6 mt -76.89 -36.1 56.94 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.401 -0.592 . . . . 73.21 109.401 170.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HG3' HG21 ' A' ' 31' ' ' THR . 73.4 ttt180 -61.61 -38.57 88.08 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.796 1.239 . . . . 71.41 112.028 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 17' ' ' GLU . 16.5 ptmt -57.84 -37.66 74.26 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.526 0.516 . . . . 73.21 109.742 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.55 -37.78 62.91 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.119 -0.946 . . . . 70.43 111.825 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.18 -43.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 123.847 0.717 . . . . 75.25 110.394 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.8 -33.31 75.57 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.891 -1.05 . . . . 63.33 110.924 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -83.62 -24.43 31.44 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.603 0.761 . . . . 72.41 111.529 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -80.28 -48.04 13.64 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.256 1.022 . . . . 64.3 109.948 -176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -159.92 124.97 2.2 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.61 0.764 . . . . 70.22 109.557 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.74 -16.43 20.92 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.544 2.163 . . . . 63.04 113.464 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -81.14 -37.86 28.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 75.24 110.232 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 53' ' ' PRO . 42.1 t -65.07 110.98 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.081 -0.711 . . . . 51.22 109.081 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -91.36 159.29 16.07 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.936 -0.575 . . . . 75.43 110.947 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 19' ' ' ARG . 31.1 p -122.68 121.29 36.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.797 0.839 . . . . 73.41 109.844 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 t -112.85 124.89 30.79 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 123.728 0.811 . . . . 73.43 109.04 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.2 176.96 9.45 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.381 2.054 . . . . 62.32 113.683 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.73 -33.29 75.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.19 -1.368 . . . . 73.11 112.966 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -71.76 -19.03 62.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.376 0.67 . . . . 74.23 112.505 -172.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 40' ' ' VAL . 69.5 m-20 -103.01 35.92 2.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 119.02 -0.515 . . . . 70.52 111.607 -172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -50.77 -48.36 59.34 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 124.042 0.937 . . . . 73.0 111.001 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.59 -39.65 88.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.071 0.549 . . . . 72.45 110.356 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 53.1 mtpt -74.45 -25.15 59.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.249 -0.887 . . . . 73.2 111.707 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.9 t -60.46 -38.51 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 118.42 0.554 . . . . 53.44 110.363 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.94 -40.92 73.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.817 0.847 . . . . 72.35 110.971 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.8 -37.38 79.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.68 0.792 . . . . 51.32 110.216 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 25.2 mm-40 -69.14 -34.84 75.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.64 0.776 . . . . 64.21 111.769 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 69' ' ' ILE . 85.2 mt -71.17 -40.85 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.255 1.022 . . . . 75.43 109.442 175.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.4 -39.97 81.13 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.195 0.998 . . . . 75.42 109.58 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -70.62 -37.87 73.87 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.096 0.958 . . . . 63.22 111.525 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.53 -29.72 70.75 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.519 0.728 . . . . 71.14 111.88 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 78' ' ' LEU . 59.5 mtm180 -58.56 -49.98 75.45 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.212 0.605 . . . . 75.54 110.031 173.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.372 -1.285 . . . . 71.52 110.298 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -79.88 -21.64 43.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.29 -0.414 . . . . 72.45 111.539 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.98 26.68 49.19 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.445 0.465 . . . . 72.31 113.681 -173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 mtt-85 -117.05 160.06 38.63 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 123.728 0.811 . . . . 60.23 110.287 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 29' ' ' VAL . 42.0 Cg_endo -66.12 152.52 81.01 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.252 1.968 . . . . 71.03 112.245 168.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.72 131.39 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.78 -1.192 . . . . 64.42 107.78 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG21 HD21 ' A' ' 119' ' ' LEU . 39.7 t -96.41 135.33 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.172 -0.677 . . . . 73.42 109.172 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 6' ' ' LEU . 87.4 t -131.83 110.43 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.328 -1.36 . . . . 65.33 107.328 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.12 107.49 13.97 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 74.53 108.962 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 49.0 t -101.07 151.31 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.457 -1.312 . . . . 74.35 107.457 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -75.59 131.08 39.76 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.303 -0.629 . . . . 75.13 109.303 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.73 73.72 1.41 Allowed Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.685 0.66 . . . . 43.2 112.011 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.12 -30.98 0.1 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.876 -0.89 . . . . 61.3 110.876 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 10.3 m-20 -74.13 86.13 1.87 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.075 0.55 . . . . 72.24 109.619 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.17 -50.15 74.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.08 -0.964 . . . . 64.44 110.734 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.557 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 36.7 tt0 -62.75 -53.06 60.07 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 124.36 1.037 . . . . 65.23 110.845 -175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 84.5 mtt85 -63.57 -35.5 80.69 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.804 0.442 . . . . 71.04 111.963 -176.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.2 -48.62 70.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.671 0.388 . . . . 42.05 111.427 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 64' ' ' GLU . 55.0 pttt -75.85 -28.48 58.22 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.123 0.569 . . . . 74.42 112.347 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.16 -45.22 77.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 73.44 110.181 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.506 HD11 ' HG2' ' A' ' 37' ' ' LYS . 97.1 mt -67.33 -43.43 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.418 -1.265 . . . . 60.23 110.12 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.77 91.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.991 0.917 . . . . 61.31 111.653 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.72 -41.68 68.24 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 115.667 -0.697 . . . . 75.25 110.088 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.3 t80 -55.9 -46.1 78.48 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.762 0.664 . . . . 65.44 110.414 175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.54 92.61 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.553 -0.749 . . . . 74.11 111.652 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.99 -33.3 74.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.139 0.575 . . . . 55.32 111.102 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -64.94 -33.0 74.99 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.939 0.496 . . . . 72.53 110.635 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 13.7 mm-40 -83.09 -2.67 55.99 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 123.146 0.279 . . . . 75.21 110.942 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.33 16.49 80.58 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 122.764 0.221 . . . . 53.31 113.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 18.7 mt -83.95 147.53 27.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.437 0.695 . . . . 63.55 109.802 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.525 ' HB2' HG22 ' A' ' 3' ' ' VAL . 68.1 mtp85 -67.39 112.32 4.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.874 0.47 . . . . 73.12 109.944 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.86 114.49 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.9 -0.778 . . . . 64.51 108.9 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 2.4 mp -115.0 117.11 54.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.874 -1.158 . . . . 53.24 107.874 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 8' ' ' LEU . 59.7 t -110.56 112.98 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.422 -0.955 . . . . 74.11 108.422 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.7 mt -111.19 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.442 HG12 ' HA3' ' A' ' 95' ' ' GLY . 2.2 mp -83.44 122.17 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.207 -1.034 . . . . 52.0 108.207 176.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' OG ' ' A' ' 109' ' ' SER . 25.2 t -114.94 103.86 15.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 124.685 1.194 . . . . 71.31 108.859 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 m -149.41 153.44 37.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.246 1.018 . . . . 73.42 108.821 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -94.67 10.82 33.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.422 0.689 . . . . 74.21 109.822 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.12 128.13 55.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.123 0.969 . . . . 62.53 109.42 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -59.29 -42.86 92.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.283 1.033 . . . . 63.05 111.936 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.49 -35.86 75.95 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.819 0.448 . . . . 72.13 111.633 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.0 85.73 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.654 0.382 . . . . 63.22 110.76 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 84' ' ' ILE . 44.9 mt -71.32 -49.2 44.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.133 0.973 . . . . 55.5 111.159 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.68 -50.96 46.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 75.04 110.866 -173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -69.01 -39.57 79.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.827 -176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 84' ' ' ILE . . . -65.24 -34.02 88.41 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 123.608 0.567 . . . . 61.24 112.538 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.628 ' HA ' HG11 ' A' ' 106' ' ' VAL . 43.1 t80 -63.8 -56.94 11.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.517 0.727 . . . . 71.24 110.6 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -70.37 -32.73 70.54 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.549 -1.205 . . . . 75.53 111.962 -171.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.42 -52.88 50.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.739 0.816 . . . . 52.31 111.903 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 3.1 mptp? -76.67 -26.87 55.28 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.065 -0.516 . . . . 73.11 110.572 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -69.22 -28.04 66.0 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 64.1 111.834 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.1 mttp -63.82 -32.47 73.99 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 120.933 0.396 . . . . 71.44 110.863 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 26.6 mtpp -82.31 -1.03 48.31 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.622 0.769 . . . . 65.14 111.777 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.6 46.75 5.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.349 0.405 . . . . 64.21 113.883 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 14.0 m-85 -115.92 150.33 37.3 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.262 0.625 . . . . 73.32 109.609 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 m-20 -75.17 99.08 3.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.716 -1.216 . . . . 51.02 107.716 172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 96' ' ' TYR . 41.1 t -104.31 118.19 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.806 -0.442 . . . . 74.05 109.806 -172.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.487 ' HB2' HG12 ' A' ' 83' ' ' ILE . 24.5 m-85 -98.75 151.61 20.58 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.432 0.693 . . . . 64.5 109.54 173.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.2 p -115.65 166.22 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.014 0.926 . . . . 63.21 109.558 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 85' ' ' VAL . 80.0 p -127.83 179.07 5.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.478 -0.783 . . . . 73.21 109.291 171.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -111.13 -32.18 6.86 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.6 -1.259 . . . . 75.04 107.6 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.87 -164.33 1.3 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.528 -1.215 . . . . 45.45 108.635 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.91 -31.81 63.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.781 1.232 . . . . 62.34 113.229 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.93 -53.27 59.38 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.604 0.762 . . . . 71.12 111.541 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 18.4 mp0 -67.55 -34.88 77.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.287 0.635 . . . . 72.31 110.396 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.52 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.703 0.801 . . . . 60.43 111.192 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -69.8 -35.8 75.13 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.963 1.305 . . . . 71.42 110.454 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 114' ' ' GLU . 61.0 mttm -67.46 -53.66 26.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.613 0.765 . . . . 74.04 110.183 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt -68.2 -27.91 66.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.803 0.841 . . . . 74.22 112.459 -171.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 55' ' ' VAL . 4.8 tt -67.11 -48.79 67.04 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.692 -0.855 . . . . 64.01 108.692 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 123' ' ' LEU . 97.3 mttt -68.35 -30.06 68.93 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.93 -0.577 . . . . 73.5 111.679 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 50.2 mt-10 -69.98 -34.55 73.5 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.611 0.569 . . . . 74.23 110.403 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -69.44 -32.04 70.73 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.361 0.664 . . . . 74.42 110.786 174.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 120' ' ' LYS . 83.2 mt -71.74 -27.84 63.26 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.921 0.889 . . . . 73.54 110.434 173.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 50.9 mt-10 -76.26 -31.43 58.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 121.831 -0.543 . . . . 74.23 110.857 172.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 73.3 mmtt -76.01 -14.9 60.22 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.099 0.56 . . . . 75.12 111.628 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.4 p -91.98 -6.18 51.71 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.168 0.587 . . . . 75.54 111.729 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.7 13.62 72.23 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.372 0.42 . . . . 62.14 113.643 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.9 m -81.08 -57.4 3.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.991 0.516 . . . . 74.3 109.869 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 7.7 mp 65.98 167.81 0.21 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.957 1.303 . . . . 64.34 112.692 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.64 168.55 9.26 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.931 0.892 . . . . 72.31 108.959 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.41 86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.632 0.729 . . . . 64.52 109.633 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -116.0 -54.21 2.51 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.976 -1.12 . . . . 65.11 107.976 171.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 m80 61.75 25.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.618 -1.173 . . . . 74.22 111.711 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -130.89 166.72 20.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.752 1.221 . . . . 71.14 108.251 171.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -77.63 82.67 4.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.379 -0.601 . . . . 63.34 109.379 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.213 -0.662 . . . . 74.11 109.213 177.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.42 0.629 . . . . 70.22 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.15 38.74 Favored Glycine 0 C--O 1.242 0.614 0 N-CA-C 109.506 -1.437 . . . . 62.23 109.506 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 97.8 t -140.98 140.31 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 108.845 -0.798 . . . . 65.11 108.845 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.93 112.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.769 . . . . 51.41 108.922 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.468 HG12 ' HB ' ' A' ' 81' ' ' ILE . 69.6 mt -102.92 107.61 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.252 1.021 . . . . 73.4 108.619 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 56' ' ' VAL . 31.3 mt -97.52 103.18 15.09 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.661 -0.866 . . . . 74.33 108.661 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.47 105.46 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 109.338 -0.616 . . . . 64.14 109.338 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.468 HD13 HG13 ' A' ' 82' ' ' VAL . 9.8 mp -89.57 104.65 17.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.235 1.014 . . . . 73.41 108.837 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -104.97 137.0 43.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.173 -0.677 . . . . 71.24 109.173 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.97 -48.69 59.11 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.997 -0.841 . . . . 74.23 110.997 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.9 m-20 -94.05 120.38 34.22 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.171 -1.048 . . . . 64.05 108.171 171.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.83 -26.8 62.5 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.501 1.12 . . . . 63.44 111.418 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -52.42 -49.36 64.68 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.006 1.322 . . . . 73.43 111.63 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -62.1 -31.28 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.485 0.714 . . . . 73.43 111.196 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 57' ' ' PHE . . . -57.36 -39.39 75.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.788 0.835 . . . . 71.44 112.008 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.08 -34.79 61.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.745 0.818 . . . . 73.55 111.806 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.17 -35.26 76.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.698 0.799 . . . . 75.53 110.818 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.8 mt -77.44 -36.68 52.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 62.2 110.433 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -58.16 -45.4 87.52 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.852 0.861 . . . . 71.23 111.614 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 19.1 ptmt -66.43 -35.05 79.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.185 -0.916 . . . . 72.41 110.867 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -30.02 63.83 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' LEU . 67.2 t -64.89 -46.52 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.104 -0.702 . . . . 73.4 109.104 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.4 -29.5 70.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.076 -0.965 . . . . 64.32 111.462 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 97.9 mttt -76.36 -44.09 38.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.395 0.678 . . . . 70.14 111.312 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -63.77 -49.99 70.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.087 0.555 . . . . 63.12 110.044 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -147.16 113.77 4.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.288 -1.004 . . . . 65.44 108.288 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.85 -8.29 14.48 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.118 2.545 . . . . 62.5 113.125 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -84.37 -22.81 30.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.678 0.791 . . . . 71.2 109.973 -178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 53' ' ' PRO . 64.4 t -68.68 130.15 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.979 0.512 . . . . 73.23 110.437 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.9 139.04 46.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.061 0.944 . . . . 70.33 109.93 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.5 p -131.93 119.9 21.77 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.519 -0.549 . . . . 70.31 109.519 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 t -126.92 117.97 22.26 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 108.515 -0.92 . . . . 63.52 108.515 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 69.5 Cg_endo -80.2 -173.69 1.96 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.677 2.252 . . . . 71.15 113.334 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.443 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 73.4 p -71.26 -18.72 62.42 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.157 -0.929 . . . . 71.01 112.88 -172.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -71.74 -31.7 66.96 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.431 0.634 . . . . 75.22 110.749 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -109.34 36.23 3.0 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.049 -0.978 . . . . 73.42 110.657 -166.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 34' ' ' THR . 48.7 mtmt -61.32 -27.88 68.8 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.492 0.717 . . . . 74.13 112.224 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.37 -29.98 67.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.758 0.823 . . . . 72.1 110.791 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 88.7 mttt -94.64 -14.69 24.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.28 1.032 . . . . 74.31 111.571 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.69 -50.95 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 123.873 0.869 . . . . 75.12 111.488 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.92 -38.49 79.05 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.295 1.038 . . . . 73.32 111.203 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.23 -49.68 63.55 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.652 0.781 . . . . 71.13 109.27 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 22.9 mm-40 -67.7 -26.16 66.03 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.276 -0.874 . . . . 72.33 111.998 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.8 mt -69.48 -44.91 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.858 0.863 . . . . 72.51 110.127 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 33.0 tt0 -64.39 -31.27 72.41 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.327 0.584 . . . . 75.32 110.427 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -75.75 -35.02 60.3 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.135 0.974 . . . . 63.52 111.569 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.42 75.57 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.053 0.541 . . . . 71.34 111.013 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 5.8 ptm180 -64.65 -30.69 71.71 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.696 0.798 . . . . 75.41 111.522 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -66.73 -40.11 88.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.517 0.727 . . . . 73.02 110.411 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -83.19 -10.72 58.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.758 0.823 . . . . 71.31 111.271 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.37 37.55 92.87 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.297 0.373 . . . . 74.33 112.62 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -135.33 152.95 77.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.297 1.039 . . . . 72.43 110.782 -172.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 29' ' ' VAL . 51.9 Cg_endo -69.85 159.35 53.65 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.675 2.25 . . . . 63.23 113.442 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tt -136.97 120.83 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.471 -1.241 . . . . 73.41 107.868 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 29' ' ' VAL . 62.1 t -95.81 105.71 17.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.21 -1.033 . . . . 73.5 108.21 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' HD23 ' A' ' 6' ' ' LEU . 94.7 t -88.35 140.47 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.328 1.451 . . . . 70.02 108.894 175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 97.8 m-85 -112.48 113.31 25.41 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.694 -0.854 . . . . 71.1 108.694 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 74.0 t -118.96 135.32 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.518 1.527 . . . . 74.23 107.682 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 61' ' ' GLY . 4.8 tmm_? -83.83 146.63 28.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.606 -1.257 . . . . 75.12 107.606 172.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.59 -18.04 9.89 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 116.13 1.212 . . . . 43.33 116.13 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' H ' ' HD2' ' A' ' 59' ' ' ARG . . . -62.81 -35.87 92.57 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 117.198 0.499 . . . . 42.33 112.312 175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 65' ' ' ARG . 4.6 m-20 -89.92 46.04 1.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.136 0.974 . . . . 73.24 110.914 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.88 -31.39 71.96 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.634 0.774 . . . . 62.54 111.34 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -71.59 -39.96 70.18 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.738 0.815 . . . . 70.42 110.57 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 4.1 mpt_? -62.98 -38.53 91.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 109.167 -0.679 . . . . 72.52 109.167 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.74 -31.66 70.98 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.909 0.884 . . . . 62.23 112.096 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -70.52 -47.81 58.61 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.175 0.59 . . . . 71.21 110.567 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.23 -43.55 73.81 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.915 0.886 . . . . 72.21 112.48 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.2 mt -66.92 -37.99 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.104 0.962 . . . . 61.33 109.975 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -68.28 -36.86 80.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.573 0.749 . . . . 44.25 111.805 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.68 -45.15 76.03 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.31 0.644 . . . . 73.1 109.332 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -60.23 -45.39 93.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.115 0.966 . . . . 65.54 110.726 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.47 -50.94 71.98 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 124.114 0.884 . . . . 70.22 110.759 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -62.1 -35.12 77.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.774 0.83 . . . . 53.13 110.797 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.94 -33.2 75.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.866 0.866 . . . . 73.34 110.72 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.14 0.49 44.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.209 0.603 . . . . 74.31 112.022 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.0 28.14 50.92 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 123.273 0.358 . . . . 40.32 112.304 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 48' ' ' ARG . 26.4 mt -98.98 138.32 36.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.467 0.707 . . . . 75.25 109.179 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' HB2' HG22 ' A' ' 3' ' ' VAL . 89.5 mtt-85 -67.83 115.27 7.18 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.998 -0.741 . . . . 74.23 108.998 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.607 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.3 t -94.76 115.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.411 -0.589 . . . . 64.32 109.411 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 5' ' ' ILE . 2.1 mp -110.28 137.79 41.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.613 -1.625 . . . . 65.33 106.613 172.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 8' ' ' LEU . 86.3 t -126.62 111.7 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.274 -1.01 . . . . 72.3 108.274 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.72 105.29 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.161 -0.681 . . . . 75.05 109.161 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.0 mt -92.76 110.83 23.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.954 -0.758 . . . . 54.1 108.954 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 14' ' ' ILE . 8.4 t -104.17 103.5 15.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 73.14 108.488 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -155.32 140.42 17.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.929 -0.767 . . . . 73.23 108.929 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -93.6 42.01 1.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.441 1.115 . . . . 73.54 109.009 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -145.99 118.25 8.39 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.518 -1.219 . . . . 63.14 108.524 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.89 -35.44 68.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.636 1.174 . . . . 64.12 112.773 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.78 -50.05 39.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.037 0.535 . . . . 65.23 110.743 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.57 75.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.071 0.548 . . . . 73.54 111.44 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.66 -54.7 10.89 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.808 -0.633 . . . . 71.54 110.682 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -67.58 -50.95 55.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.197 0.599 . . . . 75.41 112.438 -171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.02 -45.24 93.43 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.993 0.808 . . . . 74.31 110.413 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.27 -40.4 92.1 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.053 0.845 . . . . 62.01 112.498 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HA ' HG11 ' A' ' 106' ' ' VAL . 30.1 t80 -57.56 -57.53 12.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.909 0.884 . . . . 61.14 110.316 -175.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -71.36 -37.24 71.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.287 0.992 . . . . 63.5 110.86 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.4 -52.34 62.04 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.076 0.55 . . . . 65.33 110.718 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -76.56 -38.81 54.37 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.263 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -66.39 -36.27 82.42 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.418 0.687 . . . . 74.14 111.774 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -77.11 -10.93 59.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.156 0.982 . . . . 62.05 111.81 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -91.23 3.66 54.28 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.424 0.69 . . . . 70.04 110.612 169.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.02 43.47 Favored Glycine 0 C--N 1.353 1.485 0 C-N-CA 123.004 0.335 . . . . 60.22 113.436 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -99.58 139.2 35.59 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.25 -1.019 . . . . 74.12 108.25 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 24.6 t70 -78.19 99.15 6.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.41 0.684 . . . . 72.25 109.192 176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.9 t -105.48 137.05 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.02 0.438 . . . . 70.42 110.529 -170.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.455 ' HD2' ' HD2' ' A' ' 118' ' ' LYS . 77.2 m-85 -114.8 151.79 33.23 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.73 1.212 . . . . 74.34 108.159 171.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -129.27 156.97 43.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.522 0.729 . . . . 65.23 109.422 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.2 p -152.75 132.03 12.81 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 122.854 0.462 . . . . 60.31 111.173 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -72.3 -23.46 61.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.788 0.835 . . . . 73.3 111.656 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.96 178.78 9.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.968 0.413 . . . . 74.22 111.184 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -65.46 -34.53 78.51 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.531 1.532 . . . . 73.51 112.89 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 7.3 m-20 -63.3 -48.73 76.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.717 0.407 . . . . 73.41 110.351 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -61.58 -37.92 85.63 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.248 0.967 . . . . 72.12 111.058 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.8 88.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.092 0.87 . . . . 63.13 110.873 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.2 -32.16 64.63 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 124.531 1.145 . . . . 72.43 111.249 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 113' ' ' ASP . 29.5 mmmt -61.68 -51.17 69.55 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.578 -0.897 . . . . 53.3 108.578 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' A' ' 107' ' ' TYR . 70.1 mmtt -70.7 -25.83 63.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.941 -1.481 . . . . 64.45 111.716 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.78 -47.99 67.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.092 0.957 . . . . 73.22 110.331 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.18 -31.55 67.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.345 0.403 . . . . 75.54 111.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.31 -42.3 98.43 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.487 0.492 . . . . 61.41 110.044 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.27 95.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 63.14 111.469 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.65 -30.3 66.88 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.45 -0.796 . . . . 71.33 111.002 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -74.94 -29.32 60.91 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.796 -0.565 . . . . 53.23 110.682 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -73.7 -29.25 62.17 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.292 0.637 . . . . 72.22 110.657 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 3' ' ' VAL . 88.0 p -78.49 -26.44 45.99 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.308 0.38 . . . . 74.34 111.344 175.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.55 -3.06 42.59 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 115.688 -0.687 . . . . 70.22 112.034 -176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.1 m -72.0 85.54 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.3 1.04 . . . . 72.42 109.329 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.75 -65.01 0.99 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.453 0.701 . . . . 71.53 109.446 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 63.68 12.13 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.401 1.481 . . . . 60.41 112.299 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -145.0 167.02 23.66 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.779 1.632 . . . . 74.35 107.982 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -76.33 113.65 14.15 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.485 -0.931 . . . . 71.33 108.485 167.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -71.02 -59.51 2.74 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.637 0.775 . . . . 51.54 109.453 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -150.83 -70.35 0.18 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 107.134 -1.432 . . . . 71.02 107.134 170.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -125.31 98.86 5.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.701 -1.963 . . . . 72.23 105.701 171.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.992 1.317 . . . . 71.34 109.23 -162.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.065 0.46 . . . . 70.23 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.66 29.44 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 110.653 -0.979 . . . . 74.05 110.653 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 55.3 t -138.14 141.64 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.59 0.756 . . . . 75.44 109.555 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.59 114.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.8 109.76 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.476 1.111 . . . . 55.22 108.703 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.4 mt -98.49 102.85 14.72 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.311 0.644 . . . . 73.15 109.371 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.2 t -91.71 104.67 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.161 -0.681 . . . . 70.0 109.161 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 9.3 mp -89.55 103.09 15.76 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.794 0.838 . . . . 54.13 108.775 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -104.45 135.21 46.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.639 -0.504 . . . . 72.2 109.639 -174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.44 -42.96 80.19 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.498 -0.641 . . . . 74.1 111.498 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.28 143.7 26.16 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.374 -0.913 . . . . 64.22 110.288 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -72.36 -37.96 68.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.039 1.336 . . . . 73.53 111.61 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 97.3 mtt180 -69.25 -39.9 78.18 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.38 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 85' ' ' VAL . 60.3 mt -56.83 -37.74 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 124.048 0.843 . . . . 63.53 110.731 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.62 89.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.153 0.581 . . . . 34.31 111.956 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 35.3 tt0 -75.88 -33.31 59.95 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.941 0.497 . . . . 71.44 111.488 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 8.4 mm-40 -70.32 -40.48 74.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.072 0.463 . . . . 62.11 110.103 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.8 mt -68.49 -29.99 68.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.433 -0.803 . . . . 60.01 110.444 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 57.8 ttp180 -61.84 -44.96 95.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.174 0.59 . . . . 75.5 110.792 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HZ2' ' HG2' ' A' ' 16' ' ' GLU . 61.8 mttp -57.78 -47.59 82.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.278 0.986 . . . . 73.42 109.885 173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 11.1 tp10 -63.05 -37.2 86.24 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.521 -1.218 . . . . 72.44 112.453 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.8 t -69.0 -39.98 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.236 0.614 . . . . 71.11 110.677 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.67 -32.0 72.36 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.763 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -66.36 -42.99 87.23 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.861 0.865 . . . . 75.45 109.919 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 8.2 t60 -64.18 -53.39 50.04 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.127 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -158.99 120.42 1.86 Allowed Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 114.849 -1.068 . . . . 72.3 108.787 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -11.15 18.47 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.779 2.319 . . . . 73.0 113.424 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -89.24 -22.18 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.687 0.795 . . . . 62.31 110.369 -177.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 53' ' ' PRO . 57.3 t -67.96 116.14 7.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 108.79 -0.819 . . . . 61.22 108.79 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -72.57 140.96 48.39 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.833 0.708 . . . . 71.34 110.429 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 19' ' ' ARG . 32.0 p -125.76 120.25 30.1 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.216 0.606 . . . . 73.12 110.074 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.2 127.27 27.0 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.37 0.668 . . . . 71.02 109.246 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.96 169.16 22.84 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.532 2.155 . . . . 63.2 112.488 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.7 p -62.62 -26.44 68.62 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.786 -1.097 . . . . 60.44 111.601 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -68.45 -25.92 65.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.719 1.208 . . . . 72.21 111.806 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 5.7 m-20 -111.44 51.0 0.8 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.39 1.076 . . . . 72.01 110.613 -169.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 65' ' ' ARG . 89.6 mttt -57.31 -38.76 74.54 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.155 0.982 . . . . 74.23 112.792 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.62 -32.31 60.22 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.519 0.728 . . . . 75.4 110.48 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 25.2 mmmt -72.44 -22.33 61.11 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 118.587 -0.721 . . . . 72.13 112.468 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG11 HD13 ' A' ' 69' ' ' ILE . 62.2 t -53.32 -54.4 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.786 0.678 . . . . 70.44 111.028 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.39 -37.62 75.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.431 1.092 . . . . 71.5 111.245 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -69.81 -42.12 74.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.217 -0.901 . . . . 60.3 111.24 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.74 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 19.2 mm-40 -77.54 -23.81 50.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.71 0.404 . . . . 71.2 111.491 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.95 -39.88 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.857 0.863 . . . . 72.15 109.082 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -37.0 85.27 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.946 0.779 . . . . 65.23 109.325 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 64.6 mmtt -63.86 -52.73 58.71 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.115 0.26 . . . . 70.22 110.546 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.64 91.91 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.625 0.578 . . . . 72.12 111.158 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt-85 -55.64 -45.22 77.64 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.596 1.158 . . . . 73.55 111.315 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.49 -35.0 60.89 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.479 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -80.25 -13.76 58.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.724 0.81 . . . . 73.3 112.01 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.98 91.0 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 111.978 -0.449 . . . . 43.41 111.978 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.87 159.32 43.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.244 1.418 . . . . 74.14 110.566 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HG2' HG22 ' A' ' 29' ' ' VAL . 56.0 Cg_endo -74.71 157.48 43.95 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.964 1.776 . . . . 74.41 112.0 164.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tt -132.77 134.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.649 -1.241 . . . . 54.53 107.649 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG21 HD21 ' A' ' 119' ' ' LEU . 49.0 t -107.03 106.3 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.59 0.709 . . . . 63.33 109.585 174.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.9 t -90.56 140.97 15.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.097 1.359 . . . . 62.21 109.611 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.33 113.51 26.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.714 -0.847 . . . . 73.23 108.714 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 65.9 t -116.18 152.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.794 1.638 . . . . 50.24 106.879 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -77.23 149.58 35.46 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.31 0.959 . . . . 73.52 108.961 173.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.93 -41.67 92.02 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.418 0.449 . . . . 33.22 112.217 177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.51 4.21 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.875 -0.49 . . . . 73.21 111.875 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.91 44.82 0.5 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.448 1.594 . . . . 55.32 108.623 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.47 -25.86 68.46 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 112.866 -1.97 . . . . 73.4 111.77 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.921 -1.036 . . . . 71.41 112.286 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -79.76 -40.12 29.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.878 0.308 . . . . 72.13 110.228 171.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.74 -37.51 68.55 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.338 0.655 . . . . 72.22 112.323 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -71.56 -30.99 66.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.22 0.608 . . . . 72.55 111.955 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.23 -51.0 16.72 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.015 0.912 . . . . 71.0 110.243 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD13 HG11 ' A' ' 40' ' ' VAL . 97.7 mt -67.71 -49.14 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 113.265 -1.789 . . . . 64.01 110.896 -170.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.98 -33.28 73.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.21 0.604 . . . . 61.22 111.798 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.76 -40.96 72.36 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.562 0.539 . . . . 74.23 110.421 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 87.1 t80 -61.81 -49.5 76.06 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 123.734 0.646 . . . . 73.11 109.449 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.76 82.23 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.407 1.067 . . . . 73.34 111.709 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.607 HE21 ' HE1' ' A' ' 104' ' ' TYR . 7.3 tt0 -58.62 -47.01 85.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.538 0.735 . . . . 63.53 110.662 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -72.64 -17.36 61.67 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.301 -0.863 . . . . 73.44 112.311 -176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 9.4 mm-40 -84.53 -1.94 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.061 0.545 . . . . 72.55 111.534 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.3 38.17 53.79 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 111.862 -0.495 . . . . 62.23 111.862 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -109.03 125.95 52.62 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.798 -1.186 . . . . 65.11 107.798 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.473 HH12 ' HB3' ' A' ' 105' ' ' ASP . 1.6 tmt_? -66.7 116.52 7.7 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.681 0.792 . . . . 64.23 108.956 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.2 t -93.69 132.23 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.643 0.735 . . . . 73.11 110.716 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.35 138.58 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.475 -2.046 . . . . 75.34 105.475 172.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 99' ' ' LYS . 98.7 t -128.19 113.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 107.801 -1.185 . . . . 64.24 107.801 175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.75 105.36 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.137 -0.69 . . . . 61.24 109.137 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 8' ' ' LEU . 72.1 mt -96.29 111.88 27.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -94.87 109.04 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.725 1.21 . . . . 74.22 108.822 176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.7 t -144.86 136.96 25.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.178 -0.675 . . . . 63.04 109.178 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -67.25 -16.26 64.18 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.206 1.002 . . . . 74.41 111.598 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.68 131.43 53.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.55 1.14 . . . . 73.23 110.387 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -70.31 -34.83 73.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.554 0.742 . . . . 72.42 112.449 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.45 -34.56 77.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.164 0.585 . . . . 72.23 111.056 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.47 83.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.661 -0.699 . . . . 55.3 110.897 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.04 -40.11 95.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.505 -0.771 . . . . 65.41 111.041 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.32 -51.4 24.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.631 0.772 . . . . 74.45 111.45 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -60.63 -48.61 81.02 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.873 0.733 . . . . 70.1 110.504 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.8 -36.44 91.9 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 124.068 0.855 . . . . 65.51 113.654 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.0 t80 -63.32 -61.06 2.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.788 0.435 . . . . 70.25 110.947 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.18 -29.49 62.88 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.472 0.483 . . . . 64.42 112.263 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -58.47 -49.5 77.13 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.382 0.673 . . . . 71.4 111.779 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 82' ' ' VAL . 12.3 mptt -78.24 -35.92 47.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.014 -0.365 . . . . 74.14 110.014 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -68.26 -28.69 67.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.606 0.762 . . . . 50.22 112.501 -173.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -69.47 -15.62 63.3 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.378 0.271 . . . . 73.45 111.667 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -90.54 1.32 56.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.594 0.758 . . . . 73.43 111.813 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.54 14.95 59.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.994 -0.337 . . . . 42.43 113.314 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.607 ' HE1' HE21 ' A' ' 74' ' ' GLN . 11.0 m-85 -88.2 128.78 35.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.803 -0.814 . . . . 72.11 108.803 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.473 ' HB3' HH12 ' A' ' 79' ' ' ARG . 54.2 t0 -77.62 105.41 8.75 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.911 -1.144 . . . . 74.44 107.911 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.5 t -100.33 146.17 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.833 0.853 . . . . 74.34 109.398 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -128.34 142.9 50.99 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.03 -1.47 . . . . 63.11 107.03 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -108.39 150.19 27.71 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -150.75 134.68 16.7 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.277 0.631 . . . . 73.2 110.047 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.24 26.46 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.399 0.437 . . . . 75.14 109.957 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.45 -176.28 5.73 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.169 0.293 . . . . 75.44 110.942 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.41 -39.38 64.27 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.243 1.417 . . . . 74.02 112.823 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.24 -52.18 66.41 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.236 0.614 . . . . 73.4 112.387 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.9 mp0 -61.42 -46.52 89.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.622 0.576 . . . . 53.03 110.337 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 119' ' ' LEU . . . -57.49 -42.56 82.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.365 1.041 . . . . 72.21 111.646 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -67.89 -41.55 82.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.92 1.288 . . . . 64.31 111.128 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -66.06 -44.43 84.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.781 0.675 . . . . 74.44 109.36 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 74.9 mmtt -64.8 -39.31 93.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.242 0.617 . . . . 71.22 110.939 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 55' ' ' VAL . 1.7 tt -65.13 -48.49 73.42 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.774 -1.103 . . . . 34.33 109.578 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -69.17 -34.69 75.35 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.314 -0.857 . . . . 72.53 111.505 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.19 -43.89 98.16 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 123.395 0.434 . . . . 54.32 111.17 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.45 72.29 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.034 0.834 . . . . 72.11 111.001 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.04 -38.67 56.9 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.774 0.829 . . . . 74.41 111.765 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 129' ' ' LEU . 33.2 mt-10 -65.46 -45.81 82.28 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.502 0.721 . . . . 72.35 110.095 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -74.08 -26.05 60.16 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.815 -1.084 . . . . 71.12 111.519 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.5 p -75.4 -12.93 60.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.436 0.294 . . . . 72.43 111.178 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.11 14.24 34.15 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.138 -0.812 . . . . 52.45 113.838 171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.2 p -74.41 -37.69 63.28 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 118.473 1.136 . . . . 61.43 108.889 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 124' ' ' GLU . 18.9 mt -112.28 -178.08 3.32 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.171 0.589 . . . . 71.24 110.31 170.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -76.19 167.49 21.76 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.91 0.884 . . . . 72.34 110.639 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.22 104.39 16.4 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.787 -0.82 . . . . 75.1 108.787 174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -66.5 133.15 49.79 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.891 0.876 . . . . 74.22 110.803 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -95.35 141.67 28.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.763 0.825 . . . . 72.32 109.423 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.7 m80 64.64 -175.9 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.152 0.981 . . . . 54.43 111.889 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 69.26 -178.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.735 1.214 . . . . 74.44 111.064 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 CA--C 1.556 1.202 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 174.494 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.128 0.49 . . . . 70.03 109.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.77 31.74 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.44 -1.064 . . . . 71.11 110.44 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 79' ' ' ARG . 82.6 t -139.5 127.05 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 109.191 -0.67 . . . . 63.44 109.191 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.76 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.792 -0.818 . . . . 71.44 108.792 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.13 109.99 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.957 -0.757 . . . . 75.21 108.957 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.99 102.59 14.38 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.512 -0.922 . . . . 63.33 108.512 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 HG23 ' A' ' 9' ' ' THR . 47.5 t -92.93 104.78 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.201 -0.666 . . . . 70.32 109.201 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 82' ' ' VAL . 10.2 mp -88.45 103.11 15.55 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.422 -0.955 . . . . 73.53 108.422 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 7' ' ' VAL . 40.9 p -105.31 136.97 43.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.6 -0.519 . . . . 43.02 109.6 -174.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.02 11.95 52.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.913 -0.585 . . . . 61.23 112.26 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -153.33 135.77 15.06 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.684 1.194 . . . . 65.55 109.16 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.22 -37.88 78.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.448 0.699 . . . . 63.3 111.86 -174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 52.7 ttp180 -65.95 -41.88 90.71 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-O 119.261 -0.4 . . . . 74.33 110.583 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 85' ' ' VAL . 60.9 mt -57.06 -37.53 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.77 0.669 . . . . 64.4 110.618 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.19 -42.7 81.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.282 0.633 . . . . 73.22 111.049 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -77.07 -32.48 56.8 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.325 0.65 . . . . 72.32 111.971 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 55.2 mm-40 -69.94 -32.11 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.712 0.405 . . . . 61.21 110.675 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.1 mt -78.67 -34.63 46.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.686 0.794 . . . . 64.54 110.83 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.25 -47.33 85.75 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.593 1.157 . . . . 73.54 112.345 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 19.8 ptmt -61.73 -34.44 75.81 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.298 -0.865 . . . . 74.41 111.039 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HE2' ' A' ' 116' ' ' LYS . 16.3 mm-40 -73.2 -30.3 63.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.255 1.022 . . . . 73.2 112.011 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.1 t -60.07 -43.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.62 0.575 . . . . 70.41 109.61 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.07 -29.01 62.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.707 -1.133 . . . . 71.13 110.985 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 74.4 mmtt -75.02 -29.77 60.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.553 0.741 . . . . 75.31 111.054 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.7 -47.33 32.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.114 -0.698 . . . . 62.23 109.114 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -162.26 119.05 1.3 Allowed Pre-proline 0 CA--C 1.557 1.249 0 CA-C-N 114.715 -1.129 . . . . 73.12 109.393 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.64 -1.07 10.77 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.982 2.455 . . . . 54.31 113.989 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.53 -21.46 20.1 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.147 0.579 . . . . 52.34 110.784 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 ' HG2' ' A' ' 53' ' ' PRO . 25.4 t -67.03 129.6 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.703 -0.48 . . . . 41.53 109.703 176.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.66 140.82 29.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.046 0.538 . . . . 73.25 109.718 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.1 p -130.02 119.93 23.92 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.499 0.72 . . . . 61.02 109.641 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.7 t -119.09 130.07 25.04 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.171 0.588 . . . . 71.33 110.407 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.04 173.84 12.21 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.617 2.212 . . . . 75.11 113.137 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 59' ' ' ARG . 80.5 p -63.98 -37.32 86.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.714 1.206 . . . . 71.31 113.044 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.04 -31.2 72.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.136 0.575 . . . . 73.51 111.058 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 19.0 m-20 -92.8 37.8 1.02 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 70.13 111.761 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.97 -38.3 70.2 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.92 0.888 . . . . 71.2 111.686 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.23 -42.14 96.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.125 0.97 . . . . 72.03 110.651 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 30.6 mmtm -70.54 -24.71 62.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.103 -0.953 . . . . 62.5 112.162 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 36' ' ' ASP . 92.9 t -54.84 -46.86 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.484 0.49 . . . . 74.4 111.672 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -47.26 67.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.547 1.139 . . . . 74.42 109.583 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -66.87 -42.39 85.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.221 -1.354 . . . . 73.12 110.245 -175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -71.95 -34.14 68.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.188 0.995 . . . . 74.04 112.117 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.75 -41.2 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.554 0.742 . . . . 70.31 109.36 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.76 -37.24 85.84 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.122 0.969 . . . . 74.32 110.576 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -69.74 -38.69 76.92 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.191 -0.913 . . . . 73.42 110.964 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.68 -40.73 97.53 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.9 -0.591 . . . . 55.32 110.125 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 50.6 mtp85 -60.36 -42.32 95.51 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.884 0.874 . . . . 63.32 111.86 174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -65.09 -41.43 95.01 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.662 0.785 . . . . 65.02 110.187 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -94.29 0.87 55.89 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.615 -0.72 . . . . 72.11 111.579 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.7 40.63 98.31 Favored Glycine 0 C--N 1.361 1.97 0 CA-C-O 121.479 0.488 . . . . 61.23 113.186 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -124.17 159.36 57.26 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.021 1.328 . . . . 74.01 110.903 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' HG22 ' A' ' 29' ' ' VAL . 79.8 Cg_endo -81.18 179.77 5.65 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.589 2.193 . . . . 63.12 113.088 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.16 129.37 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.287 -0.87 . . . . 74.42 109.415 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.19 110.55 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.356 0.663 . . . . 61.25 109.762 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 69' ' ' ILE . 50.2 t -98.29 115.76 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.707 0.803 . . . . 75.35 109.429 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.43 109.55 18.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.307 0.575 . . . . 75.33 109.605 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 66' ' ' ALA . 97.0 t -101.7 142.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.941 1.297 . . . . 72.32 108.082 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.551 ' HB2' HG21 ' A' ' 34' ' ' THR . 41.6 ttm180 -85.6 148.97 25.66 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.11 -1.071 . . . . 62.11 108.11 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.52 97.14 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.242 -0.743 . . . . 71.21 111.242 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.16 -4.11 5.25 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 111.274 -0.73 . . . . 71.53 111.274 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -98.67 37.88 1.44 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.408 1.083 . . . . 74.44 110.291 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -69.0 -27.08 65.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.425 0.69 . . . . 73.22 112.408 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -65.25 -33.9 77.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.534 0.734 . . . . 73.43 110.071 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -73.98 -46.87 41.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.704 -0.68 . . . . 70.34 109.843 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.587 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -61.12 -35.96 78.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.148 0.979 . . . . 41.33 112.7 -173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -67.12 -40.87 86.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.666 0.386 . . . . 73.21 111.016 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.82 -40.44 75.91 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.163 0.985 . . . . 74.21 111.463 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 HG11 ' A' ' 56' ' ' VAL . 99.1 mt -67.37 -46.12 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.472 -0.786 . . . . 65.43 109.85 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.36 -36.98 80.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.863 0.865 . . . . 74.23 112.087 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -71.57 -39.98 70.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.261 0.624 . . . . 73.33 110.169 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.517 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 71.6 t80 -59.13 -56.0 27.79 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.28 -33.67 67.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.074 0.95 . . . . 33.35 112.578 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -63.58 -47.05 83.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.068 0.947 . . . . 75.2 109.928 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -71.21 -24.94 62.31 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.876 -1.056 . . . . 74.13 111.09 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 9.4 mm-40 -82.95 1.48 39.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.814 0.445 . . . . 72.14 111.737 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.6 92.57 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 121.334 0.408 . . . . 51.03 112.471 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 mt -115.46 136.92 52.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.917 -1.142 . . . . 63.55 107.917 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.97 113.58 4.53 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.548 -0.538 . . . . 72.42 109.548 177.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.0 t -93.67 118.42 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 3' ' ' VAL . 2.2 mp -110.41 144.85 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 106.949 -1.501 . . . . 74.54 106.949 174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG13 HD13 ' A' ' 8' ' ' LEU . 72.9 t -130.36 112.86 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.886 -1.153 . . . . 71.25 107.886 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.484 HG12 ' HB2' ' A' ' 107' ' ' TYR . 66.4 mt -109.18 106.39 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 118.534 0.606 . . . . 62.44 109.88 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.8 mt -87.98 124.75 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.81 -0.811 . . . . 70.41 108.81 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 14' ' ' ILE . 10.9 t -111.96 106.91 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.2 t -153.74 133.76 13.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.228 1.011 . . . . 52.14 108.642 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -60.34 -33.26 72.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.661 0.6 . . . . 75.33 110.063 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.78 105.82 8.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.511 1.124 . . . . 74.33 109.283 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -70.69 -22.81 62.42 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.106 0.962 . . . . 75.21 111.146 -174.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.78 -46.61 81.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.101 0.56 . . . . 70.12 110.359 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.46 75.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.389 0.676 . . . . 63.13 111.347 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 89' ' ' GLU . 68.0 mt -62.95 -53.99 45.4 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 115.53 -0.759 . . . . 72.25 111.053 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -72.07 -37.39 69.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 62.23 112.122 -170.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -70.09 -37.35 75.39 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.401 -0.363 . . . . 72.45 110.027 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.76 -34.94 72.72 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.529 -0.76 . . . . 24.45 112.283 172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' HA ' HG11 ' A' ' 106' ' ' VAL . 56.1 t80 -57.46 -55.44 34.83 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.631 0.773 . . . . 74.21 109.532 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.41 -30.86 67.85 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.9 -1.045 . . . . 64.22 112.271 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.03 -53.13 42.47 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.783 0.833 . . . . 73.12 112.414 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 2.5 mptp? -77.55 -31.47 53.26 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 110.149 -0.315 . . . . 73.44 110.149 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' TYR . 59.0 tttm -63.89 -38.92 92.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.439 0.696 . . . . 74.35 112.423 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.43 -12.29 61.04 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 116.185 -0.461 . . . . 74.35 111.475 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.72 10.53 36.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.118 0.967 . . . . 73.31 111.415 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.08 47.69 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 113.979 0.352 . . . . 74.33 113.979 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 7.4 m-85 -109.0 128.4 54.92 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.111 -1.07 . . . . 64.43 108.111 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.69 103.46 6.68 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 118.139 0.427 . . . . 65.41 109.891 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 96' ' ' TYR . 31.9 t -99.29 139.01 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.711 0.404 . . . . 61.51 110.929 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 83' ' ' ILE . 93.5 m-85 -119.25 153.62 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.73 1.212 . . . . 72.2 108.056 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 57.4 p -133.46 149.25 51.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.151 0.58 . . . . 70.04 110.033 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 p -151.25 144.85 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.165 0.586 . . . . 73.44 111.167 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.7 -25.08 19.26 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.76 0.662 . . . . 74.44 110.684 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -135.3 176.02 9.05 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.817 0.341 . . . . 71.12 111.624 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.81 -48.34 69.25 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.427 1.091 . . . . 63.04 111.56 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.81 -35.33 80.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.262 0.625 . . . . 75.33 111.338 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.46 -44.73 77.93 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.159 -0.473 . . . . 63.33 110.284 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.18 80.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.302 1.041 . . . . 63.34 111.616 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HE2' ' HG3' ' A' ' 21' ' ' GLU . 38.9 ttmt -68.74 -42.59 77.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.243 1.417 . . . . 75.05 111.264 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.01 -43.38 71.49 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.298 -0.864 . . . . 73.13 109.899 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 107' ' ' TYR . 39.0 mmtm -59.43 -35.7 74.52 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.602 0.761 . . . . 64.43 111.675 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.45 -49.54 63.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.649 -1.16 . . . . 73.34 110.429 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.45 -30.43 67.27 Favored 'General case' 0 C--O 1.215 -0.711 0 O-C-N 123.686 0.616 . . . . 70.3 111.105 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 36.6 mt-10 -58.75 -41.27 86.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.335 0.654 . . . . 74.24 110.244 173.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.53 70.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.966 0.906 . . . . 73.44 111.471 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.64 -29.33 67.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.514 0.726 . . . . 72.31 111.229 176.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -71.73 -27.51 63.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 74.45 111.342 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 44.6 mmtm -76.09 -14.3 60.19 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.285 0.634 . . . . 73.02 111.48 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.3 p -103.77 -172.93 2.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.057 0.543 . . . . 71.32 110.873 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 60.34 4.48 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 116.306 -0.406 . . . . 74.12 112.262 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.2 m -143.09 87.18 1.95 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.781 -1.192 . . . . 71.35 107.781 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.5 mt -135.87 105.51 6.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.601 0.76 . . . . 74.42 110.483 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 130.98 55.48 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.163 -1.792 . . . . 72.44 106.163 167.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -74.23 81.32 1.82 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.916 -0.772 . . . . 72.4 108.916 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -72.87 102.88 3.54 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.162 -0.927 . . . . 74.53 109.01 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -67.26 88.87 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.564 0.745 . . . . 71.35 109.184 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -83.81 106.34 15.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.927 0.491 . . . . 70.32 110.492 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -145.19 65.25 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.531 1.132 . . . . 72.04 108.105 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.855 1.262 . . . . 75.33 111.282 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.328 -0.619 . . . . 74.42 109.328 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.96 168.57 11.29 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 109.953 -1.259 . . . . 53.44 109.953 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 79' ' ' ARG . 77.5 t -138.26 138.18 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.214 0.605 . . . . 75.03 109.413 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.89 111.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.118 -1.067 . . . . 64.43 108.118 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 62.1 mt -97.35 107.97 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.279 0.631 . . . . 64.5 109.899 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.98 101.8 13.46 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.594 -0.891 . . . . 75.3 108.594 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG12 HG23 ' A' ' 9' ' ' THR . 60.6 t -93.96 104.01 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 109.474 -0.565 . . . . 61.04 109.474 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 82' ' ' VAL . 8.8 mp -89.7 103.87 16.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.085 0.954 . . . . 64.32 108.93 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 7' ' ' VAL . 40.2 p -106.59 132.82 52.15 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.55 0.34 . . . . 65.4 110.155 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.14 7.74 70.15 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.593 -0.603 . . . . 34.24 111.593 171.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -147.1 114.49 6.3 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.149 -1.426 . . . . 75.51 107.149 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -70.4 -39.16 74.65 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.14 0.793 . . . . 71.25 113.14 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 6.1 ppt_? -64.03 -29.91 71.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.307 0.503 . . . . 70.1 111.365 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.586 HG21 HG11 ' A' ' 85' ' ' VAL . 39.8 mt -60.1 -45.18 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 123.765 0.666 . . . . 54.53 109.979 172.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -36.4 74.64 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.446 0.698 . . . . 74.31 111.963 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.87 -31.64 59.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.54 0.736 . . . . 70.41 111.098 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 36.5 mm-40 -74.22 -31.77 62.74 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.353 0.661 . . . . 72.32 110.891 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.9 mt -74.94 -33.85 62.01 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.329 -0.85 . . . . 64.41 109.746 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -63.19 -46.42 87.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.65 0.78 . . . . 75.24 109.944 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -52.98 -44.2 67.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.508 -1.678 . . . . 74.02 110.771 171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 9.1 tp10 -75.18 -31.58 61.01 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 114.994 -1.003 . . . . 73.32 112.91 -172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.5 t -63.02 -43.5 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.322 0.649 . . . . 75.1 109.965 175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -65.37 -32.09 73.54 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.699 -1.137 . . . . 65.21 111.265 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.46 -27.28 46.33 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.343 0.657 . . . . 73.34 111.212 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 120' ' ' LYS . 59.4 t60 -83.81 -24.78 30.86 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.888 0.475 . . . . 75.34 110.912 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.26 129.87 0.87 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 123.12 0.568 . . . . 70.41 109.746 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.17 -16.58 13.86 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.001 2.467 . . . . 63.5 113.694 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.22 -29.77 20.22 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.024 0.53 . . . . 54.22 110.963 -171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.37 121.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.362 0.414 . . . . 71.42 110.172 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -101.34 159.91 14.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.785 0.803 . . . . 54.53 111.587 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 55' ' ' VAL . 35.0 p -133.94 128.03 33.64 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 113.942 -1.481 . . . . 75.23 109.867 -167.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.84 131.44 24.43 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.693 0.797 . . . . 61.23 110.105 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.22 177.07 8.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.661 2.241 . . . . 71.01 113.622 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 58' ' ' VAL . 61.3 p -64.84 -32.33 73.98 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.399 1.08 . . . . 71.23 112.521 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.84 -42.0 78.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.547 1.139 . . . . 70.13 111.553 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -88.91 41.87 1.05 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.81 -1.086 . . . . 54.12 111.262 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -54.08 -50.36 66.97 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.778 1.231 . . . . 73.21 113.263 -171.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.63 -32.91 70.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.269 0.557 . . . . 73.1 110.129 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.5 mtpm? -72.01 -27.33 62.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.682 -1.145 . . . . 72.53 111.437 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 36' ' ' ASP . 49.8 t -54.79 -45.8 74.3 Favored 'Isoleucine or valine' 0 C--N 1.368 1.375 0 O-C-N 123.695 0.622 . . . . 73.23 110.178 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.58 -41.21 69.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.176 1.39 . . . . 61.44 111.627 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.42 -40.78 73.63 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.53 -0.759 . . . . 63.5 110.631 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 9.0 mm-40 -72.61 -22.3 60.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 54.34 112.525 -176.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 69' ' ' ILE . 71.1 mt -70.24 -37.92 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.675 0.79 . . . . 74.31 109.237 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.4 -34.69 76.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.194 0.598 . . . . 72.44 110.177 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 39.6 mmtm -64.66 -40.41 95.37 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.67 -0.493 . . . . 73.32 109.67 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 -41.12 98.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.317 1.047 . . . . 62.12 111.024 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 83.1 mtp180 -62.27 -45.86 91.4 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.209 0.604 . . . . 73.1 110.898 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.71 -42.19 91.43 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.909 0.884 . . . . 74.03 109.803 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -80.04 -12.46 59.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.837 0.855 . . . . 74.31 111.675 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.57 27.14 73.01 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.515 0.509 . . . . 65.22 112.908 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -122.4 156.39 60.89 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.431 1.093 . . . . 74.14 110.498 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.58 171.94 17.12 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.056 1.837 . . . . 63.04 113.569 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 tt -143.2 123.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.332 1.053 . . . . 63.31 108.741 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 31' ' ' THR . 43.3 t -101.75 107.28 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.066 0.547 . . . . 74.21 109.797 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 69' ' ' ILE . 41.8 t -93.61 116.69 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.515 0.726 . . . . 72.02 109.336 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -86.34 106.87 17.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.527 0.68 . . . . 74.34 109.664 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 34' ' ' THR . 38.7 t -101.68 151.48 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.671 -1.604 . . . . 62.03 107.831 177.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.87 160.73 22.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.352 -0.843 . . . . 72.33 110.14 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.36 2.44 71.54 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.662 -0.699 . . . . 73.34 113.658 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.17 22.94 6.6 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 171.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -131.33 38.05 3.66 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.252 1.021 . . . . 72.02 110.339 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.12 -30.72 60.33 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.989 1.315 . . . . 65.15 112.434 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -60.08 -37.71 80.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.277 0.631 . . . . 73.54 111.594 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -67.23 -47.54 70.49 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.01 -51.92 66.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.42 1.075 . . . . 64.21 112.036 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -68.34 -27.87 66.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.27 0.628 . . . . 61.02 112.196 -174.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -66.62 -53.98 28.29 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.129 0.572 . . . . 72.45 110.329 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 44' ' ' ILE . 84.9 mt -61.05 -32.84 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.6 1.16 . . . . 75.55 110.335 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 -46.01 57.79 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.762 1.225 . . . . 64.31 111.718 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.09 -44.17 97.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.549 0.53 . . . . 61.23 110.099 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 84.9 t80 -63.32 -45.86 89.34 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 124.3 1.0 . . . . 74.13 110.333 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.29 -51.41 69.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.8 0.84 . . . . 31.22 111.798 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.86 -32.98 74.33 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.691 0.396 . . . . 72.43 110.645 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -69.03 -29.89 68.14 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.003 0.921 . . . . 41.12 110.91 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 8.4 mm-40 -76.11 -10.18 59.21 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.088 0.555 . . . . 55.53 111.131 174.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.92 11.61 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.633 0.583 . . . . 61.3 111.996 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.5 mt -109.08 147.09 32.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.762 0.825 . . . . 55.24 109.762 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.9 mmp_? -74.14 122.26 22.46 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.767 0.427 . . . . 74.02 109.969 171.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.02 115.29 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.729 -0.841 . . . . 71.44 108.729 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 3' ' ' VAL . 1.8 mp -107.88 112.95 42.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.882 -1.155 . . . . 70.53 107.882 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 8' ' ' LEU . 94.9 t -98.72 118.12 44.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 108.545 -0.909 . . . . 64.22 108.545 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 107' ' ' TYR . 70.6 mt -112.43 105.02 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 119.168 0.894 . . . . 62.52 109.816 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.14 120.05 37.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 14' ' ' ILE . 19.9 t -109.19 108.58 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.676 1.19 . . . . 72.42 108.132 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -154.74 144.35 21.45 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.162 0.505 . . . . 74.52 110.324 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -73.12 -11.97 60.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.724 -1.125 . . . . 64.41 111.102 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -103.92 114.29 28.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.208 1.003 . . . . 62.01 109.726 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 92' ' ' LEU . 44.4 mt-10 -67.32 -21.64 65.66 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.721 0.808 . . . . 73.23 112.492 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 -31.36 62.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.938 0.495 . . . . 64.45 110.444 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.26 -37.07 66.45 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.271 0.628 . . . . 53.25 110.485 171.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 89' ' ' GLU . 89.0 mt -59.07 -53.83 53.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.25 0.969 . . . . 64.22 110.47 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 31.5 mtp180 -74.45 -31.03 62.11 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.854 0.686 . . . . 74.14 112.854 -175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -60.07 -50.01 75.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.088 0.555 . . . . 65.34 110.827 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.77 -31.48 58.26 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.966 -0.561 . . . . 63.53 112.686 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.749 ' HA ' HG11 ' A' ' 106' ' ' VAL . 74.6 t80 -59.63 -58.95 6.37 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 123.663 0.785 . . . . 63.2 110.859 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 35.2 mt-10 -73.29 -32.38 64.6 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 124.256 0.972 . . . . 40.32 110.662 -172.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.82 -54.66 42.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.107 0.963 . . . . 70.02 111.611 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 104' ' ' TYR . 46.2 mttp -79.29 -26.27 42.31 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.711 0.805 . . . . 65.21 112.12 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -64.92 -38.27 90.42 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.389 0.675 . . . . 75.12 110.786 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 63.3 mttm -58.88 -35.19 72.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.607 0.763 . . . . 63.1 111.562 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -78.48 -6.34 55.09 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.066 -0.97 . . . . 72.1 111.712 -175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.21 25.04 11.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.07 -0.514 . . . . 72.04 112.639 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HD2' ' HB3' ' A' ' 99' ' ' LYS . 5.3 m-85 -103.38 134.75 46.23 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.577 -0.897 . . . . 75.4 108.577 177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 32.4 m-20 -77.18 100.34 5.74 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.426 -0.953 . . . . 60.41 108.426 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 96' ' ' TYR . 14.9 t -99.02 142.81 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.638 -0.505 . . . . 74.01 109.638 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 97.9 m-85 -125.94 140.78 52.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.483 1.513 . . . . 74.0 108.341 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.3 p -108.49 147.18 32.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.185 0.994 . . . . 73.4 108.765 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.9 p -144.66 132.64 21.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.804 0.335 . . . . 72.04 111.539 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 89' ' ' GLU . 6.0 tpm_? -55.52 -42.19 74.2 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.802 1.641 . . . . 75.32 111.011 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -169.01 -162.9 0.39 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.654 1.182 . . . . 62.34 108.784 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.76 -35.9 61.77 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.717 1.207 . . . . 63.24 113.263 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.57 -51.7 68.41 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.282 0.563 . . . . 71.05 110.983 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.6 -36.94 65.58 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.667 -1.151 . . . . 75.11 110.375 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.96 87.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.161 0.985 . . . . 73.44 111.285 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.6 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 35.4 ttmt -65.78 -35.59 81.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.214 -1.357 . . . . 72.32 110.555 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -69.7 -53.46 18.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.809 -0.632 . . . . 52.02 110.014 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -62.25 -33.01 73.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.19 0.996 . . . . 72.12 111.711 -175.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -46.88 65.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.607 0.763 . . . . 71.22 109.674 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 83.9 mttt -69.37 -33.58 73.28 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.898 0.749 . . . . 70.33 111.804 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 42.8 mt-10 -62.93 -43.49 98.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.646 0.591 . . . . 73.15 110.609 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.62 76.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.726 0.81 . . . . 64.34 111.245 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 75.6 mt -71.7 -34.77 69.9 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.517 -0.765 . . . . 63.22 110.81 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 44.6 mt-10 -62.24 -37.58 85.97 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.029 0.532 . . . . 52.44 110.912 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 47.3 mmtt -77.24 -23.83 51.26 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.926 0.491 . . . . 71.13 110.773 -177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.3 p -88.03 0.2 56.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.449 0.7 . . . . 72.33 111.817 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.6 83.27 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.925 -0.58 . . . . 72.32 113.527 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 9.5 m -75.78 104.58 6.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.646 0.779 . . . . 73.21 109.612 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -141.66 115.26 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.787 0.835 . . . . 73.24 109.157 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.43 -67.56 0.85 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.259 -0.645 . . . . 72.52 109.259 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.27 169.62 16.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.833 0.853 . . . . 72.23 110.131 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -140.26 166.02 25.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.767 1.227 . . . . 74.2 108.729 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 52.65 94.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.213 1.005 . . . . 74.44 112.24 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -73.06 -53.23 11.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.64 0.376 . . . . 74.42 111.51 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.17 -41.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.677 0.275 . . . . 72.01 110.904 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 CA--C 1.551 0.991 0 C-N-CA 123.403 0.681 . . . . 71.42 110.124 -176.237 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mmm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.52 -0.548 . . . . 72.22 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.95 162.08 16.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.169 -1.572 . . . . 63.45 109.169 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 79' ' ' ARG . 90.0 t -139.19 124.05 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 117.703 0.752 . . . . 65.31 109.256 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.86 112.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.878 -0.416 . . . . 73.52 109.878 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.58 106.78 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 124.47 1.108 . . . . 75.31 108.59 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 56' ' ' VAL . 61.5 mt -98.41 104.09 16.09 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.938 0.895 . . . . 73.51 109.918 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 18' ' ' LEU . 11.6 t -97.95 106.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.726 0.41 . . . . 53.23 109.948 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 84' ' ' ILE . 7.3 mp -87.07 103.6 15.53 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 108.366 -0.975 . . . . 63.44 108.366 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -107.76 158.92 16.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.121 0.968 . . . . 74.4 110.011 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.3 -19.49 69.09 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.834 -0.621 . . . . 35.22 112.802 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.25 154.16 24.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.877 0.338 . . . . 52.13 110.972 -171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -73.61 -25.88 60.53 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 118.355 -0.831 . . . . 52.13 112.595 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -66.62 -31.34 71.97 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.62 0.645 . . . . 63.14 110.605 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 60.1 mt -68.57 -54.3 22.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.58 -27.16 64.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.925 1.29 . . . . 53.03 112.489 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HG3' ' NH2' ' A' ' 19' ' ' ARG . 37.4 tt0 -68.2 -50.27 55.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 72.34 110.912 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 70.1 mm-40 -60.75 -33.11 72.44 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.162 0.914 . . . . 63.5 111.479 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 7' ' ' VAL . 74.1 mt -72.2 -43.74 64.03 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.598 -1.183 . . . . 75.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' ' HG3' ' A' ' 16' ' ' GLU . 8.0 tmm_? -58.95 -42.76 90.59 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.865 1.266 . . . . 72.34 110.93 177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 17' ' ' GLU . 54.3 mtpt -56.95 -52.17 66.3 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.436 1.085 . . . . 75.01 109.608 174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.5 -33.69 76.13 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 124.557 1.16 . . . . 53.15 111.848 -172.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' LEU . 93.5 t -61.34 -47.36 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.817 0.698 . . . . 63.4 110.769 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -67.35 -38.82 85.44 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.931 0.769 . . . . 71.14 110.615 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -72.96 -22.76 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.916 0.886 . . . . 75.45 111.72 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -87.01 -48.43 8.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.013 0.925 . . . . 74.15 109.129 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 14.3 t70 -152.23 114.02 2.88 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.131 -1.063 . . . . 74.55 108.131 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' ASP . 16.7 Cg_exo -68.56 -2.64 9.6 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.93 2.42 . . . . 62.02 114.393 -174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -107.18 -16.05 14.51 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.416 0.686 . . . . 65.34 111.517 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.7 t -71.71 125.84 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.933 -0.395 . . . . 65.5 109.933 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.17 146.95 49.21 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.988 0.915 . . . . 73.54 111.909 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.8 p -128.46 128.7 44.89 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.501 -0.925 . . . . 41.31 108.501 168.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.79 111.47 24.98 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 107.926 -1.139 . . . . 74.13 107.926 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' PHE . 68.8 Cg_endo -71.4 175.68 9.04 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.426 2.084 . . . . 54.44 112.889 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.8 p -64.41 -16.51 62.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.72 0.808 . . . . 71.41 111.692 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -56.54 -59.01 5.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.052 1.341 . . . . 74.33 111.389 173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 7.2 m-20 -93.1 61.89 3.47 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.873 -1.058 . . . . 71.53 111.413 -165.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.42 -40.51 96.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.121 0.968 . . . . 74.12 112.567 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -69.72 -46.76 65.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.839 -0.8 . . . . 71.24 108.839 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 33.5 mmtp -65.43 -17.59 64.66 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.426 -1.261 . . . . 72.52 112.397 -171.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 69' ' ' ILE . 83.7 t -51.57 -52.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 123.923 0.764 . . . . 65.35 110.364 174.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.7 -41.01 85.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.048 1.339 . . . . 51.34 110.924 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -48.98 77.86 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.961 0.905 . . . . 74.11 110.922 177.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 6.4 mm-40 -75.28 -22.81 57.48 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.675 0.79 . . . . 70.12 112.107 -173.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 65.2 mt -61.5 -53.93 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.666 0.787 . . . . 72.31 109.846 172.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 31.6 tt0 -65.52 -34.76 79.02 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.486 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 43' ' ' GLU . 18.3 ttmt -60.27 -48.66 80.78 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.357 0.663 . . . . 63.44 110.794 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.54 -52.1 65.87 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.777 0.673 . . . . 61.02 110.595 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HD3' HD11 ' A' ' 78' ' ' LEU . 53.4 ptt85 -66.49 -30.66 71.04 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.846 0.716 . . . . 75.55 112.163 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 2.7 tmtp? -69.97 -32.07 70.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.387 0.675 . . . . 72.23 109.472 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -91.08 -7.35 51.97 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.428 0.691 . . . . 75.43 111.64 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.14 37.36 Favored Glycine 0 C--N 1.355 1.599 0 O-C-N 123.198 0.312 . . . . 71.4 113.064 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -132.19 158.12 76.43 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.627 1.171 . . . . 71.45 110.406 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 29' ' ' VAL . 4.9 Cg_exo -76.54 170.16 20.46 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.204 1.936 . . . . 75.1 112.179 169.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.95 121.26 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.12 -1.067 . . . . 70.41 108.12 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.89 105.57 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.695 0.76 . . . . 63.22 109.26 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 6' ' ' LEU . 62.0 t -90.42 142.99 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.826 1.651 . . . . 73.45 109.708 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 61.8 m-85 -112.76 117.62 32.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.887 -1.153 . . . . 72.11 107.887 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HB2' ' A' ' 66' ' ' ALA . 84.9 t -120.7 151.77 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.403 1.481 . . . . 61.32 107.329 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -84.72 160.44 20.31 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 118.616 0.643 . . . . 73.44 110.615 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.97 -28.85 72.66 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.167 -0.47 . . . . 72.11 112.731 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.77 85.88 Favored Glycine 0 N--CA 1.478 1.496 0 C-N-CA 123.073 0.368 . . . . 53.3 112.893 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -116.03 26.52 9.9 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.145 1.378 . . . . 61.32 107.868 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.39 -38.15 88.53 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.574 1.55 . . . . 74.42 113.043 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -58.91 -46.74 87.19 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.607 0.567 . . . . 74.32 111.132 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ttm105 -60.2 -40.76 91.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.71 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -57.56 -49.88 74.92 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.516 0.726 . . . . 60.43 112.797 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -27.35 65.11 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.162 0.431 . . . . 74.01 112.162 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.41 -40.45 73.85 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.955 0.502 . . . . 73.44 111.475 172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 40' ' ' VAL . 98.8 mt -68.03 -37.05 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.433 0.693 . . . . 52.2 109.512 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.56 88.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.332 1.053 . . . . 60.2 111.11 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.81 -40.78 97.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.6 1.16 . . . . 75.34 110.756 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 69.4 t80 -66.03 -47.17 75.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.466 0.706 . . . . 73.12 110.458 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.47 -40.33 96.3 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.902 0.881 . . . . 71.12 111.599 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -67.42 -37.55 83.22 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.556 0.742 . . . . 74.02 110.424 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.04 -36.12 82.97 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.54 -0.755 . . . . 73.5 110.765 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 7.9 mm-40 -72.2 -10.48 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.421 0.688 . . . . 74.4 111.358 176.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.76 44.94 13.7 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 111.329 -0.709 . . . . 62.13 111.329 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' HD3' ' A' ' 48' ' ' ARG . 33.8 mt -116.29 154.61 29.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.723 0.809 . . . . 53.11 109.549 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HB2' HG22 ' A' ' 3' ' ' VAL . 3.3 mpt_? -74.05 112.75 10.49 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.536 -0.913 . . . . 73.11 108.536 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.19 113.52 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.574 -0.899 . . . . 52.22 108.574 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 122' ' ' ALA . 1.9 mp -111.53 112.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -102.22 112.17 34.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.558 -0.905 . . . . 34.02 108.558 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 107' ' ' TYR . 76.6 mt -109.56 110.58 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.536 0.734 . . . . 72.22 109.391 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 8' ' ' LEU . 62.6 mt -105.12 127.68 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.76 -0.459 . . . . 63.43 109.76 -176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.35 110.67 33.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.039 1.336 . . . . 74.53 108.203 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.1 t -152.62 141.63 21.24 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 123.553 0.533 . . . . 73.11 109.721 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -70.14 -27.09 64.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.559 0.744 . . . . 74.31 110.061 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -81.5 107.29 14.14 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 123.781 0.832 . . . . 71.31 109.179 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.91 -31.23 71.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.8 0.84 . . . . 61.04 109.664 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -61.32 -41.39 96.94 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.149 0.98 . . . . 74.53 111.234 175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.55 76.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.39 0.676 . . . . 64.53 110.783 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 73.7 mt -59.05 -39.1 80.99 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 73.44 110.974 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -66.17 -45.11 82.06 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.799 0.839 . . . . 72.23 110.949 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.68 -51.84 66.76 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.714 0.634 . . . . 75.13 110.127 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.88 -31.35 69.96 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.929 -1.032 . . . . 53.43 113.566 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.671 ' HA ' HG11 ' A' ' 106' ' ' VAL . 51.1 t80 -65.04 -58.71 5.38 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 110.032 -0.359 . . . . 74.12 110.032 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.5 mt-10 -72.86 -42.98 63.12 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 124.297 0.998 . . . . 73.34 111.058 -170.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 25.0 t70 -54.97 -48.37 73.32 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.633 0.773 . . . . 72.33 111.768 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.08 -34.38 56.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.228 0.611 . . . . 70.31 111.01 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -68.77 -28.13 66.51 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.279 0.632 . . . . 64.13 111.258 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 57.6 mtpt -67.19 -34.03 76.65 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.081 0.952 . . . . 54.12 110.297 173.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 36.0 mttm -80.48 0.17 34.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.429 0.692 . . . . 45.54 111.039 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.01 47.17 6.69 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.374 0.421 . . . . 52.43 112.907 176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -117.25 142.18 47.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 5.6 m-20 -78.03 100.26 6.42 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.664 -0.865 . . . . 74.41 108.664 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.0 t -102.56 140.85 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.834 0.349 . . . . 72.4 110.475 -173.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . 72.2 m-85 -126.1 135.46 51.74 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.599 1.559 . . . . 70.33 107.969 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -108.48 141.27 40.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.391 0.676 . . . . 70.44 109.43 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.6 p -130.29 132.17 45.77 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.18 0.592 . . . . 65.13 109.673 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -81.28 -18.7 44.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.682 -0.69 . . . . 71.53 111.14 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -162.11 -175.61 4.7 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.702 0.801 . . . . 72.41 110.656 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.45 -42.73 92.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.711 1.204 . . . . 75.42 112.083 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -61.48 -40.72 95.58 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.23 0.612 . . . . 65.12 110.94 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 40.6 mm-40 -62.21 -49.62 75.04 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.878 0.737 . . . . 74.34 110.903 173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.84 82.75 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.651 1.219 . . . . 61.33 111.016 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -66.56 -40.15 88.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.948 1.299 . . . . 70.23 110.738 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 117' ' ' LYS . 0.9 OUTLIER -74.4 -29.31 61.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.547 1.139 . . . . 62.22 110.72 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 107' ' ' TYR . 71.8 mmtt -70.81 -37.38 73.25 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.215 0.606 . . . . 64.3 110.931 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 mp -59.83 -40.66 89.24 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.595 0.559 . . . . 72.21 109.956 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -64.66 -37.04 86.21 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.802 0.689 . . . . 62.51 111.286 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.46 -32.9 74.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.67 0.388 . . . . 64.42 111.629 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -75.74 -51.75 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.16 0.584 . . . . 53.25 110.803 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 128' ' ' SER . 87.3 mt -68.63 -44.99 73.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.226 1.01 . . . . 74.45 112.024 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.87 -42.49 84.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 74.42 112.386 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -80.11 -15.93 56.06 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.281 0.632 . . . . 75.22 111.813 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.542 ' HB2' HG21 ' A' ' 3' ' ' VAL . 95.8 p -96.48 -19.43 19.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.129 0.789 . . . . 73.12 113.129 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.0 -14.95 2.83 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 114.03 0.372 . . . . 63.24 114.03 178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 123' ' ' LEU . 35.5 m -96.87 102.6 14.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.539 0.735 . . . . 73.43 109.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 71.05 71.95 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.21 1.404 . . . . 73.11 110.105 -165.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.72 158.8 35.49 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.889 -1.05 . . . . 72.55 111.069 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.7 123.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.129 1.372 . . . . 62.33 110.365 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -52.65 106.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.129 0.972 . . . . 73.54 112.377 -170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -65.09 127.94 33.72 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.028 1.331 . . . . 74.51 109.587 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -54.7 -47.71 73.37 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 124.158 0.911 . . . . 65.33 112.356 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.3 t60 66.88 115.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.414 1.086 . . . . 71.23 111.729 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 109.214 -0.662 . . . . 74.43 109.214 173.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 ttm . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 120.873 0.368 . . . . 72.22 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.65 -179.31 30.85 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.601 -1.0 . . . . 73.32 110.601 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 79' ' ' ARG . 81.5 t -142.44 143.93 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.833 0.853 . . . . 64.4 109.0 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.97 114.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 73.01 109.098 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.75 108.19 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.583 -0.895 . . . . 75.14 108.583 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 ' HB ' ' A' ' 56' ' ' VAL . 40.7 mt -95.7 102.34 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.667 0.787 . . . . 73.44 108.981 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 t -92.09 104.43 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.056 -0.72 . . . . 74.25 109.056 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 82' ' ' VAL . 7.3 mp -89.22 107.36 19.01 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -104.89 139.06 40.18 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.497 0.719 . . . . 54.43 110.197 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.81 -10.55 75.68 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.789 -0.641 . . . . 63.23 111.777 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' HB2' HG12 ' A' ' 14' ' ' ILE . 14.1 m-20 -127.96 125.36 39.34 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.691 -1.226 . . . . 62.14 107.691 169.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.69 -24.64 67.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.478 0.711 . . . . 55.02 111.152 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -58.3 -39.22 78.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.783 0.833 . . . . 64.32 111.263 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 11' ' ' ASP . 13.4 mm -57.45 -40.59 75.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 123.97 0.794 . . . . 72.35 110.156 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.41 79.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.698 0.799 . . . . 65.21 112.436 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -76.0 -51.19 12.89 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.399 0.68 . . . . 73.31 110.169 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -67.55 -30.43 70.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.064 0.546 . . . . 65.14 112.031 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 115' ' ' ALA . 56.8 mt -75.31 -41.7 56.26 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.391 0.276 . . . . 51.24 110.517 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -57.67 -49.67 75.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.781 0.833 . . . . 72.2 112.154 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -34.3 74.46 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.512 1.132 . . . . 74.03 110.975 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 5.2 tm-20 -76.85 -35.98 57.14 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.218 1.007 . . . . 64.14 110.879 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.37 -33.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 75.34 110.513 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.98 -28.11 66.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.088 0.555 . . . . 74.53 111.055 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -32.52 58.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.79 0.436 . . . . 73.11 110.504 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.455 ' ND1' ' HD2' ' A' ' 120' ' ' LYS . 46.6 t60 -70.07 -48.38 58.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.683 0.793 . . . . 64.03 110.139 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.61 110.31 1.64 Allowed Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.913 1.285 . . . . 74.25 108.589 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 -10.36 26.23 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.191 2.594 . . . . 54.34 113.787 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -87.36 -18.61 29.67 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.612 0.365 . . . . 73.22 110.385 -176.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 53' ' ' PRO . 71.4 t -63.56 116.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 N-CA-C 109.708 -0.479 . . . . 72.14 109.708 172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.48 133.58 44.89 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.636 -0.876 . . . . 60.21 108.636 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.635 HG22 ' HB ' ' A' ' 55' ' ' VAL . 37.3 p -136.56 119.61 16.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.541 -0.911 . . . . 62.5 108.541 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.37 122.37 37.77 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.28 -0.637 . . . . 72.02 109.28 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.48 168.57 23.97 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.362 2.041 . . . . 45.12 112.297 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.5 p -66.04 -32.76 74.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.65 . . . . 64.51 112.089 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -71.99 -23.24 61.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.358 0.663 . . . . 52.54 112.253 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -102.18 29.99 4.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.229 0.612 . . . . 65.42 110.702 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HA ' HG23 ' A' ' 40' ' ' VAL . 23.1 pttm -62.27 -17.82 59.56 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.796 0.439 . . . . 75.51 111.953 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -64.18 -37.92 89.21 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.061 0.944 . . . . 74.41 111.216 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 33.2 mmtp -83.81 -13.86 52.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.673 0.789 . . . . 72.14 112.709 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 37' ' ' LYS . 42.0 t -53.07 -45.42 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 123.464 0.478 . . . . 74.53 111.29 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.07 -39.23 85.33 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.656 0.782 . . . . 55.33 111.586 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.35 -51.91 52.38 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.302 0.641 . . . . 72.54 110.206 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 30.1 mm-40 -68.53 -25.86 65.14 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.3 -0.864 . . . . 71.24 112.058 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.17 -44.81 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.313 0.645 . . . . 65.54 109.943 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -67.87 -33.73 75.32 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.44 -0.8 . . . . 75.14 110.813 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -74.17 -39.86 62.95 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.805 0.842 . . . . 65.21 110.567 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.52 -31.09 68.04 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.386 0.675 . . . . 52.1 110.922 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 61.7 ttt180 -58.15 -48.19 81.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.008 0.923 . . . . 60.51 110.43 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.81 -40.14 79.72 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.941 -1.027 . . . . 73.12 110.41 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -86.29 -9.9 55.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.313 0.645 . . . . 64.42 111.709 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.2 13.99 76.59 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.681 0.613 . . . . 50.15 113.845 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -80.13 144.18 58.23 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.978 0.911 . . . . 62.42 111.166 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' HG2' HG22 ' A' ' 29' ' ' VAL . 57.3 Cg_endo -73.87 134.88 20.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 121.936 1.757 . . . . 73.25 110.024 161.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -118.46 122.25 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.038 -0.727 . . . . 72.42 109.038 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 31' ' ' THR . 71.6 t -96.12 105.42 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.746 0.784 . . . . 72.4 109.118 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HB ' HD23 ' A' ' 6' ' ' LEU . 90.1 t -87.82 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 124.995 1.318 . . . . 71.44 109.409 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.96 130.46 55.84 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 66' ' ' ALA . 94.9 t -123.57 134.19 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.899 1.279 . . . . 74.51 108.158 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 76.0 3.91 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.813 0.445 . . . . 72.25 109.874 -171.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.72 -85.11 0.01 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 115.772 1.069 . . . . 65.53 115.772 171.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.85 -14.23 50.92 Favored Glycine 0 C--N 1.358 1.771 0 C-N-CA 123.784 0.707 . . . . 62.42 114.762 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.429 ' HB2' HG13 ' A' ' 58' ' ' VAL . 10.5 m-20 -75.95 15.93 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.815 0.807 . . . . 74.15 111.276 171.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.0 -45.94 61.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.274 1.829 . . . . 74.42 112.254 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.85 -39.02 83.76 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.824 -1.08 . . . . 73.25 111.073 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -77.34 -35.24 54.87 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.958 . . . . 60.33 110.736 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -65.13 -34.19 77.8 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.736 0.815 . . . . 54.55 112.045 -175.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptpt -77.19 -27.56 53.61 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.698 0.399 . . . . 75.44 111.935 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -68.96 -39.92 79.18 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.031 0.443 . . . . 60.24 110.049 170.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.16 -34.97 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.355 1.062 . . . . 53.33 109.853 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -67.0 -40.21 87.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.805 0.842 . . . . 55.31 111.322 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 43.6 tt0 -64.34 -46.09 85.01 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.702 -0.681 . . . . 74.23 109.753 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 83.9 t80 -57.59 -46.21 84.32 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.13 0.894 . . . . 73.55 110.981 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.01 -41.37 91.97 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.66 0.784 . . . . 71.43 111.383 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -68.1 -33.03 73.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.237 -0.892 . . . . 73.3 110.689 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 61.1 mtpt -69.81 -28.41 65.69 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 73.14 111.147 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 12.1 mm-40 -76.68 -1.22 26.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.023 0.529 . . . . 74.14 111.868 177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.26 26.56 61.45 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.847 -0.501 . . . . 55.3 111.847 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 76' ' ' GLU . 14.7 mt -107.99 154.68 21.29 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.682 0.793 . . . . 72.04 109.214 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' HG22 ' A' ' 3' ' ' VAL . 1.2 mpp_? -82.56 146.33 29.24 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.95 -0.759 . . . . 70.22 108.95 173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.8 t -115.76 115.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 122.931 0.492 . . . . 72.42 109.709 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.9 mp -106.89 117.94 53.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 N-CA-C 108.041 -1.096 . . . . 72.35 108.041 172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 8' ' ' LEU . 85.2 t -104.57 115.19 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.939 -0.763 . . . . 72.41 108.939 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 107' ' ' TYR . 53.5 mt -111.25 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.179 0.592 . . . . 70.42 109.832 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -95.78 124.12 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.819 -0.808 . . . . 74.32 108.819 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 14' ' ' ILE . 14.7 t -110.33 106.78 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.6 m -153.42 143.95 22.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.92 -0.771 . . . . 74.41 108.92 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -84.89 31.27 0.54 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.23 0.612 . . . . 74.14 111.237 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -144.39 117.19 8.74 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.795 0.838 . . . . 62.45 108.962 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.76 -27.16 69.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.311 1.045 . . . . 72.42 112.699 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.22 -41.99 63.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.573 0.349 . . . . 74.5 110.608 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.64 -36.26 75.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.206 0.603 . . . . 70.34 110.657 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.18 -50.11 71.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.034 -0.985 . . . . 65.34 110.875 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 96' ' ' TYR . 53.3 ttt-85 -77.15 -31.59 55.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.735 0.643 . . . . 71.1 112.735 -168.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -65.84 -43.72 87.67 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.098 0.408 . . . . 65.04 110.729 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.39 -36.73 62.99 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.577 0.548 . . . . 55.12 111.876 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.764 ' HA ' HG11 ' A' ' 106' ' ' VAL . 67.1 t80 -57.87 -56.13 26.01 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.892 0.877 . . . . 72.02 110.471 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.98 -46.0 92.52 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 124.458 1.099 . . . . 62.53 110.235 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -53.72 -52.89 58.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.594 0.758 . . . . 75.01 112.498 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 67' ' ' LYS . 13.3 mptt -78.01 -30.8 50.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.026 0.53 . . . . 71.55 111.654 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.12 -34.75 78.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.131 0.573 . . . . 72.41 110.911 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -74.45 -18.76 60.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.454 1.101 . . . . 71.54 110.756 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.68 3.9 46.11 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.909 0.884 . . . . 70.35 110.854 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.61 67.88 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.233 0.444 . . . . 61.11 113.452 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -76.55 148.41 37.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.178 0.489 . . . . 64.21 110.475 -175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 27.9 t70 -88.87 108.07 19.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 96' ' ' TYR . 21.8 t -106.3 123.99 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 122.382 0.273 . . . . 73.24 111.294 -171.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.605 ' HB2' HG12 ' A' ' 83' ' ' ILE . 83.7 m-85 -97.53 154.87 17.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 108.798 -0.815 . . . . 73.14 108.798 168.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -134.42 154.94 51.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.585 0.754 . . . . 75.05 110.085 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 p -150.84 135.79 17.46 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.481 0.713 . . . . 65.22 110.572 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -84.4 -21.91 30.63 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.318 0.386 . . . . 65.25 111.232 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.07 -173.12 4.07 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.397 -0.594 . . . . 63.44 109.397 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -54.88 -44.54 74.18 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 124.291 0.994 . . . . 74.32 111.859 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.6 -50.1 63.72 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.289 0.495 . . . . 71.24 111.946 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 2.3 mp0 -69.92 -32.07 70.16 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.878 -0.601 . . . . 53.03 110.769 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -64.64 -49.35 71.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.177 0.591 . . . . 74.25 111.178 -177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 21' ' ' GLU . 3.6 ttmp? -59.9 -39.67 86.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.717 1.207 . . . . 74.43 110.951 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -60.36 -53.32 59.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.056 0.942 . . . . 74.42 109.285 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 107' ' ' TYR . 10.8 mmpt? -70.13 -30.7 67.95 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.15 -0.932 . . . . 71.52 111.335 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.18 -45.14 50.31 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 123.659 0.784 . . . . 61.22 110.96 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD2' ' ND1' ' A' ' 25' ' ' HIS . 42.3 mtmt -75.03 -26.2 59.29 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.381 0.272 . . . . 63.05 111.506 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -57.97 -48.52 79.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.681 -0.488 . . . . 71.44 109.681 164.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.13 72.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.037 0.935 . . . . 74.14 112.122 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.35 -43.67 73.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.078 0.551 . . . . 51.52 110.795 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 15.7 mt-10 -73.43 -29.37 62.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.864 0.364 . . . . 72.33 111.49 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -77.39 -27.65 52.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.873 1.269 . . . . 72.54 109.983 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' VAL . 78.4 p -78.98 -29.71 43.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.028 -0.533 . . . . 72.14 110.077 173.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.78 9.97 10.55 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 118.796 -1.002 . . . . 72.32 114.502 171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.4 p -72.28 -38.33 68.83 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.629 1.215 . . . . 72.42 110.22 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 95.7 mt 66.07 167.5 0.21 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.847 1.259 . . . . 70.44 112.179 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.55 117.14 22.93 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.516 -0.55 . . . . 62.1 109.516 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -79.57 -33.62 41.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.549 0.69 . . . . 73.03 109.663 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.412 ' HE1' ' HA ' ' A' ' 25' ' ' HIS . 36.4 p-80 -103.7 171.01 7.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.906 1.282 . . . . 64.32 109.361 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -129.86 147.96 51.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.128 -0.693 . . . . 73.35 109.128 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -111.11 116.92 31.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.29 0.636 . . . . 75.04 109.379 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -172.22 124.37 0.51 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.432 0.693 . . . . 64.41 109.962 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 124.803 1.241 . . . . 64.22 110.759 177.766 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.925 -0.398 . . . . 74.4 109.925 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.47 133.34 25.66 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.942 -0.572 . . . . 25.24 111.857 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 79' ' ' ARG . 69.0 t -120.68 131.46 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.828 0.851 . . . . 74.11 108.994 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.2 t -116.62 110.79 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.945 -0.761 . . . . 75.43 108.945 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 mt -101.33 107.82 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.084 0.954 . . . . 71.53 109.216 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.36 101.46 13.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.234 -0.654 . . . . 63.33 109.234 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.7 t -92.91 105.21 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 109.264 -0.643 . . . . 73.11 109.264 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 9.1 mp -89.48 103.05 15.72 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.678 -0.86 . . . . 63.22 108.678 177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.7 p -106.28 131.17 53.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.097 -0.705 . . . . 64.13 109.097 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.56 -32.63 57.33 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.51 -1.036 . . . . 42.33 110.51 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.07 109.07 21.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.119 -1.04 . . . . 72.41 108.647 175.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -71.59 -25.82 62.34 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.278 1.031 . . . . 73.44 111.647 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -60.11 -45.96 91.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.138 0.975 . . . . 55.35 110.426 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.431 HG21 HG11 ' A' ' 85' ' ' VAL . 56.8 mt -57.59 -39.6 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.906 -1.043 . . . . 55.12 111.082 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.87 74.55 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.04 0.756 . . . . 64.25 113.04 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 31.5 tt0 -71.11 -40.83 71.25 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.717 0.407 . . . . 71.32 110.454 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.84 -38.08 85.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.885 0.874 . . . . 64.14 111.184 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 89.0 mt -65.07 -36.83 85.57 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.994 -1.003 . . . . 52.23 110.623 174.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -64.41 -46.91 81.19 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.902 0.481 . . . . 72.12 111.16 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 59.8 mttm -54.51 -45.45 73.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.231 0.957 . . . . 73.13 109.759 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' A' ' 116' ' ' LYS . 13.8 tp10 -62.19 -39.01 91.27 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.256 -1.338 . . . . 70.53 111.887 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -66.65 -43.9 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.135 0.574 . . . . 54.15 110.929 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -69.47 -30.99 69.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.224 0.61 . . . . 62.33 111.1 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -81.47 -25.03 36.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.424 0.689 . . . . 74.11 110.615 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -70.6 -44.12 67.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.355 0.662 . . . . 74.23 109.54 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HB3' HG23 ' A' ' 29' ' ' VAL . 31.5 t70 -159.99 129.44 3.25 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.102 0.961 . . . . 65.34 109.654 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.46 -12.14 15.53 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.635 2.223 . . . . 63.34 113.876 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.59 -13.93 27.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.037 0.535 . . . . 73.45 112.264 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HG2' ' A' ' 53' ' ' PRO . 62.1 t -65.24 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.392 0.277 . . . . 65.23 110.511 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.78 143.45 34.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.488 0.715 . . . . 75.25 109.563 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 p -142.97 120.83 11.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.574 -0.528 . . . . 75.44 109.574 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.82 126.0 26.85 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.484 0.714 . . . . 74.04 109.64 -174.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.24 178.26 6.46 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.433 2.089 . . . . 64.22 113.179 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 79.9 p -60.99 -40.44 93.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.579 1.152 . . . . 73.24 111.723 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -57.1 -36.79 71.05 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.551 -1.204 . . . . 74.14 111.962 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.29 36.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.302 0.641 . . . . 64.3 111.598 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG2' HD11 ' A' ' 69' ' ' ILE . 13.6 tmtt? -55.71 -41.78 74.31 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.997 0.919 . . . . 54.24 111.575 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.9 -34.68 71.8 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.667 0.787 . . . . 65.45 109.152 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 72.0 tttt -83.81 -13.69 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.874 -1.512 . . . . 65.4 111.442 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.2 -53.53 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.423 0.689 . . . . 54.52 111.372 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -60.13 -30.45 69.3 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.84 0.856 . . . . 63.01 111.518 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -68.8 -46.09 69.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.453 -0.794 . . . . 61.33 110.415 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 13.0 mm-40 -66.83 -33.45 75.64 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.875 0.87 . . . . 73.33 111.241 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -59.2 -38.31 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.607 1.163 . . . . 75.42 110.87 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' HH22 ' A' ' 48' ' ' ARG . 4.0 tm-20 -57.07 -53.69 55.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.571 1.148 . . . . 74.22 111.41 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -77.09 -33.68 56.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 118.878 -0.582 . . . . 51.14 112.523 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.67 -40.23 72.02 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.298 0.57 . . . . 61.23 110.814 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.41 HH22 ' HG2' ' A' ' 45' ' ' GLU . 38.9 ttp180 -60.07 -53.61 55.74 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.351 -1.295 . . . . 73.32 112.792 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.84 -17.39 57.45 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.626 0.602 . . . . 64.53 112.626 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -89.12 2.67 53.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.098 0.559 . . . . 73.41 111.032 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.3 31.55 81.11 Favored Glycine 0 C--N 1.359 1.825 0 O-C-N 123.416 0.447 . . . . 73.11 113.071 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -110.93 152.38 43.58 Favored Pre-proline 0 C--O 1.244 0.765 0 C-N-CA 124.116 0.966 . . . . 71.21 110.573 -174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HG2' HG13 ' A' ' 29' ' ' VAL . 66.0 Cg_endo -76.99 158.45 34.37 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 121.545 1.497 . . . . 53.43 110.439 162.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.57 118.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.834 -1.173 . . . . 70.15 107.834 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.12 103.89 15.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.789 -0.819 . . . . 72.2 108.789 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.95 109.84 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 125.016 1.326 . . . . 52.21 109.809 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -84.98 106.62 16.62 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.161 -0.681 . . . . 64.12 109.161 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 60.4 t -101.94 145.57 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.764 -1.569 . . . . 62.31 106.764 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -85.51 130.38 34.59 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.87 -13.18 46.11 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 123.851 0.72 . . . . 61.34 113.94 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.78 -13.87 57.18 Favored Glycine 0 C--N 1.358 1.755 0 O-C-N 123.694 0.291 . . . . 42.21 112.928 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -131.9 101.03 5.27 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.746 -0.835 . . . . 71.23 108.746 170.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.6 -29.12 59.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.062 0.945 . . . . 61.12 110.766 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.99 -36.48 72.51 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.967 0.907 . . . . 74.41 111.826 -171.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HD3' ' HE3' ' A' ' 37' ' ' LYS . 12.6 mmp_? -61.56 -40.82 96.11 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 70.53 111.108 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.52 74.99 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.033 0.833 . . . . 63.22 111.61 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.79 -42.54 73.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.314 0.646 . . . . 63.42 111.126 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -59.92 -44.54 94.25 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.42 0.688 . . . . 74.51 111.195 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 37' ' ' LYS . 98.0 mt -71.64 -38.53 67.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 114.45 -1.25 . . . . 64.3 110.721 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.78 91.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.626 0.77 . . . . 65.21 111.731 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.55 -45.99 90.44 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.787 1.235 . . . . 74.25 110.8 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.0 t80 -60.49 -54.28 47.36 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.984 0.802 . . . . 71.43 109.803 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.43 77.71 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.315 -0.857 . . . . 72.23 112.206 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -65.95 -41.41 91.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.032 0.933 . . . . 65.21 110.916 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -68.69 -30.16 68.77 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.666 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' TYR . 11.6 mm-40 -78.55 -6.17 54.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.977 0.511 . . . . 72.34 111.375 176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.3 56.35 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.617 0.573 . . . . 50.33 112.855 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.0 mt -97.82 146.13 25.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.32 0.648 . . . . 74.24 110.683 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB2' HG22 ' A' ' 3' ' ' VAL . 99.4 mtt180 -69.07 106.55 2.83 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 123.911 0.757 . . . . 72.35 109.09 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.1 t -95.38 115.05 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.163 -0.68 . . . . 74.04 109.163 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 105' ' ' ASP . 2.8 mp -113.0 112.36 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.627 -0.879 . . . . 75.05 108.627 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 8' ' ' LEU . 64.8 t -98.12 112.18 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 109.09 -0.708 . . . . 74.54 109.09 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.7 104.36 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.687 -0.633 . . . . 75.03 109.434 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.19 109.83 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 109.269 -0.641 . . . . 54.0 109.269 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 14' ' ' ILE . 6.2 t -98.99 100.66 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.246 -1.02 . . . . 62.35 108.246 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m -149.9 133.8 16.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.287 1.035 . . . . 72.23 108.501 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -64.58 -27.35 68.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.647 0.379 . . . . 70.42 110.302 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.38 99.2 0.28 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.552 1.141 . . . . 65.01 110.04 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.49 -22.79 61.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.938 0.718 . . . . 62.01 112.938 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.62 -38.64 62.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.328 -0.619 . . . . 75.22 109.328 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.7 -31.16 70.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.955 0.502 . . . . 72.42 110.912 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.5 mt -60.32 -50.59 73.02 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.834 0.709 . . . . 61.34 109.614 170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -62.08 -46.72 87.87 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.647 0.61 . . . . 64.53 112.647 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.71 -49.73 71.95 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.059 0.543 . . . . 75.31 110.976 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.37 -33.96 83.65 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.705 -0.68 . . . . 70.1 112.829 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.728 ' HA ' HG11 ' A' ' 106' ' ' VAL . 91.8 t80 -63.39 -58.48 6.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.962 0.505 . . . . 54.53 110.576 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 40.0 mt-10 -71.06 -39.77 72.02 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.863 -1.062 . . . . 65.52 110.555 -171.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 102' ' ' LYS . 28.1 t70 -60.47 -53.85 52.54 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.408 0.443 . . . . 74.12 111.019 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -67.73 -33.07 74.15 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.806 0.442 . . . . 72.41 111.248 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.75 -28.62 68.55 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.344 0.658 . . . . 51.54 111.853 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 29.2 mtpp -64.14 -29.65 70.76 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.518 0.727 . . . . 52.23 111.353 175.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 0.1 OUTLIER -82.99 -16.13 48.44 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.005 0.922 . . . . 63.31 110.216 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.98 19.55 23.77 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 116.447 -0.342 . . . . 63.52 112.607 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -87.14 123.93 32.71 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 81' ' ' ILE . 21.0 m-20 -76.82 101.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.236 -0.653 . . . . 64.31 109.236 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 96' ' ' TYR . 13.7 t -100.16 137.99 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.09 0.471 . . . . 64.41 110.335 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.2 137.16 54.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.51 1.124 . . . . 75.44 108.124 173.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 p -107.89 144.69 34.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.438 0.695 . . . . 74.2 109.703 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 p -156.07 141.92 18.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.559 0.744 . . . . 73.11 109.436 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -92.68 -31.17 15.21 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.738 -0.468 . . . . 74.34 109.738 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -138.52 178.49 7.1 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 -172.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -35.74 82.06 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.995 1.318 . . . . 73.42 112.524 -174.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 7.4 m-20 -61.28 -52.83 63.09 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.38 0.272 . . . . 75.25 110.43 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 45.9 mt-10 -58.01 -47.22 83.7 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.274 0.984 . . . . 72.53 110.754 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.63 89.26 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.437 -1.256 . . . . 65.21 111.823 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.577 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 39.4 ttmt -63.8 -37.04 85.9 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.694 1.198 . . . . 72.11 111.444 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 113' ' ' ASP . 95.3 mttt -65.77 -51.61 57.71 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 74.55 110.019 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 64.9 mmtt -66.37 -27.82 68.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.22 -0.9 . . . . 72.21 111.411 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.0 tp -69.43 -45.02 70.13 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.894 -1.048 . . . . 74.14 110.823 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 94.3 mttt -71.74 -35.24 70.07 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.359 0.412 . . . . 72.42 110.791 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -57.01 -34.56 68.28 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.221 0.608 . . . . 50.34 111.07 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.54 -37.81 59.75 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.265 1.026 . . . . 64.02 111.876 176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.32 -31.47 70.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.641 0.776 . . . . 72.15 111.087 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 120' ' ' LYS . 50.0 mt-10 -67.51 -26.53 66.38 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.105 0.962 . . . . 73.14 112.258 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -67.05 -33.72 76.14 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.534 0.734 . . . . 75.42 112.122 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 p -83.77 -21.79 32.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.452 0.701 . . . . 72.24 111.214 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.0 -111.22 1.13 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.035 -1.626 . . . . 64.14 109.035 -171.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 t 55.86 28.45 12.48 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.752 1.221 . . . . 71.21 112.528 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.13 167.32 13.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.956 0.903 . . . . 71.42 111.297 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -123.62 98.62 5.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.244 1.018 . . . . 74.21 108.266 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -68.18 91.36 0.36 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.575 -0.898 . . . . 73.22 108.575 174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -68.07 156.37 37.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.315 0.646 . . . . 62.23 110.911 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.34 -20.99 63.86 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.382 0.673 . . . . 73.4 111.233 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.52 120.64 36.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.065 0.546 . . . . 71.43 111.209 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -127.9 3.92 5.98 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.283 1.033 . . . . 75.31 109.506 168.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 124.951 1.3 . . . . 71.13 108.161 176.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.237 -0.282 . . . . 72.3 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.22 172.12 17.83 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.903 -0.59 . . . . 61.32 111.635 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 79' ' ' ARG . 62.0 t -137.05 125.08 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.899 0.88 . . . . 74.43 109.419 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.37 112.13 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.888 -0.782 . . . . 51.11 108.888 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 HG22 ' A' ' 55' ' ' VAL . 26.6 mt -99.42 105.94 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.652 1.181 . . . . 72.02 108.84 -176.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 56' ' ' VAL . 41.4 mt -97.02 100.84 12.33 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.202 -1.036 . . . . 74.43 108.202 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 9' ' ' THR . 48.0 t -93.51 103.65 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 8.2 mp -89.86 105.45 17.81 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.534 1.133 . . . . 74.44 108.748 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 7' ' ' VAL . 56.7 p -106.92 141.12 38.64 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.087 0.47 . . . . 63.52 110.517 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.11 -0.3 90.17 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.017 -0.992 . . . . 71.12 112.215 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -147.68 136.62 22.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.048 0.939 . . . . 62.02 110.174 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' HB2' HH12 ' A' ' 59' ' ' ARG . 36.3 tt0 -73.46 -37.47 65.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.164 0.986 . . . . 64.21 111.959 -175.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -39.56 85.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.758 0.823 . . . . 70.45 110.115 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.558 HG21 HG11 ' A' ' 85' ' ' VAL . 67.8 mt -61.2 -43.58 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.392 0.677 . . . . 74.25 110.58 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.49 72.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.487 0.715 . . . . 63.23 111.609 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -68.85 -38.53 79.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 55.21 111.703 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.37 -35.35 80.11 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.403 0.681 . . . . 75.35 111.531 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . 71.5 mt -70.47 -48.88 53.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.231 -0.655 . . . . 64.23 109.231 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -52.7 -49.6 65.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.944 1.698 . . . . 60.3 113.084 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -69.21 -33.19 72.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.71 0.804 . . . . 70.13 111.661 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 116' ' ' LYS . 0.8 OUTLIER -72.2 -35.69 69.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.982 0.513 . . . . 74.52 111.677 177.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.93 -37.8 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.155 0.582 . . . . 75.53 110.945 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -64.92 -36.1 83.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.857 0.463 . . . . 75.44 111.084 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -87.47 -12.19 46.77 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.577 0.751 . . . . 72.12 112.033 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -78.36 -47.01 18.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.139 -1.06 . . . . 55.42 108.139 171.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 29' ' ' VAL . 16.5 t70 -158.95 120.93 1.91 Allowed Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.683 -1.144 . . . . 61.24 108.374 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.97 -2.38 12.06 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.064 2.509 . . . . 74.34 113.159 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -100.42 -4.08 29.69 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 62.23 110.886 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 53' ' ' PRO . 22.9 t -80.13 119.46 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.184 -0.673 . . . . 62.33 109.184 173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -78.77 133.32 37.11 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.513 0.725 . . . . 63.31 110.506 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 55' ' ' VAL . 31.3 p -119.24 120.14 36.15 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.736 -0.839 . . . . 71.43 108.736 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 113.36 20.84 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.909 0.884 . . . . 60.11 109.569 -168.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.84 -179.22 5.13 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.683 2.255 . . . . 75.14 113.721 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 59' ' ' ARG . 22.3 p -68.6 -27.12 65.77 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.175 0.99 . . . . 54.55 113.419 -173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -68.43 -30.81 69.79 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.316 0.579 . . . . 74.02 110.519 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.0 m-20 -90.59 44.49 1.2 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.415 1.086 . . . . 42.43 109.661 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.825 0.85 . . . . 71.41 112.287 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -75.93 -37.46 58.7 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.76 0.824 . . . . 60.02 109.28 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 6.1 tmtt? -62.67 -27.33 69.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.968 1.307 . . . . 72.43 110.96 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 36' ' ' ASP . 85.8 t -52.95 -51.07 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.061 0.944 . . . . 73.43 110.787 175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -54.79 -40.2 69.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.657 1.183 . . . . 72.44 111.405 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 29.9 mm-40 -66.99 -52.61 40.54 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.103 -0.953 . . . . 72.4 110.592 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 39' ' ' LYS . 4.5 mm-40 -68.07 -24.41 65.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.631 0.582 . . . . 73.11 112.114 -172.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 40' ' ' VAL . 88.1 mt -62.43 -46.89 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.18 0.592 . . . . 75.1 109.876 172.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 43.6 tt0 -68.56 -36.3 78.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.975 -0.557 . . . . 52.23 110.876 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 61.0 mttm -68.3 -31.06 70.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.26 0.624 . . . . 74.41 110.296 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.78 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.771 0.829 . . . . 71.12 111.32 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.76 ' HD2' ' HB3' ' A' ' 76' ' ' GLU . 71.0 mtp180 -63.93 -51.04 66.27 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.435 0.636 . . . . 63.34 109.807 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.61 -39.92 94.58 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.872 -1.513 . . . . 73.32 111.839 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -90.57 -11.79 38.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.739 . . . . 64.35 111.25 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.59 34.13 60.26 Favored Glycine 0 C--N 1.358 1.774 0 O-C-N 123.421 0.451 . . . . 74.51 112.773 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 21.0 mmt180 -118.52 159.99 41.71 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.194 0.997 . . . . 72.12 111.969 -173.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 29' ' ' VAL . 84.7 Cg_endo -80.91 169.39 16.47 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.298 1.999 . . . . 60.24 112.543 167.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.93 121.91 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.301 -1.0 . . . . 72.34 108.301 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' THR . 18.1 t -96.16 104.35 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.431 -0.581 . . . . 74.35 109.431 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 6' ' ' LEU . 39.2 t -91.31 115.38 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.353 1.061 . . . . 62.21 109.713 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -86.21 107.93 18.13 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.153 -0.684 . . . . 73.13 109.153 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG11 ' HB2' ' A' ' 66' ' ' ALA . 48.5 t -110.42 152.69 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 125.516 1.526 . . . . 75.13 108.835 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.677 ' HG2' HG21 ' A' ' 34' ' ' THR . 21.4 mmt180 -80.27 155.6 27.23 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.986 -0.447 . . . . 73.33 110.128 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -35.52 92.14 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 123.513 0.508 . . . . 70.44 112.896 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.13 79.78 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 122.897 0.284 . . . . 75.25 112.991 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.61 26.08 4.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.998 0.919 . . . . 63.11 110.046 176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.15 -23.9 64.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.602 0.361 . . . . 71.4 111.115 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.11 -30.01 63.33 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.824 0.703 . . . . 73.43 111.058 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 69' ' ' ILE . 97.2 mtt180 -75.77 -36.4 59.84 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.833 -0.432 . . . . 72.03 109.833 171.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' HG11 ' A' ' 58' ' ' VAL . . . -67.29 -37.37 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.697 0.799 . . . . 71.43 112.109 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -68.9 -28.67 66.89 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.918 0.487 . . . . 53.52 111.516 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.21 -36.71 58.48 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.906 0.482 . . . . 74.12 111.579 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 65' ' ' ARG . 66.1 mt -65.34 -38.89 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.697 -0.853 . . . . 63.11 108.697 172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -64.04 -46.5 84.14 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.349 -1.296 . . . . 74.42 110.793 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 11.3 tp10 -64.03 -45.56 88.33 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.82 -0.627 . . . . 65.41 110.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 89.7 t80 -57.73 -50.54 72.86 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.686 0.616 . . . . 61.14 110.302 177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.71 74.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.635 1.174 . . . . 55.23 112.561 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.57 -36.71 65.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.699 0.799 . . . . 45.43 110.018 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 29.9 mtpp -71.11 -24.91 62.39 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.319 1.048 . . . . 63.43 110.917 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 15.6 mm-40 -72.72 -13.71 61.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.248 1.019 . . . . 62.32 111.369 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.13 21.52 41.57 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 116.31 -0.405 . . . . 33.54 112.5 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.73 157.85 17.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.486 0.714 . . . . 71.33 110.288 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' HG22 ' A' ' 3' ' ' VAL . 2.6 mpt_? -83.33 125.7 31.92 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.133 -1.062 . . . . 74.45 108.133 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 HG11 ' HB1' ' A' ' 70' ' ' ALA . 60.7 t -95.66 115.29 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 122.885 0.474 . . . . 75.24 109.825 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -112.63 114.72 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.007 -1.109 . . . . 71.12 108.007 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.6 t -103.15 114.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.633 0.773 . . . . 62.41 109.044 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG12 ' HB2' ' A' ' 107' ' ' TYR . 62.0 mt -108.3 109.27 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.953 0.501 . . . . 64.55 110.444 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mt -91.15 123.95 43.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.445 -0.946 . . . . 64.12 108.445 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 14' ' ' ILE . 6.6 t -116.63 101.38 12.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.182 -1.044 . . . . 64.34 108.182 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.1 m -151.11 138.91 19.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.116 -1.068 . . . . 70.23 108.116 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.99 -19.95 65.8 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.727 0.411 . . . . 74.11 110.737 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.34 116.38 23.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.902 0.881 . . . . 71.44 110.295 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.01 -44.65 78.87 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.317 1.047 . . . . 73.0 113.039 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -66.76 -31.33 71.89 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.664 0.385 . . . . 71.13 110.397 -173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.75 -40.51 76.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.251 0.62 . . . . 74.33 110.979 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.67 -54.75 19.88 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.504 0.721 . . . . 73.34 111.418 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.3 mtp85 -74.62 -34.56 62.82 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.454 1.101 . . . . 62.34 112.05 -166.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.28 -41.35 63.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.468 0.307 . . . . 73.42 110.588 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.1 -34.58 86.89 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.929 -0.468 . . . . 72.1 111.929 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.713 ' HA ' HG11 ' A' ' 106' ' ' VAL . 60.8 t80 -60.43 -59.61 5.13 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 124.473 1.109 . . . . 70.42 110.073 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.73 -31.18 69.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.132 0.895 . . . . 74.44 111.831 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 34.8 t70 -63.63 -52.56 60.28 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.7 0.625 . . . . 73.13 111.451 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.36 -31.75 54.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.326 0.25 . . . . 71.22 110.995 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.52 -37.13 84.37 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.694 0.798 . . . . 73.32 111.932 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 98' ' ' ASP . 21.5 pttp -73.57 -12.67 60.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.442 0.697 . . . . 54.34 111.042 177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -99.02 10.73 40.86 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.172 0.989 . . . . 72.5 110.698 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.84 0.93 89.1 Favored Glycine 0 C--N 1.355 1.635 0 CA-C-N 116.124 -0.489 . . . . 75.21 114.237 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -86.73 113.5 22.63 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.988 -1.116 . . . . 62.11 107.988 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' ILE . 14.6 t70 -69.1 105.57 2.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.129 0.572 . . . . 74.31 110.455 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.713 HG11 ' HA ' ' A' ' 96' ' ' TYR . 25.8 t -98.9 136.15 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.964 0.411 . . . . 74.42 111.087 -172.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 83' ' ' ILE . 97.1 m-85 -113.39 144.91 41.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.442 1.097 . . . . 74.42 108.067 165.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.7 p -125.42 152.47 44.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.36 0.664 . . . . 73.44 109.711 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.8 p -157.2 142.84 17.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.679 -0.691 . . . . 75.02 110.107 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -69.91 -49.88 47.7 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.463 -0.94 . . . . 63.22 108.463 170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -135.46 178.51 6.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.623 -0.717 . . . . 65.12 111.616 -163.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -47.97 72.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.901 1.68 . . . . 71.31 113.147 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.67 -45.2 81.85 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.317 0.58 . . . . 71.02 111.494 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -70.27 -44.47 68.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.678 -1.146 . . . . 71.32 110.67 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.56 76.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.43 1.092 . . . . 62.41 112.138 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 34.7 ttmt -72.86 -43.26 62.8 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.814 1.246 . . . . 65.1 110.818 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.83 -32.96 71.65 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.575 -0.739 . . . . 64.42 110.227 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 121' ' ' GLU . 4.6 mmtm -75.38 -25.77 57.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.851 0.86 . . . . 70.22 111.308 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.6 tt -74.29 -38.47 63.38 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.925 -0.769 . . . . 73.43 108.925 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 43.8 mtpt -60.28 -31.47 70.27 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.33 -0.85 . . . . 43.43 111.836 175.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 68.8 mm-40 -53.0 -55.16 25.68 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.835 0.709 . . . . 62.05 109.721 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -72.92 -31.45 64.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.369 -1.287 . . . . 62.44 112.485 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 29' ' ' VAL . 96.9 mt -61.78 -46.03 91.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.245 0.618 . . . . 75.4 110.17 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.51 ' HB3' HD23 ' A' ' 129' ' ' LEU . 26.5 mt-10 -77.15 -27.74 53.93 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.561 -0.745 . . . . 65.35 111.934 -178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 125' ' ' LYS . 9.8 mmpt? -69.14 -32.01 71.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.712 0.405 . . . . 75.42 111.256 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.1 p -75.99 -26.56 56.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.698 0.285 . . . . 74.11 111.282 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.02 2.75 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.961 -0.563 . . . . 73.53 113.231 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 m -74.69 76.93 2.04 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.545 0.688 . . . . 63.44 110.963 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 124' ' ' GLU . 96.7 mt -83.42 153.67 24.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.16 0.984 . . . . 62.03 110.808 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -95.64 52.36 1.35 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.118 0.967 . . . . 73.13 108.739 167.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.424 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 29.2 t-80 64.18 -161.67 0.28 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.579 1.152 . . . . 72.12 110.171 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.424 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 74.8 m80 -80.29 13.98 2.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.173 0.989 . . . . 71.15 112.592 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -75.54 78.93 2.55 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 122.025 0.917 . . . . 71.44 109.657 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -149.61 -58.67 0.2 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 105.156 -2.164 . . . . 75.33 105.156 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -161.12 106.29 1.36 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.208 -1.36 . . . . 54.01 107.891 167.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.252 1.208 0 N-CA-C 108.581 -0.896 . . . . 71.22 108.581 172.769 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtm . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.737 -0.468 . . . . 74.42 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.62 135.7 8.06 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.858 -0.897 . . . . 55.31 110.858 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.684 HG22 ' HB2' ' A' ' 79' ' ' ARG . 40.7 t -142.94 127.18 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.136 0.975 . . . . 74.22 108.884 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.61 111.96 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.335 -0.617 . . . . 75.12 109.335 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.16 108.67 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.321 1.049 . . . . 50.43 109.239 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HB ' ' A' ' 56' ' ' VAL . 32.9 mt -96.51 101.9 13.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.658 0.783 . . . . 61.23 109.214 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 119' ' ' LEU . 45.6 t -97.91 105.55 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.744 -0.465 . . . . 61.14 109.744 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 7.9 mp -88.22 100.26 12.84 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.142 -0.688 . . . . 74.42 109.142 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 HG23 HG12 ' A' ' 7' ' ' VAL . 69.2 p -106.25 135.05 48.41 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.012 -0.736 . . . . 74.23 109.012 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -38.33 95.82 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.759 0.662 . . . . 44.14 112.63 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' HG13 ' A' ' 14' ' ' ILE . 4.3 m-20 -113.77 136.71 52.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.241 1.016 . . . . 72.31 109.094 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -67.11 -25.3 66.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.684 0.794 . . . . 55.51 110.772 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -53.07 -48.53 67.65 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.447 0.699 . . . . 74.34 110.138 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 11' ' ' ASP . 49.4 mt -61.91 -46.58 96.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-N 114.958 -1.019 . . . . 73.05 109.595 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.86 69.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.476 0.71 . . . . 72.43 112.565 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -72.46 -44.06 62.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.193 0.997 . . . . 72.44 111.704 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.86 -30.07 58.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.67 0.388 . . . . 54.3 111.335 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 119' ' ' LEU . 43.8 mt -66.71 -34.22 77.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.789 0.436 . . . . 74.5 110.87 172.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 49.7 ttt-85 -56.87 -43.22 81.0 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.189 0.596 . . . . 63.31 110.763 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -59.15 -44.99 92.11 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.32 1.012 . . . . 61.54 110.393 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.427 0.691 . . . . 63.51 111.706 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.3 t -64.02 -47.64 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.96 0.904 . . . . 72.35 110.954 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 19' ' ' ARG . 21.4 mm-40 -72.66 -32.81 66.12 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.922 0.489 . . . . 71.44 111.811 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -74.19 -41.86 60.77 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.858 0.463 . . . . 74.1 110.892 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -67.69 -36.66 81.08 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.964 -0.562 . . . . 72.3 109.946 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.4 t70 -155.73 123.79 2.88 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.83 0.452 . . . . 65.33 111.489 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.91 -12.75 9.58 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.683 2.255 . . . . 61.22 113.031 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -76.56 -19.09 58.27 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.206 0.602 . . . . 62.13 111.135 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 53' ' ' PRO . 4.3 t -72.84 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.108 0.563 . . . . 74.44 110.836 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -83.26 148.72 27.23 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.233 -0.654 . . . . 74.31 109.233 167.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.7 p -136.43 126.28 25.77 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.128 -0.693 . . . . 75.12 109.128 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.94 121.74 11.63 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.61 0.764 . . . . 73.24 109.714 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.51 179.56 5.69 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.69 2.26 . . . . 64.03 113.403 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.435 HG21 ' HG3' ' A' ' 59' ' ' ARG . 33.8 p -63.55 -35.76 81.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.568 1.147 . . . . 52.04 112.492 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -67.42 -13.48 62.06 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.55 0.74 . . . . 71.24 112.445 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -120.74 34.07 5.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.03 0.932 . . . . 65.4 110.108 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HA ' HG23 ' A' ' 40' ' ' VAL . 14.1 tmtt? -62.47 -30.99 71.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.625 0.77 . . . . 62.22 110.903 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.57 -27.85 67.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.565 0.746 . . . . 74.42 111.004 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -83.68 -21.76 32.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.303 0.641 . . . . 75.21 111.38 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 37' ' ' LYS . 37.9 t -52.56 -48.06 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.095 0.958 . . . . 73.02 112.379 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -56.26 -41.79 76.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.298 0.639 . . . . 73.41 111.373 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -69.23 -43.77 73.39 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.232 -0.895 . . . . 75.03 110.263 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.41 -28.31 64.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.68 0.792 . . . . 60.42 112.316 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -65.85 -47.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.909 -0.774 . . . . 74.14 108.909 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -58.51 -40.66 83.49 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.877 0.736 . . . . 75.4 111.254 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -65.87 -50.73 63.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.222 1.009 . . . . 74.23 111.717 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.13 88.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.429 0.692 . . . . 72.03 110.685 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.551 ' HG3' HD21 ' A' ' 78' ' ' LEU . 74.8 ttt-85 -59.66 -41.57 90.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.209 1.403 . . . . 72.11 111.608 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -61.55 -32.13 72.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.217 1.007 . . . . 64.3 111.176 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -96.66 2.04 51.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.481 0.712 . . . . 75.12 111.47 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.94 48.39 66.4 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.244 -0.343 . . . . 55.2 112.244 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -135.16 155.85 78.62 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.109 0.964 . . . . 64.42 111.268 -167.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 29' ' ' VAL . 86.1 Cg_endo -77.08 163.3 30.89 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.68 2.253 . . . . 72.21 113.631 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.97 121.26 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.01 -1.45 . . . . 64.03 107.36 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 HG11 ' A' ' 29' ' ' VAL . 94.4 t -94.76 106.18 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.679 -0.86 . . . . 64.02 108.679 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.577 HG11 HD13 ' A' ' 69' ' ' ILE . 53.4 t -89.31 110.18 21.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.581 -1.191 . . . . 63.42 108.977 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -81.06 106.28 12.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.657 0.741 . . . . 73.25 109.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 58.4 t -102.95 155.54 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 125.58 1.552 . . . . 65.12 108.05 175.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HG3' HG21 ' A' ' 34' ' ' THR . 46.4 mtp85 -72.9 149.24 43.62 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.486 -0.759 . . . . 71.42 111.138 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 8' ' ' LEU . . . -78.33 77.35 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.621 -1.392 . . . . 61.13 109.621 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.54 -24.05 0.65 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.103 -0.799 . . . . 54.4 111.103 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.16 72.07 8.17 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.619 0.723 . . . . 63.12 110.107 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.16 -28.76 69.63 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.841 -1.072 . . . . 63.43 110.097 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 5.1 tp10 -58.97 -48.91 79.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.657 1.183 . . . . 71.15 110.546 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -72.98 -41.12 64.7 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.733 -0.667 . . . . 61.44 110.831 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.35 83.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.57 0.748 . . . . 33.25 112.081 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 55.5 pttt -74.2 -39.58 63.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.374 0.67 . . . . 72.12 111.075 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -72.93 -47.29 46.91 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.355 0.662 . . . . 71.13 111.26 -173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HD13 HG11 ' A' ' 56' ' ' VAL . 71.5 mt -69.13 -33.2 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.809 -0.632 . . . . 74.12 110.339 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 104' ' ' TYR . . . -68.41 -40.63 81.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.374 0.67 . . . . 74.34 111.634 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.27 -40.76 87.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.407 1.083 . . . . 61.41 110.529 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -62.08 -56.55 17.79 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.162 -0.681 . . . . 73.45 109.162 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.67 79.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.983 1.313 . . . . 32.44 113.541 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -68.91 -43.5 75.08 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 120.971 0.415 . . . . 64.33 110.431 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -76.18 -15.46 60.05 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.459 -0.791 . . . . 74.13 110.955 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.75 -13.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.798 0.686 . . . . 73.55 111.04 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.0 34.74 41.15 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.315 -0.402 . . . . 74.22 112.257 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HG3' ' A' ' 48' ' ' ARG . 34.9 mt -107.85 150.66 26.76 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.323 0.649 . . . . 72.23 110.174 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.684 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.07 118.57 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 171.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 104' ' ' TYR . 24.9 t -104.02 115.42 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.217 -1.031 . . . . 71.1 108.217 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 105' ' ' ASP . 1.8 mp -110.45 113.35 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.639 -1.245 . . . . 63.42 107.639 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' HG22 ' A' ' 106' ' ' VAL . 58.9 t -101.07 112.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.864 -0.791 . . . . 64.35 108.864 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 7' ' ' VAL . 65.6 mt -107.42 104.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.688 -0.856 . . . . 73.04 108.688 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -93.83 110.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.737 -0.838 . . . . 64.11 108.737 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 14' ' ' ILE . 13.8 t -95.48 101.08 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 108.951 -0.759 . . . . 63.22 108.951 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m -153.3 140.66 19.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.899 1.28 . . . . 71.45 108.063 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -81.7 -1.97 48.82 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.369 0.668 . . . . 73.34 111.779 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -102.28 116.85 33.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.817 0.847 . . . . 62.14 109.291 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG3' HH21 ' A' ' 110' ' ' ARG . 3.2 mp0 -67.21 -28.65 68.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.62 1.168 . . . . 55.24 112.021 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -74.14 -33.1 63.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.022 0.529 . . . . 61.52 111.032 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.86 -34.49 69.27 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.021 0.528 . . . . 75.05 110.426 174.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 -47.06 79.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.381 -0.827 . . . . 72.22 109.73 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.437 1.095 . . . . 72.13 112.253 -168.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -62.86 -42.49 99.77 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.789 0.436 . . . . 72.35 110.835 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.82 -29.1 61.62 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 116.384 -0.371 . . . . 74.41 112.238 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.722 ' HA ' HG11 ' A' ' 106' ' ' VAL . 88.9 t80 -66.58 -60.53 2.64 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 122.968 0.507 . . . . 74.31 111.527 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 39.3 mt-10 -71.95 -37.61 69.95 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.665 0.603 . . . . 74.45 111.064 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.44 -53.25 59.85 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.605 0.565 . . . . 73.52 111.205 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -70.54 -32.6 70.1 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.415 0.686 . . . . 75.21 110.496 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -65.58 -29.28 69.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.825 0.85 . . . . 75.32 111.911 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 65.8 mttm -65.08 -34.86 79.42 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.107 0.563 . . . . 71.01 111.098 173.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -73.64 -16.18 61.23 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.912 -0.585 . . . . 71.22 110.891 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.01 13.26 40.28 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.245 -0.434 . . . . 50.04 113.131 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.553 ' CE2' ' HB1' ' A' ' 70' ' ' ALA . 11.1 m-30 -80.09 128.98 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.995 -0.743 . . . . 73.32 108.995 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' HG13 ' A' ' 81' ' ' ILE . 5.6 m-20 -71.77 101.27 2.55 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.104 -0.702 . . . . 73.15 109.104 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' HA ' ' A' ' 96' ' ' TYR . 18.1 t -100.74 125.43 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.876 -0.416 . . . . 71.23 109.876 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.46 141.43 34.34 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.491 -0.929 . . . . 71.24 108.491 170.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -107.55 129.61 54.96 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.474 -0.936 . . . . 74.24 108.474 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.7 p -141.57 136.0 30.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.304 0.642 . . . . 63.35 109.323 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 89' ' ' GLU . 7.3 mpt_? -84.59 -29.41 25.84 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.98 0.512 . . . . 64.51 110.793 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -149.18 174.05 12.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.483 -0.781 . . . . 61.35 111.643 -164.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -38.57 89.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.04 1.336 . . . . 55.52 112.06 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.85 -49.53 70.88 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.583 0.753 . . . . 74.25 110.73 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 19.1 tp10 -70.19 -46.61 64.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.566 -1.197 . . . . 54.31 110.908 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.98 76.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.339 1.055 . . . . 74.22 112.377 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.19 -44.33 83.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.097 1.359 . . . . 75.52 111.426 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.45 -48.19 80.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.077 -0.965 . . . . 72.42 109.129 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 8.6 mmpt? -62.3 -39.13 91.95 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.752 -1.113 . . . . 72.2 111.304 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 7' ' ' VAL . 50.7 mt -59.05 -54.57 45.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.55 1.14 . . . . 75.22 111.161 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.83 -32.6 72.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.161 -0.927 . . . . 42.41 111.839 -172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 47.6 mt-10 -64.34 -42.51 96.21 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.161 0.913 . . . . 64.12 110.353 170.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.19 -29.65 67.68 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.028 0.931 . . . . 74.44 111.796 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 119' ' ' LEU . 60.7 mt -74.61 -26.92 60.22 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.169 0.988 . . . . 73.22 110.409 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.03 -34.37 59.67 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.848 -0.615 . . . . 74.25 110.413 169.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 75.1 mmtt -69.74 -26.76 64.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.415 0.686 . . . . 53.34 111.309 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.645 ' HA ' HG21 ' A' ' 3' ' ' VAL . 83.3 p -78.89 -6.95 57.44 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.082 0.553 . . . . 63.21 112.249 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.41 1.39 88.49 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.77 -0.461 . . . . 34.51 112.754 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.9 m -64.58 -47.35 79.0 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.352 0.661 . . . . 51.12 109.496 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 26' ' ' ASP . 3.6 mm? -117.35 163.34 16.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.985 -1.007 . . . . 70.14 109.914 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.73 148.17 13.97 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.069 -1.423 . . . . 72.2 107.714 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 55.19 74.34 0.37 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.182 0.926 . . . . 65.11 110.251 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -55.38 -49.11 73.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.029 -0.73 . . . . 71.24 109.029 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 60.0 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.88 1.272 . . . . 74.11 111.741 174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -116.03 145.51 42.93 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.488 0.715 . . . . 44.14 109.913 176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -114.91 142.01 47.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.105 0.962 . . . . 73.22 108.813 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 33.2 m170 . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 108.898 -0.778 . . . . 72.42 108.898 172.453 . . . . . . . . 0 0 . 1 stop_ save_